CANVAS

Mendelian MONDO:0044720 Pathograph 77 Show in embeddings browser Hereditary Ataxia

CANVAS is an autosomal recessive RFC1-related neurodegenerative disorder characterized by sensory neuronopathy, cerebellar dysfunction and bilateral vestibular hypofunction. This entry includes the broader RFC1 spectrum, in which sensory neuropathy with or without cough may precede or remain unaccompanied by the complete triad. Neurological onset is usually in adulthood; a large cohort spanned ages 25–80 years. Chronic cough can precede imbalance by decades. Most affected individuals carry biallelic intronic repeat expansions, commonly AAGGG; rare individuals carry an expansion in trans with a truncating, splice or deletion allele. Sensory ganglion neuronal loss and Purkinje cell depletion are established pathological features. Clinical sensory loss may be length-dependent or non-length-dependent, and unrelated hearing loss can coexist. The molecular mechanism remains unresolved: structural-repeat effects, altered RNA processing, repeat-derived products, synaptic dysfunction and context-dependent RFC1 reduction have different levels of experimental support. Dedicated repeat testing is needed; coding sequencing can identify a second allele when only one expansion is found.

Ask OpenScientist

Ask a research question about CANVAS. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

🔗

Mappings

MONDO

MONDO:0044720 cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome

MONDO:0044720 is the exact disease concept — an autosomal recessive syndromic cerebellar ataxia caused by variation in RFC1, characterized by late-onset cerebellar dysfunction, bilateral vestibulopathy, and axonal sensory neuropathy.

👪

Inheritance

Autosomal recessive HP:0000007

Most cases carry two pathogenic repeat expansions; rare cases are compound heterozygous for an expansion and another pathogenic RFC1 allele. Pseudodominant pedigrees reflect frequent carrier alleles and do not establish dominant inheritance. Penetrance and presentation depend on age, repeat configuration and incompletely understood modifiers.

Autosomal recessive inheritance

Show evidence (2 references)

PMID:39230846 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We describe pseudodominance in two families affected with RFC1 disorder (10 affected, 5 oligo/asymptomatic individuals)."

Documents actual multigenerational families, including oligo/asymptomatic biallelic relatives.

PMID:36289003 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We identified 7 patients from 5 unrelated families with clinically defined CANVAS carrying a heterozygous (AAGGG)n expansion together with a second truncating variant in trans in RFC1"

Establishes compound heterozygous expansion/truncating genotypes.

◈

Mechanistic Hypotheses

Context-dependent RFC1 loss of function

rfc1_loss_of_function EMERGING

Evidence balance 1 support 3 refute

Tested truncating alleles reduce RNA and protein. A 2025 preprint proposes smaller tissue-specific transcript reductions in repeat-only disease, whereas published cortical-like cell models and earlier tissue studies found preserved expression. A general protein-loss mechanism and the identity of vulnerable-cell intermediates remain unproven.

Pathograph links

Biallelic RFC1 Intronic Repeat Expansion -> Context-Dependent Reduction of RFC1 Transcript Abundance UNKNOWN In the unreviewed 2025 preprint, isogenic deletion of the repeat-containing region increased transcript abundance in sensory and motor neurons; preserved-expression studies limit generalization.

Context-Dependent Reduction of RFC1 Transcript Abundance -> Delayed Repair of Platinum-Induced DNA Damage UNKNOWN Reduced expression and altered platinum response co-occur in the preprint, but expression-specific rescue was not performed.

Show evidence (4 references)

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml SUPPORT DIRECT PRIMARY RESULT In Vitro

"expression could only be detected when comparing CANVAS lines with their isogenic corrected counterpart, but not when comparing CANVAS lines with non-isogenic controls"

Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Motor-neuron qPCR showed about 23% lower expression versus isogenic controls; sensory-neuron reduction was about 15%.

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml REFUTE DIRECT PRIMARY RESULT In Vitro

"we were unable to demonstrate a significant effect of the repeat expansion on RFC1 protein."

Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). The preprint does not establish reduced protein abundance.

PMID:30926972 REFUTE DIRECT PRIMARY RESULT Human Clinical

"does not affect RFC1 expression in patient peripheral and brain tissue, suggesting no overt loss of function"

Original bulk-tissue results argue against a universal expression-loss model.

+ 1 more reference

Repeat-intrinsic DNA and RNA structural effects

repeat_structural_toxicity EMERGING

Evidence balance 2 support

G-quadruplex and triplex formation, replication stalling and reporter translation effects are experimentally observed in defined systems. Their contribution at the endogenous locus in postmitotic vulnerable neurons remains hypothetical.

Pathograph links

Biallelic RFC1 Intronic Repeat Expansion -> Repeat DNA Secondary Structures UNKNOWN The AAGGG sequence forms noncanonical DNA structures in short-repeat biophysical assays; structure at the endogenous expanded locus has not been demonstrated.

Biallelic RFC1 Intronic Repeat Expansion -> Repeat RNA G-Quadruplex Formation UNKNOWN AAGGG RNA forms G-quadruplexes in defined short-repeat assays; their formation in vulnerable patient neurons is unresolved.

Repeat DNA Secondary Structures -> Repeat-Associated Replication Fork Stalling DIRECT Noncanonical DNA folding can impede polymerase progression in the tested biochemical and plasmid contexts.

Repeat RNA G-Quadruplex Formation -> Reduced Translation in Repeat Reporter Assays DIRECT Repeat folding is implicated in the reporter translation phenotype; relevance to endogenous RFC1 requires testing.

Show evidence (2 references)

PMID:38266156 SUPPORT DIRECT PRIMARY RESULT In Vitro

"we report that the pathogenic RFC1 AAGGG repeats form DNA and RNA parallel G-quadruplex (G4) structures that play a role in impairing biological processes"

Biophysical assays establish folding capacity of short repeats.

PMID:38381906 SUPPORT DIRECT PRIMARY RESULT In Vitro

"The observed DNA polymerase stalling at the center of the (A2G3)10 strand strongly implicates H-r DNA triplex formation"

A competing structural explanation is supported under other assay conditions.

Context-dependent intron retention

intron2_retention_rna_processing ALTERNATIVE

Evidence balance 1 support 1 refute

The original pre-mRNA retention finding has not been consistently reproduced. Altered RNA processing remains a candidate rather than an established obligatory mechanism.

Pathograph links

Biallelic RFC1 Intronic Repeat Expansion -> RFC1 Intron 2 Retention UNKNOWN The founding study detected increased intronic RNA, but later cell assays did not consistently reproduce retention.

Show evidence (2 references)

PMID:30926972 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"we detected a consistent increase across different tissues of the retention of intron 2 in RFC1 pre-mRNA"

Original observation in limited tissue samples.

PMID:39231235 REFUTE DIRECT PRIMARY RESULT In Vitro

"no back-spliced reads were identified to map to RFC1 intron 2 or across the RFC1 transcript"

No detectable circular intronic RNA was found in this study.

Repeat RNA and pentapeptide effects

repeat_rna_peptide_effects EMERGING

Evidence balance 4 support 1 refute

RNA foci and poly-KGREG signals occur in some tissues and reporters, but negative and incompletely specific findings constrain their interpretation. Production of a repeat-associated product does not demonstrate that it causes neuronal death.

Pathograph links

Biallelic RFC1 Intronic Repeat Expansion -> Repeat RNA Foci UNKNOWN Two genetically confirmed autopsies contained repeat RNA foci, whereas earlier patient brains and later cell assays were negative.

Biallelic RFC1 Intronic Repeat Expansion -> Repeat-Associated Poly-KGREG Production UNKNOWN Short-repeat reporter constructs can produce poly-KGREG; this does not establish toxic peptide accumulation from the endogenous expanded alleles.

Show evidence (5 references)

PMID:38062616 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"RNA fluorescence in situ hybridization of the 2 patients revealed CCTGT- and CCCTT-containing RNA foci, respectively, in neuronal nuclei of tissues with neuronal loss."

Autopsy findings support foci formation in two cases; toxicity remains unproven.

PMID:30926972 REFUTE DIRECT PRIMARY RESULT Human Clinical

"We did not observe in patient brains the presence of RNA foci of either the sense or antisense repeated unit."

Preserves the earlier negative finding.

PMID:39231235 SUPPORT DIRECT PRIMARY RESULT In Vitro

"the overall abundance of foci was low, and the specificity was imperfect, with 8.94% of control neurons and 11.3% of CANVAS neurons showing antisense CCCTT RNA foci"

Patient-neuron signal was small and incompletely specific.

+ 2 more references

Discussions and Knowledge Gaps

Which repeat-dependent processes mediate selective neuronal dysfunction, and how much depends on RFC1 expression in each vulnerable lineage?

KNOWLEDGE GAP OPEN canvas_mechanism_unresolved

Attached to

pathophysiology#Context-Dependent Reduction of RFC1 Transcript Abundance pathophysiology#Repeat DNA Secondary Structures pathophysiology#RFC1 Intron 2 Retention pathophysiology#Repeat RNA Foci pathophysiology#Repeat-Associated Poly-KGREG Production pathophysiology#Impaired Neuronal Synaptic Signaling pathophysiology#Delayed Repair of Platinum-Induced DNA Damage

Published 2024 cortical-like neurons show synaptic dysfunction and partial rescue after monoallelic Alu-repeat deletion, despite preserved RFC1 expression and normal UV-damage recovery. An unreviewed 2025 study of sensory/motor neurons reports modest isogenic-relative transcript reduction and rescue of platinum sensitivity by biallelic deletion. The same deletion can alter expression, repeat products and Alu regulatory functions, so neither result identifies a unique mediator. Foci findings conflict across tissue and assay contexts; positive autopsies keep RNA-mediated hypotheses open. Short-repeat negative toxicity assays cannot exclude longer or endogenous-context effects. Selective vulnerability and relative auditory preservation remain unexplained.

Proposed experiments

Ganglion-resolved RFC1 expression comparison

canvas_ganglion_resolved_rfc1_expression

Compare matched patient and corrected sensory, vestibular, auditory and Purkinje-lineage cultures using allele-resolved RNA, validated protein quantification and standardized maturation. Test RFC1 replacement independently of repeat deletion and quantify both synaptic and DNA-damage phenotypes.

Decision criterion

Concordant lineage-specific protein reduction plus rescue by expression restoration would support an expression-mediated mechanism. Preserved protein or failure of adequately controlled replacement would constrain that model without excluding repeat-dependent processes.

G-quadruplex modulation in patient-derived sensory neurons

canvas_g4_modulation_sensory_neurons

Measure endogenous repeat DNA and RNA structures with orthogonal, strand-specific methods and perturb G-quadruplex versus triplex formation separately in isogenic neurons.

Decision criterion

A structure-selective intervention must change the proposed structure and rescue a neuronal endpoint without merely changing RFC1 abundance or causing nonspecific toxicity.

Replication-independent repeat toxicity assay

canvas_replication_independent_toxicity

Reassess repeat RNA foci, R-loops and poly-KGREG with validated specificity controls across genotypes, repeat motifs, cell types and ages. Compare published negative short-repeat assays with native-locus and longer-repeat systems.

Decision criterion

Reproducible genotype-associated products plus selective depletion and neuronal rescue would support toxicity. Product detection alone, or a negative result in one short-term model, would not settle the mechanism.

Show evidence (3 references)

PMID:38062616 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"RNA fluorescence in situ hybridization of the 2 patients revealed CCTGT- and CCCTT-containing RNA foci, respectively, in neuronal nuclei of tissues with neuronal loss."

Autopsy findings support foci formation in two cases; toxicity remains unproven.

PMID:30926972 REFUTE DIRECT PRIMARY RESULT Human Clinical

"We did not observe in patient brains the presence of RNA foci of either the sense or antisense repeated unit."

Preserves the earlier negative finding.

+ 1 more reference

Show evidence (6 references)

PMID:39231235 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Gene Ontology (GO) analysis indicated a significant overrepresentation of neuronal signaling processes including synaptic signaling and processes that regulate synaptic signaling"

Transcriptomic changes converge on neuronal signaling.

PMID:39231235 SUPPORT DIRECT PRIMARY RESULT In Vitro

"CANVAS patient iPSC–derived neurons remained devoid of detectable synchronous firing even between 7 and 11 weeks after differentiation"

Patient neurons had impaired network synchrony.

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml SUPPORT DIRECT PRIMARY RESULT In Vitro

"expression could only be detected when comparing CANVAS lines with their isogenic corrected counterpart, but not when comparing CANVAS lines with non-isogenic controls"

Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Motor-neuron qPCR showed about 23% lower expression versus isogenic controls; sensory-neuron reduction was about 15%.

+ 3 more references

Should the peripheral lesion of CANVAS be modeled as a ganglionopathy rather than conforming to the length-dependent peripheral axonal degeneration module?

INTERPRETATION OPEN canvas_ganglionopathy_not_axonopathy

Attached to

pathophysiology#Dorsal Root Ganglion Sensory Neuronopathy

Neuropathology localizes the predominant peripheral lesion to sensory ganglion neuronal bodies, with secondary tract degeneration. Clinical sensory loss can nevertheless show a distal-to-proximal gradient, so a length-dependent examination pattern does not refute the ganglion lesion. The existing peripheral_axonal_degeneration module specifies a primary dying-back process that is not established here. Purkinje-cell loss supports the existing cerebellar_purkinje_degeneration conformance. A future ganglionopathy module could capture the primary lesion without forcing every clinical case into one sensory distribution.

Retains the module-conformance question while removing the false claim that all CANVAS sensory loss is non-length-dependent.

Show evidence (2 references)

PMID:24682971 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Spinal cord pathology demonstrated a marked dorsal root ganglionopathy with secondary tract degeneration."

Direct neuropathology in clinically defined CANVAS predating molecular diagnosis.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Altered sensation in all limbs in either a length-dependent (distal extremities worse) or non-length-dependent pattern."

Clinical distribution does not by itself determine the site of the primary lesion.

Do DNA-repair pathway variants modify penetrance of biallelic RFC1 expansions?

INTERPRETATION OPEN canvas_penetrance_modifiers

Attached to

genetic#RFC1

A 2026 study associated DNA mismatch-repair polygenic scores and rs245100 upstream of MSH3 with clinically affected biallelic carriers across discovery and replication cohorts. This is candidate modifier evidence, not proof that rs245100 regulates MSH3 or that altered somatic expansion mediates RFC1 disease. Clinical-record ascertainment, repeat configuration and age complicate classification of apparently unaffected carriers. A separate unreviewed platinum-neuropathy association in heterozygotes does not establish dominant CANVAS or a clinical pharmacogenetic recommendation.

Show evidence (1 reference)

PMID:42473260 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"The variant rs245100, upstream MSH3, was the biggest contributor to this elevated risk"

Association nominates a locus; it does not establish a regulatory target or causal mechanism.

How closely do ortholog-depletion models represent the human intronic-repeat disorder?

HUMAN MODEL MISMATCH OPEN canvas_ortholog_loss_model_mismatch

Attached to

pathophysiology#Context-Dependent Reduction of RFC1 Transcript Abundance pathophysiology#Cerebellar Purkinje Cell Loss

The zebrafish model is a complete rfc1 knockout with early cerebellar progenitor loss and death by 10 days; the fly preprint uses neuronal ortholog knockdown. Neither organism model carries the human intronic expansion. Human repeat-only neurons can preserve RFC1 protein, and clinical disease is usually late onset. The models support a requirement for RFC1 but cannot establish that expansion-mediated disease is equivalent to complete or partial gene depletion.

Show evidence (1 reference)

PMID:40595562 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the loss of RFC1 jeopardizes the genomic integrity of these progenitor cells"

Complete knockout disrupts developing progenitor populations.

⚙

Pathophysiology

Biallelic RFC1 Intronic Repeat Expansion

Mechanism confidence: Established

The usual genotype contains two expanded nonreference pentanucleotide tracts within RFC1 intron 2, overlapping the poly(A) tail of AluSx3. AAGGG is written on the opposite strand to the RFC1 transcript (CCCTT). Motif, interruptions and length affect interpretation; neither intronic location nor repeat size alone proves regulatory loss of function.

Context-dependent intron retention Context-dependent RFC1 loss of function Repeat RNA and pentapeptide effects Repeat-intrinsic DNA and RNA structural effects

RFC1 hgnc:9969

Genetic context RFC1 hgnc:9969 Variant type: short tandem repeat expansion Genomic context: intron variant_origin: GERMLINE functional_impact_category: UNKNOWN

Biallelic pathogenic repeat expansions; their physical class and intronic Alu overlap are established, while the molecular effect remains disputed.

Downstream

Repeat DNA Secondary Structures The AAGGG sequence forms noncanonical DNA structures in short-repeat biophysical assays; structure at the endogenous expanded locus has not been demonstrated.

Repeat RNA G-Quadruplex Formation AAGGG RNA forms G-quadruplexes in defined short-repeat assays; their formation in vulnerable patient neurons is unresolved.

RFC1 Intron 2 Retention The founding study detected increased intronic RNA, but later cell assays did not consistently reproduce retention.

Context-Dependent Reduction of RFC1 Transcript Abundance In the unreviewed 2025 preprint, isogenic deletion of the repeat-containing region increased transcript abundance in sensory and motor neurons; preserved-expression studies limit generalization.

Repeat RNA Foci Two genetically confirmed autopsies contained repeat RNA foci, whereas earlier patient brains and later cell assays were negative.

Repeat-Associated Poly-KGREG Production Short-repeat reporter constructs can produce poly-KGREG; this does not establish toxic peptide accumulation from the endogenous expanded alleles.

Impaired Neuronal Synaptic Signaling Monoallelic deletion of the Alu-repeat region partially rescued synaptic readouts in one patient-derived neuronal line; the intervening molecular mechanism remains unresolved.

Dorsal Root Ganglion Sensory Neuronopathy Sensory neuronopathy is a defining manifestation of genetically confirmed RFC1 disease; the repeat-dependent route to ganglion injury remains unknown.

Cranial Sensory Ganglionopathy Vestibular failure in genetically confirmed disease is consistent with cranial ganglion pathology in historical clinical CANVAS, although those temporal-bone cases were not genotyped.

Cerebellar Purkinje Cell Loss A genetically confirmed CANVAS autopsy showed Purkinje depletion and Bergmann gliosis; the repeat-to-cell-death intermediates remain unresolved.

Autonomic Nervous System Dysfunction Autonomic testing documents sympathetic and parasympathetic dysfunction in RFC1 disease; the route from the repeat genotype to autonomic injury and its anatomical site remain unresolved.

Cough Reflex Hypersensitivity Heightened capsaicin sensitivity is documented in a small group of biallelic carriers with refractory cough; the repeat-dependent process causing reflex sensitization has not been demonstrated.

Motor Circuit Dysfunction Upper and lower motor signs in genetically confirmed cases suggest additional motor-circuit involvement, with axonal and glial abnormalities documented in one autopsy; the repeat-dependent mechanism remains unknown.

Cognitive Network Dysfunction Genetically confirmed CANVAS cohorts show cognitive deficits; the route from the repeat genotype to cerebellar or extra-cerebellar cognitive-network dysfunction remains unresolved.

Show evidence (2 references)

PMID:30926972 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We used non-parametric linkage analysis and genome sequencing to identify a biallelic intronic AAGGG repeat expansion in the replication factor C subunit 1 (RFC1) gene as the cause of familial CANVAS and a frequent cause of late-onset ataxia, particularly if sensory neuronopathy and bilateral..."

Identifies biallelic intronic RFC1 AAGGG expansion as the cause of CANVAS.

PMID:31230722 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"a recessively inherited, ancient RE located in intron 2 of RFC1 is the predominant cause of CANVAS"

Independent confirmation that the intron 2 repeat expansion is the predominant cause.

RFC1 Nonsense Allele in Trans with a Repeat Expansion

Mechanism confidence: Established

Rare patients carry a coding nonsense allele in trans with an expanded RFC1 repeat. Two siblings with c.1267C>T (p.Arg423Ter) showed mutant-transcript depletion and reduced full-length protein in fibroblasts. The coding single-nucleotide change and its measured consequences are distinct from the intronic repeat alteration.

RFC1 hgnc:9969

Genetic context RFC1 hgnc:9969 Variant type: single nucleotide variant Genomic context: coding sequence variant_origin: GERMLINE zygosity: COMPOUND_HETEROZYGOUS functional_impact_category: LOSS_OF_FUNCTION

A premature-termination single-nucleotide variant in RFC1 coding sequence, in trans with an intronic repeat expansion. The tested p.Arg423Ter allele undergoes preferential transcript depletion.

Downstream

Decay of Truncating RFC1 Transcripts Tested premature-termination alleles show preferential mutant-transcript depletion.

Show evidence (1 reference)

PMID:36289003 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Together, the findings suggest that the transcript containing truncating variants in RFC1 undergo nonsense-mediated decay leading to RNA degradation."

Patient fibroblast studies characterize the truncating allele in the compound genotype.

RFC1 Frameshift Deletion in Trans with a Repeat Expansion

Mechanism confidence: Established

Rare patients carry a coding frameshift deletion in trans with an expanded RFC1 repeat. For c.2876del (p.Pro959GlnfsTer24), cDNA sequencing showed depletion of the deletion-bearing transcript and supported the trans configuration. Other reported deletions include c.1739_1740del and c.2191del; the RNA findings should not be assumed measured for every allele.

RFC1 hgnc:9969

Genetic context RFC1 hgnc:9969 Variant type: deletion Genomic context: coding sequence variant_origin: GERMLINE zygosity: COMPOUND_HETEROZYGOUS functional_impact_category: LOSS_OF_FUNCTION

A coding deletion that shifts the reading frame and introduces premature termination, in trans with an intronic repeat expansion. Allele-specific RNA depletion was measured for c.2876del.

Downstream

Decay of Truncating RFC1 Transcripts Tested premature-termination alleles show preferential mutant-transcript depletion.

Show evidence (1 reference)

PMID:36289003 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Together, the findings suggest that the transcript containing truncating variants in RFC1 undergo nonsense-mediated decay leading to RNA degradation."

Patient fibroblast studies characterize the truncating allele in the compound genotype.

Decay of Truncating RFC1 Transcripts

Mechanism confidence: Established

Allele-specific RNA sequencing and cDNA analysis showed preferential depletion of transcripts carrying p.Arg423Ter or p.Pro959GlnfsTer24, supporting nonsense-mediated decay. This result applies to the coding truncating allele, not directly to the expanded-repeat allele.

nuclear-transcribed mRNA catabolic process, nonsense-mediated decay GO:0000184 ↑ INCREASED

Experimental models

Expansion/truncating-allele patient fibroblasts PRIMARY CELL CULTURE Allele-specific RNA depletion supports nonsense-mediated decay.

Downstream

Reduced RFC1 Protein in Truncating-Allele Carriers Loss of mutant transcript reduces the contribution of the coding allele to full-length protein.

Show evidence (1 reference)

PMID:36289003 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Together, the findings suggest that the transcript containing truncating variants in RFC1 undergo nonsense-mediated decay leading to RNA degradation."

Patient fibroblast studies characterize the truncating allele in the compound genotype.

Reduced RFC1 Protein in Truncating-Allele Carriers

Mechanism confidence: Established

Fibroblasts from two related expansion/p.Arg423Ter patients had approximately 50% lower full-length RFC1 protein. Truncated isoforms were not detected. Repeat-only fibroblasts did not show the same reduction. Unaffected relatives with a single truncating allele indicate that isolated haploinsufficiency is insufficient to explain CANVAS.

Experimental models

Expansion/truncating-allele patient fibroblasts PRIMARY CELL CULTURE Full-length RFC1 protein is reduced in tested compound heterozygotes.

Show evidence (2 references)

PMID:36289003 SUPPORT DIRECT PRIMARY RESULT In Vitro

"immunoblotting showed a concordant reduction of the 140 KD full-length RFC1 protein in fibroblasts from affected individuals"

Protein reduction accompanies allele-specific RNA decay.

PMID:36289003 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"parents of the affected patients in this study, carrying a truncating variant in RFC1 but no AAGGG expansion on the second allele, did not show a phenotype despite their old age"

Limits a simple dominant haploinsufficiency interpretation.

Context-Dependent Reduction of RFC1 Transcript Abundance

Mechanism confidence: Provisional

An unreviewed November 2025 preprint reported modest RFC1 mRNA reduction in patient-derived sensory and motor neurons versus isogenic biallelic Alu-repeat deletions, and in targeted analysis of postmortem cerebellum. Protein reduction was not demonstrated. Earlier studies found preserved expression in peripheral cells, limited brain samples and mainly cortical-like neurons. Cell identity, genetic background, RNA quality and assay context may explain discrepancies. Repeat deletion removes more than an expression defect and does not identify the mediator of rescue.

Context-dependent RFC1 loss of function

Experimental models

Isogenic sensory-neuron models in the 2025 preprint IPSC DERIVED MODEL RFC1 mRNA was modestly reduced; protein reduction was not demonstrated.

Isogenic lower-motor-neuron models in the 2025 preprint IPSC DERIVED MODEL The qPCR difference depends on isogenic comparison.

Downstream

Delayed Repair of Platinum-Induced DNA Damage Reduced expression and altered platinum response co-occur in the preprint, but expression-specific rescue was not performed.

Show evidence (4 references)

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml SUPPORT DIRECT PRIMARY RESULT In Vitro

"expression could only be detected when comparing CANVAS lines with their isogenic corrected counterpart, but not when comparing CANVAS lines with non-isogenic controls"

Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Motor-neuron qPCR showed about 23% lower expression versus isogenic controls; sensory-neuron reduction was about 15%.

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml REFUTE DIRECT PRIMARY RESULT In Vitro

"we were unable to demonstrate a significant effect of the repeat expansion on RFC1 protein."

Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). The preprint does not establish reduced protein abundance.

PMID:30926972 REFUTE DIRECT PRIMARY RESULT Human Clinical

"does not affect RFC1 expression in patient peripheral and brain tissue, suggesting no overt loss of function"

Original bulk-tissue results argue against a universal expression-loss model.

+ 1 more reference

Repeat DNA Secondary Structures

Mechanism confidence: Provisional

Short synthetic AAGGG DNA repeats adopt G-quadruplex or H-r triplex structures under different ionic and temperature conditions. Triplex-sensitive probing and cellular replication assays argue against assigning all stalling to G-quadruplexes. These structures have not been shown to mediate degeneration at the endogenous expanded locus in vulnerable human neurons.

Repeat-intrinsic DNA and RNA structural effects

Experimental models

Synthetic repeat nucleic-acid structural assays OTHER AAGGG DNA can form parallel G-quadruplexes or H-r triplexes.

Downstream

Repeat-Associated Replication Fork Stalling Noncanonical DNA folding can impede polymerase progression in the tested biochemical and plasmid contexts.

Show evidence (2 references)

PMID:38266156 SUPPORT DIRECT PRIMARY RESULT In Vitro

"we report that the pathogenic RFC1 AAGGG repeats form DNA and RNA parallel G-quadruplex (G4) structures that play a role in impairing biological processes"

Biophysical assays establish folding capacity of short repeats.

PMID:38381906 SUPPORT DIRECT PRIMARY RESULT In Vitro

"The observed DNA polymerase stalling at the center of the (A2G3)10 strand strongly implicates H-r DNA triplex formation"

A competing structural explanation is supported under other assay conditions.

Repeat-Associated Replication Fork Stalling

Mechanism confidence: Provisional

Pathogenic-repeat templates inhibit polymerase progression in vitro. AAGGG tracts also stall replication in yeast plasmids and SV40-origin episomes in human cells, with orientation dependence. Lack of enhancement after PIF1 deletion favors a triplex contribution in yeast. These assays use short repeats or non-native replication systems; they do not establish replication-fork injury in postmitotic CANVAS neurons.

DNA replication GO:0006260 ↓ DECREASED

Experimental models

HEK SV40-origin repeat replication assay CELL LINE AAGGG episomes impede fork progression.

Animal models

Yeast plasmid AAGGG replication model Saccharomyces cerevisiae partially recapitulates Pathogenic-repeat plasmids show fork stalling.

Show evidence (1 reference)

PMID:38381906 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Finally, the pathogenic, but not the nonpathogenic, repeat stalls replication fork progression in yeast and human cells."

Measures replication impediments in model systems.

Repeat RNA G-Quadruplex Formation

Mechanism confidence: Provisional

Synthetic AAGGG RNA forms parallel G-quadruplexes. The RFC1 sense transcript carries the complementary CCCTT sequence; strand and transcript context must be specified before extrapolating AAGGG reporter results to endogenous RFC1 RNA.

Repeat-intrinsic DNA and RNA structural effects

Experimental models

Synthetic repeat nucleic-acid structural assays OTHER Short AAGGG RNA forms G-quadruplexes.

Downstream

Reduced Translation in Repeat Reporter Assays Repeat folding is implicated in the reporter translation phenotype; relevance to endogenous RFC1 requires testing.

Show evidence (1 reference)

PMID:38266156 SUPPORT DIRECT PRIMARY RESULT In Vitro

"we report that the pathogenic RFC1 AAGGG repeats form DNA and RNA parallel G-quadruplex (G4) structures that play a role in impairing biological processes"

Biophysical assays establish folding capacity of short repeats.

Reduced Translation in Repeat Reporter Assays

Mechanism confidence: Provisional

HEK293T reporters containing short upstream AAGGG repeats showed reduced EGFP protein with unchanged reporter mRNA. Stabilizing G-quadruplexes worsened this reporter effect. This measures translation of a construct, not reduced transcription of endogenous RFC1, and is not evidence for a therapeutic effect of G-quadruplex stabilizers.

translation GO:0006412 ↓ DECREASED

Experimental models

HEK293T repeat-dependent translation reporter CELL LINE AAGGG reporter constructs reduce protein output without a corresponding reporter-mRNA reduction.

Show evidence (1 reference)

PMID:38266156 SUPPORT DIRECT PRIMARY RESULT In Vitro

"reduce gene expression via impairing the translation process in a repeat-length-dependent manner"

Reporter assays support a translation effect in their specific construct context.

RFC1 Intron 2 Retention

Mechanism confidence: Provisional

The 2019 study found increased intron 2 retention in pre-mRNA in small lymphoblast, muscle and brain samples, without aberrantly spliced mature transcripts. The 2024 patient-cell study did not reproduce increased retention or circular RFC1 RNA; the 2025 preprint also found similar transcript processing. A uniform intron-retention mechanism is therefore unproven.

Experimental models

Patient-derived glutamatergic forebrain neurons IPSC DERIVED MODEL Intron retention and aberrant splicing were not increased.

Show evidence (3 references)

PMID:30926972 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"we detected a consistent increase across different tissues of the retention of intron 2 in RFC1 pre-mRNA"

Original observation in limited tissue samples.

PMID:39231235 REFUTE DIRECT PRIMARY RESULT In Vitro

"no back-spliced reads were identified to map to RFC1 intron 2 or across the RFC1 transcript"

No detectable circular intronic RNA was found in this study.

PMID:39231235 REFUTE DIRECT PRIMARY RESULT In Vitro

"There were no differences between cases and controls in terms of intron retention or aberrant intron 2 splicing of RFC1 in patient fibroblasts, iPSC-derived neurons, or cortical and cerebellar regions of postmortem brain"

Direct negative RNA-processing result.

Repeat RNA Foci

Mechanism confidence: Provisional

Repeat RNA foci were reported in two 2024 autopsies with ACAGG or AAGGG configurations. Earlier brain analysis was negative. Reporter foci are readily generated, but 2024 patient neurons showed only a small antisense signal difference with imperfect specificity (11.3% versus 8.94%) and no sense-repeat enrichment. Foci presence does not establish RNA-mediated toxicity.

Show evidence (3 references)

PMID:38062616 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"RNA fluorescence in situ hybridization of the 2 patients revealed CCTGT- and CCCTT-containing RNA foci, respectively, in neuronal nuclei of tissues with neuronal loss."

Autopsy findings support foci formation in two cases; toxicity remains unproven.

PMID:30926972 REFUTE DIRECT PRIMARY RESULT Human Clinical

"We did not observe in patient brains the presence of RNA foci of either the sense or antisense repeated unit."

Preserves the earlier negative finding.

PMID:39231235 SUPPORT DIRECT PRIMARY RESULT In Vitro

"the overall abundance of foci was low, and the specificity was imperfect, with 8.94% of control neurons and 11.3% of CANVAS neurons showing antisense CCCTT RNA foci"

Patient-neuron signal was small and incompletely specific.

Repeat-Associated Poly-KGREG Production

Mechanism confidence: Provisional

AAGGG reporter constructs produce poly-KGREG in HEK cells. Cerebellar granule-layer immunostaining was strong in three of four CANVAS brains, weak in one, and also present in one nonexpanded control; remaining Purkinje neurons lacked staining. Peptide production was not detected in eight-week patient neurons. Short-repeat expression did not reduce rat cortical-neuron survival over ten days, leaving length-, cell- and context-specific toxicity unresolved.

Experimental models

HEK repeat-associated poly-KGREG reporter CELL LINE AAGGG reporters produce poly-KGREG.

Show evidence (2 references)

PMID:39231235 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"These data suggest that pentapeptide KGREG repeat proteins may be produced from AAGGG repeats in patients with CANVAS in a cell type–specific manner."

Postmortem immunoreactivity is suggestive but not perfectly genotype-specific.

PMID:39231235 SUPPORT DIRECT PRIMARY RESULT In Vitro

"AAGGG repeats are translated into pentapeptide repeat proteins"

Reporter assays demonstrate translation.

Impaired Neuronal Synaptic Signaling

Mechanism confidence: Provisional

Patient-derived predominantly glutamatergic forebrain neurons showed reduced synaptic transcripts and proteins and poorly synchronized network firing. Monoallelic deletion of the Alu-repeat region partially restored these readouts. RFC1 knockdown did not reproduce most abnormalities, and re-expression did not broadly rescue them, although some firing measures changed. These immature cortical-like cultures do not reproduce the selectively vulnerable sensory ganglion and Purkinje populations.

synaptic signaling GO:0099536 ⚠ ABNORMAL

Experimental models

Patient-derived glutamatergic forebrain neurons IPSC DERIVED MODEL Synaptic transcripts/proteins and network synchrony were abnormal.

Patient-derived glutamatergic forebrain neurons IPSC DERIVED MODEL Monoallelic Alu-repeat deletion partially restored gene expression and synchrony (42% versus 70% control network correlation).

RFC1 knockdown and re-expression in forebrain neurons IPSC DERIVED MODEL Knockdown failed to reproduce the CANVAS-like transcriptomic signature or most network deficits.

Show evidence (2 references)

PMID:39231235 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Gene Ontology (GO) analysis indicated a significant overrepresentation of neuronal signaling processes including synaptic signaling and processes that regulate synaptic signaling"

Transcriptomic changes converge on neuronal signaling.

PMID:39231235 SUPPORT DIRECT PRIMARY RESULT In Vitro

"CANVAS patient iPSC–derived neurons remained devoid of detectable synchronous firing even between 7 and 11 weeks after differentiation"

Patient neurons had impaired network synchrony.

Delayed Repair of Platinum-Induced DNA Damage

Mechanism confidence: Provisional

The unreviewed 2025 preprint found slower removal of platinum-DNA adducts in patient lymphoblastoid cells and greater cisplatin-induced apoptosis in sensory and motor neurons, improved by isogenic repeat-region deletion. Earlier cortical-like neurons had normal UV-induced DNA-damage recovery. The studies test different insults and cell types; neither universal repair failure nor RFC1 mRNA reduction as the causal mediator is established.

DNA repair GO:0006281 ↓ DECREASED

Experimental models

Patient-derived glutamatergic forebrain neurons IPSC DERIVED MODEL UV-induced gamma-H2AX recovery was normal.

Isogenic sensory-neuron models in the 2025 preprint IPSC DERIVED MODEL Repeat-region deletion reduced cisplatin-induced apoptosis, reaching significance at 5 micromolar after 24 hours.

Isogenic lower-motor-neuron models in the 2025 preprint IPSC DERIVED MODEL Biallelic Alu-repeat deletion reduced cisplatin-induced apoptosis.

Patient lymphoblastoid platinum-challenge models in the 2025 preprint CELL LINE Adduct removal was slower and apoptosis occurred earlier.

Animal models

Complete rfc1 knockout zebrafish Danio rerio perturbs DNA-damage markers accumulate in developing neural progenitors.

Neuronal Gnf1 knockdown flies in the 2025 preprint Drosophila melanogaster perturbs Neuronal H2Av staining increased before and during overt motor impairment.

Show evidence (2 references)

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml SUPPORT DIRECT PRIMARY RESULT In Vitro

"repair in CANVAS LCLs was significantly slower, reaching levels comparable to control cells only after 72 h"

Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Measures delayed repair after a cisplatin pulse.

PMID:39231235 REFUTE DIRECT PRIMARY RESULT In Vitro

"First-derivative analysis of normalized γ-H2AX indicated no differences in the rate of γ-H2AX recovery after UV induction between CANVAS and control neurons"

The published UV assay limits generalization across forms of DNA damage.

Dorsal Root Ganglion Sensory Neuronopathy

Mechanism confidence: Established

sensory neuron of dorsal root ganglion CL:1001451 ↓ DECREASED

Experimental models

Isogenic sensory-neuron models in the 2025 preprint IPSC DERIVED MODEL Patient-repeat sensory neurons did not show reduced unstressed survival.

Downstream

Multisensory Balance Failure Loss of this sensory or cerebellar contribution impairs integrated balance control.

Sensory ataxia Loss of proprioceptive afferent input contributes to sensory incoordination.

Impaired proprioception Injury to sensory ganglion neurons impairs joint-position feedback.

Sensory neuropathy Sensory neuronopathy produces the clinical and electrophysiological sensory-neuropathy phenotype.

Areflexia Loss of sensory input can interrupt the afferent limb of tendon reflexes; reflexes may remain preserved or brisk in other cases.

Impaired lower-limb vibration sensation Large-fiber sensory dysfunction reduces distal vibration perception.

Paresthesia Dysfunction of sensory afferents can generate the pins-and-needles sensations described in the sensory-neuropathy spectrum.

Neuropathic pain Injury to sensory afferents provides a plausible substrate for neuropathic pain; the relative contributions of peripheral ectopic activity and central sensitization have not been established in RFC1 disease.

Show evidence (2 references)

PMID:24682971 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Spinal cord pathology demonstrated a marked dorsal root ganglionopathy with secondary tract degeneration."

Direct neuropathology in clinically defined CANVAS predating molecular diagnosis.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Altered sensation in all limbs in either a length-dependent (distal extremities worse) or non-length-dependent pattern."

Clinical distribution does not by itself determine the site of the primary lesion.

Cranial Sensory Ganglionopathy

Mechanism confidence: Established

Five temporal bones from four clinically defined, ungenotyped CANVAS patients showed severe vestibular ganglion neuronal loss, with relative preservation of spiral ganglia, sensory hair cells and vestibular nuclei. Trigeminal and geniculate ganglia were also affected. Ganglionic Nageotte nodules reflect glial replacement of lost neurons; they are not psammoma bodies. Relative auditory sparing does not exclude coincident presbycusis or another cause of hearing loss.

vestibular ganglion sensory neuron CL:0000101 ↓ DECREASED

Downstream

Multisensory Balance Failure Loss of this sensory or cerebellar contribution impairs integrated balance control.

Vestibular areflexia Vestibular ganglion degeneration impairs the afferent limb of vestibular reflexes.

Oscillopsia Vestibular afferent failure impairs stabilization of gaze during head movement.

Show evidence (1 reference)

PMID:33492056 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"In CANVAS there is a severe cranial sensory ganglionopathy neuronopathy (ganglionopathy) involving the vestibular, facial, and trigeminal ganglia but sparing the auditory ganglia."

Historical pathology localizes vestibular failure primarily to ganglion neurons; these donors were not RFC1-genotyped.

Cerebellar Purkinje Cell Loss

Mechanism confidence: Established

Purkinje-cell depletion, often greatest in the vermis, and Bergmann gliosis are documented in clinical CANVAS autopsies and a genetically confirmed 2019 case. This lesion contributes to cerebellar gait, limb, speech and oculomotor dysfunction. Molecular intermediates connecting the repeat genotype to selective adult Purkinje degeneration remain unresolved.

Purkinje cell CL:0000121 ↓ DECREASED

Experimental models

Short-repeat expression in primary rat cortical neurons PRIMARY CELL CULTURE Short CANVAS-repeat constructs did not produce neuronal death.

Animal models

Complete rfc1 knockout zebrafish Danio rerio partially recapitulates Purkinje-cell numbers are reduced following early progenitor injury.

Downstream

Multisensory Balance Failure Loss of this sensory or cerebellar contribution impairs integrated balance control.

Progressive cerebellar ataxia Purkinje-cell depletion impairs cerebellar coordination.

Dysarthria Cerebellar circuit injury can impair the timing and coordination of speech.

Cerebellar atrophy Loss of cerebellar neurons contributes to cerebellar volume loss.

Gaze-evoked nystagmus Cerebellar dysfunction can impair gaze-holding control.

Downbeat nystagmus Cerebellar ocular-motor dysfunction can produce vertical gaze instability.

Dysmetric saccades Cerebellar dysfunction impairs calibration of saccadic amplitude.

Saccadic pursuit Cerebellar dysfunction impairs smooth tracking and increases corrective saccades.

Dysphagia GeneReviews attributes later swallowing difficulty to cerebellar dysfunction; the precise swallowing circuits and any additional brainstem contributions are unresolved.

Show evidence (2 references)

PMID:24682971 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Cerebellar pathology showed loss of Purkinje cells, predominantly in the vermis."

Documents selective cerebellar pathology in historical clinical CANVAS.

PMID:30926972 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"The patient with CANVAS showed severe, widespread depletion of Purkinje cells with associated prominent Bergmann gliosis, while cell density in the granule cell layer was well preserved."

The 2019 study documents this pathology in a genetically confirmed CANVAS case.

Autonomic Nervous System Dysfunction

Mechanism confidence: Established

Sympathetic and parasympathetic dysfunction can affect blood pressure, bowel, bladder, sexual function and sweating. Severity is usually mild but can be substantial. A primary autonomic ganglion lesion has not been established across RFC1 disease; central and peripheral contributions remain possible.

Downstream

Autonomic dysfunction Impaired autonomic control is expressed clinically across several organ systems.

Orthostatic hypotension Impaired autonomic cardiovascular control can reduce the blood-pressure response to standing.

Erectile dysfunction Autonomic genital control can be impaired in the reported dysautonomic spectrum.

Chronic constipation Autonomic gastrointestinal dysfunction can impair bowel motility.

Autonomic bladder dysfunction Autonomic lower urinary-tract control can be impaired.

Anhidrosis Impaired sudomotor control can reduce sweating.

Hyperhidrosis Abnormal sudomotor regulation can increase sweating in some patients.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Autonomic testing confirms the presence of a sympathetic and/or parasympathetic dysfunction in half of individuals undergoing specific investigations."

Physiological dysfunction is established without assigning a specific ganglionic lesion.

Cough Reflex Hypersensitivity

Mechanism confidence: Provisional

Biallelic RFC1 carriers with refractory cough show heightened capsaicin sensitivity relative to historical healthy controls, broadly comparable to other refractory-cough cohorts. The mechanism may involve peripheral or central sensitization or loss of inhibitory sensory inputs. Direct demonstration of a general vagal-afferent degenerative lesion causing the cough is lacking.

Downstream

Chronic cough Heightened cough-reflex sensitivity accompanies refractory cough in studied carriers; the observational data do not identify its cause.

Show evidence (1 reference)

PMID:39811557 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"cough reflex sensitivity was heightened compared to historical healthy controls"

Four biallelic participants underwent cough-reflex testing; this is not a contemporaneous controlled comparison.

Motor Circuit Dysfunction

Mechanism confidence: Provisional

Upper and lower motor signs suggest dysfunction of descending motor control and motor-unit circuits in a subset of RFC1 cases. Their lesion-level basis remains uncertain. One genetically confirmed autopsy showed anterior-horn astrocytic gliosis and axonal swelling around motor-neuron somata, with preserved anterior-horn neurons and corticospinal tracts. This supports a possible synaptic component but does not establish generalized motor-neuron death or identify the lesion responsible for upper motor signs.

Downstream

Hyperreflexia Altered descending control of spinal reflexes is a possible explanation for brisk reflexes; the single autopsy does not establish the responsible upper motor lesion.

Spasticity Impaired descending regulation of muscle tone is inferred from the reported upper motor signs; it has not been localized to the anterior-horn changes seen at autopsy.

Babinski sign An extensor plantar response indicates abnormal descending motor control, but a corresponding corticospinal lesion has not been demonstrated in the available autopsy.

Fasciculations Motor-unit dysfunction can produce fasciculations; the limited pathology permits a synaptic or axonal mechanism without requiring loss of motor-neuron somata.

Skeletal muscle atrophy Impaired motor-unit innervation can contribute to muscle wasting; this is a provisional explanation rather than evidence of generalized motor-neuron degeneration.

Muscle weakness Motor-circuit or motor-unit dysfunction can reduce force generation; sensory impairment and disuse may also contribute in individual patients.

Show evidence (3 references)

PMID:34927205 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We observed marked astrocytic gliosis and axonal swelling of the synapse between first and second motor neurons in the anterior horn at the lumbar level."

The pathology supports circuit-level abnormality in one patient.

url:https://discovery.ucl.ac.uk/id/eprint/10141005/1/awab449%20%281%29.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Although the second motor neurons in the anterior and lateral horns were preserved"

Preserved neuronal somata are part of the reported histological finding, not evidence against the described axonal and glial changes.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Brisk reflexes, particularly in the upper limbs and at the knees, are commonly observed. Other signs of upper and lower motor neuron involvement, including spasticity and/or Babinski sign, muscle atrophy, fasciculations, and weakness, are uncommon."

Current synthesis explicitly includes these features.

Cognitive Network Dysfunction

Mechanism confidence: Provisional

Executive, attention and working-memory abnormalities have been documented, sometimes meeting cerebellar cognitive affective syndrome criteria. Cerebellar and extra-cerebellar network contributions are plausible, but the responsible anatomical and molecular pathways are unresolved. Dementia is not a typical universal outcome.

Downstream

Cognitive impairment The observed impairment of attention, working memory and executive performance is the clinical expression of the proposed cognitive-network dysfunction.

Impaired executive functioning Executive deficits are a specifically measured component of the cognitive phenotype; their cerebellar and extra-cerebellar substrates remain unresolved.

Show evidence (2 references)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Deficits most frequently involve executive functions and attention ... working memory."

Current clinical synthesis identifies the affected domains.

PMID:38480525 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Twenty-one patients underwent a complete assessment, including 71% scoring lower than the cutoff at the Montreal Cognitive assessment"

A small systematically tested cohort demonstrates impairment, not a population frequency.

Multisensory Balance Failure

Mechanism confidence: Established

Sensory, vestibular and cerebellar deficits contribute variably to progressive imbalance. Their convergence reduces compensation between balance systems, but the full triad is not required at every stage. In a 392-person cohort, only half were classified as complete CANVAS at last follow-up.

Animal models

Neuronal Gnf1 knockdown flies in the 2025 preprint Drosophila melanogaster partially recapitulates Older flies showed reduced locomotor activity.

Downstream

Progressive gait imbalance and falls Combined sensory, vestibular and cerebellar deficits reduce postural stability.

Show evidence (1 reference)

PMID:38193360 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Overall, 195 patients (50%) had complete CANVAS, 131 (33%) had a complex neuropathy, while 54 (14%) still showed an isolated sensory neuropathy."

Defines the spectrum rather than universal progression to the triad.

✶

Histopathology

Sensory ganglion neuronal loss

Loss of dorsal root ganglion sensory neurons produces peripheral sensory deafferentation and secondary posterior-column degeneration. Historical autopsies predated RFC1 genotyping, while later genetically confirmed cases show concordant sensory and posterior-column pathology. The primary ganglion lesion does not require a uniformly non-length-dependent clinical distribution. Five temporal bones from four clinically defined, ungenotyped CANVAS patients showed severe vestibular ganglion neuronal loss, with relative preservation of spiral ganglia, sensory hair cells and vestibular nuclei. Trigeminal and geniculate ganglia were also affected. Ganglionic Nageotte nodules reflect glial replacement of lost neurons; they are not psammoma bodies. Relative auditory sparing does not exclude coincident presbycusis or another cause of hearing loss.

Show evidence (2 references)

PMID:24682971 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Spinal cord pathology demonstrated a marked dorsal root ganglionopathy with secondary tract degeneration."

Direct neuropathology in clinically defined CANVAS predating molecular diagnosis.

PMID:33492056 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"In CANVAS there is a severe cranial sensory ganglionopathy neuronopathy (ganglionopathy) involving the vestibular, facial, and trigeminal ganglia but sparing the auditory ganglia."

Historical pathology localizes vestibular failure primarily to ganglion neurons; these donors were not RFC1-genotyped.

Cerebellar Purkinje cell depletion

Show evidence (2 references)

PMID:24682971 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Cerebellar pathology showed loss of Purkinje cells, predominantly in the vermis."

Documents selective cerebellar pathology in historical clinical CANVAS.

PMID:30926972 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"The patient with CANVAS showed severe, widespread depletion of Purkinje cells with associated prominent Bergmann gliosis, while cell density in the granule cell layer was well preserved."

The 2019 study documents this pathology in a genetically confirmed CANVAS case.

Spinal axonal swelling and astrocytic gliosis

Upper and lower motor signs occur in a subset of RFC1 cases. One genetically confirmed autopsy showed anterior-horn astrocytic gliosis and axonal swelling around motor-neuron somata, with preserved anterior-horn neurons and corticospinal tracts. Synaptic dysfunction is proposed; generalized motor-neuron death is not established by this case. The same individual also had Lewy body pathology consistent with coexisting Parkinson disease.

Show evidence (2 references)

PMID:34927205 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We observed marked astrocytic gliosis and axonal swelling of the synapse between first and second motor neurons in the anterior horn at the lumbar level."

The pathology supports circuit-level abnormality in one patient.

url:https://discovery.ucl.ac.uk/id/eprint/10141005/1/awab449%20%281%29.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Although the second motor neurons in the anterior and lateral horns were preserved"

Preserved neuronal somata are part of the reported histological finding, not evidence against the described axonal and glial changes.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

Cardiovascular 1

Orthostatic hypotension HP:0001278

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Signs and symptoms including postural hypotension, erectile dysfunction, chronic constipation, urinary dysfunction, and altered sweating are relatively common but rarely disabling."

Defines the autonomic spectrum without a single cross-cohort frequency.

Digestive 2

Dysphagia HP:0002015

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Dysarthria and dysphagia, attributed to cerebellar dysfunction, are possible complications later in the disease course."

Separately records swallowing difficulty without misusing the composite rate.

Chronic constipation HP:0012450

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Signs and symptoms including postural hypotension, erectile dysfunction, chronic constipation, urinary dysfunction, and altered sweating are relatively common but rarely disabling."

Defines the autonomic spectrum without a single cross-cohort frequency.

Ear 1

Vestibular areflexia FREQUENT HP:0008568

Show evidence (1 reference)

PMID:38193360 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Vestibular areflexia | 147/196 (75%) | 116/147 (79%)"

Table 1 gives assessed-patient frequencies at first and repeat examinations.

Eye 5

Oscillopsia OCCASIONAL HP:0034773

Show evidence (2 references)

PMID:38193360 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Oscillopsia | 19/352 (6%) | 94/352 (27%)"

Table 1 provides symptom-specific counts.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Oscillopsia, defined as a visual disturbance in which objects appear to oscillate during head movements"

Defines the symptom.

Gaze-evoked nystagmus HP:0000640

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Examination reveals oculomotor signs (including gaze-evoked nystagmus, downbeat nystagmus, saccadic pursuit, and dysmetric saccades) and gait and limb ataxia."

Documents cerebellar manifestations.

Downbeat nystagmus HP:0010545

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Examination reveals oculomotor signs (including gaze-evoked nystagmus, downbeat nystagmus, saccadic pursuit, and dysmetric saccades) and gait and limb ataxia."

Documents cerebellar manifestations.

Dysmetric saccades HP:0000641

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Examination reveals oculomotor signs (including gaze-evoked nystagmus, downbeat nystagmus, saccadic pursuit, and dysmetric saccades) and gait and limb ataxia."

Documents cerebellar manifestations.

Saccadic pursuit Microsaccadic pursuit HP:0007792

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Examination reveals oculomotor signs (including gaze-evoked nystagmus, downbeat nystagmus, saccadic pursuit, and dysmetric saccades) and gait and limb ataxia."

Documents cerebellar manifestations.

Genitourinary 1

Erectile dysfunction HP:0100639

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Signs and symptoms including postural hypotension, erectile dysfunction, chronic constipation, urinary dysfunction, and altered sweating are relatively common but rarely disabling."

Defines the autonomic spectrum without a single cross-cohort frequency.

Integument 2

Anhidrosis HP:0000970

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Chronic constipation and/or diarrhea ... Anhidrosis or increased sweating"

The clinical presentation list includes both reduced and increased sweating; no phenotype-specific frequency is assigned.

Hyperhidrosis HP:0000975

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Chronic constipation and/or diarrhea ... Anhidrosis or increased sweating"

The clinical presentation list includes both reduced and increased sweating; no phenotype-specific frequency is assigned.

Musculoskeletal 3

Spasticity HP:0001257

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

Current synthesis explicitly includes these features.

Skeletal muscle atrophy HP:0003202

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

Current synthesis explicitly includes these features.

Muscle weakness HP:0001324

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

Current synthesis explicitly includes these features.

Nervous System 19

Progressive cerebellar ataxia HP:0002073

Course: PROGRESSIVE

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Examination reveals oculomotor signs (including gaze-evoked nystagmus, downbeat nystagmus, saccadic pursuit, and dysmetric saccades) and gait and limb ataxia."

Documents cerebellar manifestations.

Sensory ataxia HP:0010871

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Gait ataxia ... Positive Romberg and dysmetria worsened by eye closur"

The current GeneReviews examination summary describes sensory ataxia; the cached source truncates the final word.

Impaired proprioception HP:0010831

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"reduced vibration sensation in the lower limbs, and milder reduction of position sense distally"

Documents differential sensory modalities.

Sensory neuropathy HP:0000763

Show evidence (2 references)

PMID:38193360 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"All cases had signs and/or symptoms of sensory neuropathy, when investigated."

Sensory involvement was constant in this ascertained cohort.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Altered sensation in all limbs in either a length-dependent (distal extremities worse) or non-length-dependent pattern."

Avoids equating ganglion pathology with one mandatory clinical distribution.

Areflexia HP:0001284

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Reflexes can be decreased/abolished, but retained and even brisk reflexes are possible."

Documents variability rather than an obligatory examination sign.

Autonomic dysfunction Abnormal autonomic nervous system physiology HP:0012332

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Signs and symptoms including postural hypotension, erectile dysfunction, chronic constipation, urinary dysfunction, and altered sweating are relatively common but rarely disabling."

Defines the autonomic spectrum without a single cross-cohort frequency.

Dysarthria HP:0001260

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Dysarthria and dysphagia, attributed to cerebellar dysfunction, are possible complications later in the disease course."

Documents the speech manifestation.

Cerebellar atrophy HP:0001272

Show evidence (2 references)

PMID:32851396 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Individual M2 III:4 had a normal brain MRI 3 years after symptom onset, but subsequent CT head scans showed cerebellar atrophy."

Shows that imaging can lag clinical onset.

PMID:40908706 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"No significant changes were observed in other regions of the cerebellum compared to the changes in the controls. Microstructural analysis of white matter integrity revealed no significant longitudinal changes between groups."

Preserves the negative longitudinal imaging results alongside extra-cerebellar changes.

Progressive gait imbalance and falls VERY_FREQUENT Unsteady gait HP:0002317

Course: PROGRESSIVE

Show evidence (1 reference)

PMID:38193360 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Unsteadiness | 255/388 (66%) | 366/388 (94%)"

Frequency concerns unsteadiness, not the separate frequency of falls.

Hyperreflexia HP:0001347

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

Current synthesis explicitly includes these features.

Babinski sign HP:0003487

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

Current synthesis explicitly includes these features.

Fasciculations HP:0002380

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

Current synthesis explicitly includes these features.

Paresthesia HP:0003401

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"which include loss of feeling, pins and needles, pain, and cramps"

Documents positive sensory symptoms.

Impaired lower-limb vibration sensation Impaired vibration sensation in the lower limbs HP:0002166

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"reduced vibration sensation in the lower limbs, and milder reduction of position sense distally"

Documents differential sensory modalities.

Cognitive impairment HP:0100543

Show evidence (2 references)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Deficits most frequently involve executive functions and attention ... working memory."

Current clinical synthesis identifies the affected domains.

PMID:38480525 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Twenty-one patients underwent a complete assessment, including 71% scoring lower than the cutoff at the Montreal Cognitive assessment"

A small systematically tested cohort demonstrates impairment, not a population frequency.

Impaired executive functioning HP:0033051

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Deficits most frequently involve executive functions and attention ... working memory."

Current clinical synthesis identifies the affected domains.

Parkinsonism HP:0001300

Show evidence (1 reference)

PMID:34927205 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Parkinsonism was more prevalent in this cohort than in the general population, 10% versus the expected 1%"

Reports an association in a selected series, not a general population estimate.

REM sleep behavior disorder HP:5200291

Show evidence (1 reference)

PMID:32851396 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We report rapid eye movement sleep behaviour disorder as a feature of CANVAS for the first time, occurring in both our New Zealand European and Māori patients"

Documents the feature without asserting a molecular mechanism.

Autonomic bladder dysfunction HP:0005341

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Signs and symptoms including postural hypotension, erectile dysfunction, chronic constipation, urinary dysfunction, and altered sweating are relatively common but rarely disabling."

Defines the autonomic spectrum without a single cross-cohort frequency.

Respiratory 1

Chronic cough FREQUENT HP:0034315

Show evidence (1 reference)

PMID:38193360 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Chronic cough was investigated in 358 patients (91%) and reported by 267 of them (75%). Cough was the presenting symptom in half of the cases."

Supports FREQUENT for this specified cohort.

Constitutional 1

Neuropathic pain HP:0012531

HP:6000040 Neuropathic pain is a pain-characteristic modifier rather than a descendant of Phenotypic abnormality, so the phenotype binds to Pain with its clinical specificity retained in preferred_term.

Show evidence (1 reference)

PMID:36289003 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"unsteadiness, worse in the dark, followed a few years later by neuropathic pain and oscillopsia related to head movements"

Clinical history directly documents neuropathic pain.

🧬

Genetic Associations

RFC1

Gene: RFC1 hgnc:9969 relationship_type: CAUSATIVE variant_origin: GERMLINE

Show evidence (8 references)

PMID:30926972 SUPPORT DIRECT PRIMARY RESULT Human Clinical

Identifies biallelic intronic RFC1 AAGGG expansion as the cause of CANVAS.

PMID:31230722 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"a recessively inherited, ancient RE located in intron 2 of RFC1 is the predominant cause of CANVAS"

Independent confirmation that the intron 2 repeat expansion is the predominant cause.

PMID:32851396 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We show a novel, possibly population-specific CANVAS configuration (AAAGG)10-25(AAGGG)exp, which was the cause of CANVAS in all patients."

Documents a population-specific founder repeat configuration.

+ 5 more references

💊

Medical Actions

Multidisciplinary supportive care

Action: Supportive Care NCIT:C15747

Platform: Behavioral / lifestyle

Coordinate neurology, rehabilitation, ENT, respiratory, speech and swallowing care, with annual neurological and mobility review and more frequent assessment when symptoms change. Current care maximizes function and manages complications; no disease-modifying benefit has been established.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"The goals of treatment are to maximize function and reduce complications."

Expert management synthesis; not a CANVAS-specific treatment trial.

Physical and vestibular rehabilitation

Action: Physical Therapy NCIT:C15302

Platform: Behavioral / lifestyle

Individualized balance, gait and strengthening work, occupational therapy, home adaptations and mobility aids address falls and daily function. Consider vestibular rehabilitation; these recommendations are largely extrapolated from rehabilitation practice.

Target Phenotypes: Progressive gait imbalance and falls HP:0002317 Vestibular areflexia HP:0008568

Show evidence (2 references)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"PT (balance exercises, gait training, muscle strengthening) to maintain mobility"

Current GeneReviews treatment table recommends rehabilitation.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Consider vestibular rehab. ... Home adaptations to prevent falls"

Recommendations target balance and falls.

Speech and swallowing support

Action: Supportive Care NCIT:C15747

Platform: Behavioral / lifestyle

Use speech-language therapy and communication aids as needed. Assess aspiration and nutrition; adjust food consistency for dysphagia based on swallowing assessment.

Target Phenotypes: Dysarthria HP:0001260 Dysphagia HP:0002015

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"speech-language therapy for dysarthria; modify food consistency to decrease aspiration risk in those with dysphagia"

Current expert guidance for bulbar manifestations.

Specialist management of refractory cough

Action: Supportive Care NCIT:C15747

Platform: Behavioral / lifestyle

Assess common treatable contributors. Cough-control speech or physical therapy and individualized neuromodulator trials may be considered; reflux treatment is appropriate when reflux is present. Benefits and tolerability vary.

Target Phenotypes: Chronic cough HP:0034315

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Consider cough neuromodulator (e.g. gabapentin, amitriptyline, pregabalin). ... Consider speech therapy ... PT for cough control."

Expert recommendations; comparative efficacy in RFC1 disease is uncertain.

Low-dose sustained-release morphine for refractory cough

Action: Sustained-release morphine sulfate treatment Ontology label: Pharmacotherapy NCIT:C15986

Agent: Morphine Sulfate Sustained-Release Tablet NCIT:C84853

Platform: Small molecule

A prospective uncontrolled 2026 series offered sustained-release morphine sulfate 10 mg twice daily to 17 genetically confirmed patients for six months. Eleven reported residual nondebilitating cough, four cessation, one partial improvement and one withdrew because of nausea. Follow-up used unvalidated self-report, without placebo control or repeat baseline VAS/LCQ instruments. This is symptomatic evidence requiring individualized specialist assessment, not disease modification.

Target Phenotypes: Chronic cough HP:0034315

Show evidence (1 reference)

PMID:41532091 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"11 (64.7%) had good response with residual non-debilitating cough and four (23.5%) had cough cessation ... One (5.9%) patient had to discontinue morphine because of nausea."

Small uncontrolled intervention series; outcomes require confirmation.

Autonomic symptom management

Action: Supportive Care NCIT:C15747

Platform: Behavioral / lifestyle

Tailor care to orthostatic, urinary, bowel, sexual and sudomotor symptoms; severe manifestations warrant focused evaluation for competing or additional causes.

Target Phenotypes: Autonomic dysfunction HP:0012332 Orthostatic hypotension HP:0001278 Chronic constipation HP:0012450 Erectile dysfunction HP:0100639

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Consider treatment for erectile dysfunction, urinary incontinence/retention, constipation/diarrhea, dry eyes/mouth."

Expert symptom-directed guidance.

Individualized medication and alcohol review

Action: Supportive Care NCIT:C15747

Platform: Behavioral / lifestyle

Assess medication necessity and potential peripheral, cerebellar or vestibular toxicity individually. The September 2026 GeneReviews update states that evidence does not support categorical avoidance of specific medications. Alcohol may worsen ataxia and should be consumed in moderation. A preprint association between heterozygous expansions and oxaliplatin neuropathy is not a validated prescribing rule.

Show evidence (2 references)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"there is currently no evidence-based guidance recommending avoidance of specific medications, and treatment decisions should be based on clinical need."

Replaces the older blanket medication-avoidance recommendation.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Alcohol, which can exacerbate ataxia, should only be consumed in moderation."

Current precautionary advice.

Genetic counseling

Action: Genetic Counseling NCIT:C15240

Platform: Behavioral / lifestyle

Explain recessive inheritance, motif-dependent interpretation, possible pseudodominance and age-dependent or incomplete expression. Offer appropriate family testing and reproductive counseling after molecular clarification. If both parents are heterozygous carriers, each pregnancy has a 25% chance of a child with biallelic variants, a 50% chance of a heterozygous carrier, and a 25% chance of inheriting neither familial variant. Confirm parental genotypes because pseudodominance changes this calculation.

Show evidence (2 references)

PMID:39230846 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We describe pseudodominance in two families affected with RFC1 disorder (10 affected, 5 oligo/asymptomatic individuals)."

Documents actual multigenerational families, including oligo/asymptomatic biallelic relatives.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Assuming that both parents are heterozygous for an ... pathogenic variant, each sib of an affected individual has at conception a 25% chance of inheriting biallelic ... pathogenic variants, a 50% chance of inheriting one pathogenic variant, and a 25% chance of inheriting neither of the familial..."

Conditional recurrence risks for two heterozygous parents; not a universal risk for every RFC1 family.

🔬

Diagnosis

RFC1 repeat genotyping and second-allele sequencing

Use motif-aware flanking and repeat-primed PCR, with Southern blotting, long-read sequencing or optical genome mapping when needed to resolve size and configuration. Specialized whole-genome pipelines can screen repeats; routine exome sequencing cannot reliably exclude them. If only one expansion is found in a typical phenotype, sequence RFC1 for a coding or splice second allele. Ambiguous motifs require cautious interpretation.

Genetic Testing NCIT:C15709

Show evidence (3 references)

PMID:36289003 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"full RFC1 sequencing is recommended in cases affected by typical CANVAS and carrying monoallelic (AAGGG)n expansions."

Supports the complementary role of coding sequencing.

PMID:41964406 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Both WGS and PCR methods face challenges in precisely quantifying repeat number, particularly in the presence of multiple repeat motifs."

Recognizes platform and motif limitations.

PMID:40481300 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We also demonstrate the utility of targeted long-read sequencing in resolving complex alleles."

Supports long-read resolution in an Australian clinical series.

Sensory nerve conduction studies

Reduced or absent sensory action potentials support sensory neuronopathy. Motor conduction is often preserved, but motor abnormalities should not automatically exclude RFC1 testing. Needle EMG can assess additional motor involvement.

Nerve Conduction Velocity Test NCIT:C88502

Show evidence (2 references)

PMID:36289003 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Nerve conduction studies showed absent sensory action potentials in the upper and lower limbs but normal motor studies."

Typical electrophysiology in an expansion/truncating case.

PMID:41964406 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"the presence of motor nerve involvement should not preclude patients from undergoing RFC1 repeat screening."

The broader idiopathic-neuropathy cohort included sensorimotor cases.

Vestibular and oculomotor examination

Bedside and video head-impulse testing, caloric or rotational-chair testing assess bilateral vestibular loss. Impaired visually enhanced vestibuloocular reflex suggests combined vestibular and cerebellar involvement.

Physical Examination NCIT:C20989

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Examination reveals absent/reduced vestibuloocular reflex at bedside or video head impulse test. An impaired visually enhanced vestibuloocular reflex indicates the coexistence of vestibular and cerebellar pathology."

Specifies the diagnostic physiological findings.

Brain MRI

Assess cerebellar vermian and hemispheric atrophy and alternative diagnoses. A normal early study does not exclude the disorder. Quantitative brainstem and other regional measures remain candidate progression biomarkers rather than validated diagnostic substitutes.

Magnetic Resonance Imaging NCIT:C16809

Show evidence (2 references)

PMID:32851396 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Individual M2 III:4 had a normal brain MRI 3 years after symptom onset, but subsequent CT head scans showed cerebellar atrophy."

Shows that imaging can lag clinical onset.

PMID:40908706 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"our small sample and late-stage cohort are limitations"

The ten-patient longitudinal biomarker study requires larger prospective validation.

Autonomic assessment

Evaluate postural blood pressure, bladder and bowel symptoms, sexual and sudomotor function; use targeted sympathetic and parasympathetic testing when clinically indicated.

Physical Examination NCIT:C20989

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Autonomic testing confirms the presence of a sympathetic and/or parasympathetic dysfunction in half of individuals undergoing specific investigations."

Physiological dysfunction is established without assigning a specific ganglionic lesion.

📈

Progression

Adult neurological onset

Age: 25–80 years in the 392-person cohort

Median neurological onset was 54 years; cough was excluded from this definition and can begin decades earlier. An atypical Māori patient with childhood onset was reported, but the authors could not exclude a second condition.

Show evidence (2 references)

PMID:38193360 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Median age at onset of neurological symptoms (cough excluded) was 54 years (IQR = 49–61), ranging from 25 to 80 years."

Defines the cohort and onset endpoint.

PMID:32851396 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"the possibility of a second condition cannot be excluded."

The unusual childhood presentation should not redefine the usual onset distribution.

Variable progression of multisystem involvement

At last follow-up, half of the 392-person cohort had complete CANVAS, one third complex neuropathy and 14% isolated sensory neuropathy. Walking aids were required by 54% after a median ten years and a wheelchair by 17% after fourteen years. These are retrospective cohort observations, not individual prognoses.

Show evidence (2 references)

PMID:38193360 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Overall, 195 patients (50%) had complete CANVAS, 131 (33%) had a complex neuropathy, while 54 (14%) still showed an isolated sensory neuropathy."

Defines the spectrum rather than universal progression to the triad.

PMID:38193360 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Fifty-four per cent of patients required walking aids after a median disease duration of 10 years (IQR = 5–16) and 17% needed a wheelchair after 14 years (IQR = 11–21)."

Quantifies disability milestones in a defined series.

Repeat size and modifying factors

Larger expansions, particularly the smaller allele, correlate with earlier onset and more complex or faster-progressing disease. Repeat size explained at most 6% of onset variation. Most measured transmissions changed by less than 10%; these results do not establish genetic anticipation.

Show evidence (2 references)

PMID:38193360 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"the repeat size explained only up to 6% of the variability in age of neurological disease onset"

Most onset variability remains unexplained.

PMID:38193360 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Expansion or contraction of the repeat across generations occurred with the same frequency."

Limits anticipation claims.

📊

Prevalence

European-derived 2019 estimate of the recessive genotype at birth

Birth Prevalence 5.0 per 100,000 1–9 per 100,000 (births)

Historical estimate of the biallelic genotype from the original expansion study, approximately 1 in 20,000. This is not measured clinical disease prevalence or a contemporary worldwide rate. Later population-sequencing studies report substantially higher genotype frequencies and reduced penetrance.

Show evidence (1 reference)

PMID:30926972 SUPPORT PRIMARY RESULT Human Clinical

"with an estimated prevalence at birth of the recessive trait of approximately 1 in 20,000"

Population birth prevalence of the recessive genotype, i.e. 5 per 100,000.

European general population (carrier frequency)

Carrier Frequency 700.0 per 100,000 >1 in 1,000 (carriers)

The 2019 study estimated 0.7% heterozygous carriers in Europeans. This historical estimate should be distinguished from the higher frequencies in later population-sequencing studies summarized by GeneReviews in September 2026.

Show evidence (1 reference)

PMID:30926972 SUPPORT PRIMARY RESULT Human Clinical

"an expansion carrier frequency of 0.7% in Europeans"

Original carrier-frequency estimate in Europeans.

Predominantly northern European populations, population sequencing summarized in September 2026 GeneReviews

Carrier Frequency 8000.0 per 100,000 >1 in 1,000 (carriers)

Heterozygote expansion-carrier estimate of 8%, not clinical disease prevalence. Short-read repeat calls and repeat-size-dependent penetrance affect interpretation.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"The heterozygote carrier frequency of ... AAGGG repeat expansions is 8% in populations of predominantly northern European origin"

The current chapter summarizes the population-sequencing estimate.

Biallelic RFC1 AAGGG genotype in population-sequencing studies summarized in September 2026 GeneReviews

Point Prevalence >1 in 1,000

Biallelic AAGGG genotype frequency was estimated at 1:517 to 1:951. This is a genotype frequency, not the prevalence of symptomatic CANVAS; reduced penetrance, especially for shorter expansions, limits conversion to a clinical disease rate.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"The prevalence of individuals with biallelic AAGGG repeat expansions is 1:517 to 1:951"

A genotype-frequency range; clinical manifestations may be less frequent.

Australian cohort referred with adult-onset ataxia

Unknown

Diagnostic yield was 34.1% among 232 individuals referred with adult-onset ataxia, not population prevalence. The study also estimated approximately 1 in 16 heterozygous AAGGG carriers among 269 controls.

Show evidence (1 reference)

PMID:40481300 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Biallelic pathogenic RFC1 variants were identified in 34.1% of affected individuals."

Cohort-specific yield.

US idiopathic peripheral neuropathy cohort

Unknown

18/788 patients carried biallelic AAGGG expansions versus 1/778 controls. Yield was 10/144 (6.9%) in pure sensory neuropathy. Monoallelic enrichment was not significant after appropriate control filtering (p=0.17); this study does not establish dominant RFC1 neuropathy.

Show evidence (1 reference)

PMID:41964406 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"biallelic (AAGGG)exp in RFC1 accounted for 2.3% (18/788) of iPN cases"

Cohort-specific yield.

🔀

Differential Diagnoses

Conditions with similar clinical presentations that must be differentiated from CANVAS:

Friedreich ataxia MONDO:0100339

Overlapping Features Sensory ataxia and possible vestibular impairment overlap with CANVAS.

Distinguishing Features

Usually earlier onset, although late-onset cases exist.
Cardiomyopathy, diabetes, pyramidal signs and skeletal deformities may help distinguish the phenotype.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Muscle weakness, pyramidal involvement (Babinski signs), ... skeletal deformities (pes cavus, scoliosis) are frequent features."

Current differential table identifies useful clinical contrasts.

Multiple system atrophy MONDO:0007803

Overlapping Features Cerebellar ataxia and autonomic failure can resemble CANVAS.

Distinguishing Features

More rapid progression and severe early autonomic failure favor MSA.
Prominent sensory neuronopathy and bilateral vestibular failure favor RFC1 disease; MRI pattern can help.
REM sleep behavior disorder and parkinsonism can occur in RFC1 disease and are not absolute exclusions.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable SUPPORT DIRECT REVIEW SYNTHESIS Other

"Multisystem atrophy (MSA) is a rapidly progressive neurodegenerative disease that can present with a wide range of clinical manifestations, including cerebellar ataxia and autonomic failure"

Highlights tempo and autonomic overlap.

🔬

Clinical Trials

NCT05177809 NOT_APPLICABLE RECRUITING

Prospective international observational natural-history and biomarker study, targeting 150 participants including RFC1 cases and controls over 24 months.

Show evidence (1 reference)

clinicaltrials:NCT05177809 SUPPORT DIRECT PRIMARY RESULT Other

"This international, multi-center, multi-modal and prospective observational study aims to determine the phenotypic spectrum and the natural progression of the RFC1 repeat expansion disease"

Registry summary defines the observational purpose.

NCT07156214 NOT_APPLICABLE RECRUITING

Basic-science biomarker study in CANVAS and controls, with serial blood sampling and research on available fibroblasts and induced pluripotent cells; planned enrollment 50.

Show evidence (1 reference)

clinicaltrials:NCT07156214 SUPPORT DIRECT PRIMARY RESULT Other

"limited data are available regarding its natural history and the molecular mechanisms by which this dynamic mutation leads to neurodegeneration of selective neuronal populations."

Registry rationale for mechanistic and biomarker research.

NCT06817707 NOT_APPLICABLE RECRUITING

Diagnostic study of urinary dysfunction, dysautonomia and urological complications in genetically confirmed CANVAS; planned enrollment 40.

Show evidence (1 reference)

clinicaltrials:NCT06817707 SUPPORT DIRECT PRIMARY RESULT Other

"The primary objective of this study is to evaluate the incidence of urinary symptoms in these patients, as well as the potential complications that might occur at the level of the upper and lower urinary system."

Registry describes urinary assessment.

🧫

Experimental Models

Expansion/truncating-allele patient fibroblasts PRIMARY_CELL_CULTURE

Fibroblasts from two p.Arg423Ter siblings and one p.Pro959GlnfsTer24 carrier were compared with repeat-only cases, controls and an unaffected sibling. Protein data directly characterize the two p.Arg423Ter siblings.

Publication

PMID:36289003

Pathograph links

Decay of Truncating RFC1 Transcripts partially recapitulates fidelity: high observes: molecular Allele-specific RNA depletion supports nonsense-mediated decay.

Show evidence (1 reference)

PMID:36289003 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Together, the findings suggest that the transcript containing truncating variants in RFC1 undergo nonsense-mediated decay leading to RNA degradation."

Patient fibroblast studies characterize the truncating allele in the compound genotype.

Reduced RFC1 Protein in Truncating-Allele Carriers partially recapitulates fidelity: high observes: molecular Full-length RFC1 protein is reduced in tested compound heterozygotes.

Limitations: Peripheral fibroblasts do not reproduce neuronal vulnerability, and protein reduction was not shown for every coding allele.

Show evidence (1 reference)

PMID:36289003 SUPPORT DIRECT PRIMARY RESULT In Vitro

"immunoblotting showed a concordant reduction of the 140 KD full-length RFC1 protein in fibroblasts from affected individuals"

Protein reduction accompanies allele-specific RNA decay.

Patient-derived glutamatergic forebrain neurons IPSC_DERIVED_MODEL

Four patient and three control iPSC lines were generated; key functional comparisons used three per group. These predominantly cortical-like neurons are immature and do not directly represent sensory ganglia or Purkinje cells. One patient line supplied a monoallelic Alu-repeat deletion comparator.

Publication

PMID:39231235

Pathograph links

Impaired Neuronal Synaptic Signaling partially recapitulates fidelity: moderate observes: cellular Synaptic transcripts/proteins and network synchrony were abnormal.

Limitations: Short-term forebrain cultures do not establish the mechanism of adult sensory or cerebellar neuronal loss.

Show evidence (1 reference)

PMID:39231235 SUPPORT DIRECT PRIMARY RESULT In Vitro

"CANVAS patient iPSC–derived neurons remained devoid of detectable synchronous firing even between 7 and 11 weeks after differentiation"

Patient neurons had impaired network synchrony.

Impaired Neuronal Synaptic Signaling rescues fidelity: moderate observes: cellular Monoallelic Alu-repeat deletion partially restored gene expression and synchrony (42% versus 70% control network correlation).

Limitations: Deleting the Alu-repeat region can alter several functions; rescue does not isolate toxic RNA, peptide or expression mechanisms.

Show evidence (1 reference)

PMID:39231235 SUPPORT DIRECT PRIMARY RESULT In Vitro

"with an average network correlation of 42% compared to 70% in controls"

Correction is partial and derives from one isogenic patient background.

RFC1 Intron 2 Retention fails to recapitulate fidelity: moderate observes: molecular Intron retention and aberrant splicing were not increased.

Limitations: This conflicts with earlier small-sample pre-mRNA results and does not exclude other tissues or RNA assays.

Show evidence (1 reference)

PMID:39231235 SUPPORT DIRECT PRIMARY RESULT In Vitro

Direct negative RNA-processing result.

Delayed Repair of Platinum-Induced DNA Damage fails to recapitulate fidelity: moderate observes: molecular UV-induced gamma-H2AX recovery was normal.

Limitations: UV recovery in cortical-like neurons differs from platinum-adduct repair in lymphoblasts and platinum sensitivity in sensory/motor neurons.

Show evidence (1 reference)

PMID:39231235 SUPPORT DIRECT PRIMARY RESULT In Vitro

"First-derivative analysis of normalized γ-H2AX indicated no differences in the rate of γ-H2AX recovery after UV induction between CANVAS and control neurons"

The published UV assay limits generalization across forms of DNA damage.

RFC1 knockdown and re-expression in forebrain neurons IPSC_DERIVED_MODEL

Sustained shRNA depletion in control neurons was compared with repeat-bearing patient neurons. Separate lentiviral RFC1 re-expression experiments tested patient-neuron rescue.

Publication

PMID:39231235

Pathograph links

Impaired Neuronal Synaptic Signaling fails to recapitulate fidelity: moderate observes: cellular Knockdown failed to reproduce the CANVAS-like transcriptomic signature or most network deficits.

Limitations: Knockdown did reduce burst strength; re-expression modestly changed firing correlation and burst rate but did not broadly restore the patient signature. This does not exclude effects in other neuronal lineages.

Show evidence (1 reference)

PMID:39231235 SUPPORT DIRECT PRIMARY RESULT In Vitro

"RFC1 knockdown in control neurons does not induce CANVAS-like transcriptomic alterations"

The negative transcriptomic comparison limits a simple depletion model.

HEK293T repeat-dependent translation reporter CELL_LINE

Upstream AAGGG-repeat EGFP reporters test protein output in HEK293T cells.

Publication

PMID:38266156

Pathograph links

Reduced Translation in Repeat Reporter Assays partially recapitulates fidelity: low observes: molecular AAGGG reporter constructs reduce protein output without a corresponding reporter-mRNA reduction.

Limitations: This is a translation readout; it does not measure endogenous RFC1 transcription.

Show evidence (1 reference)

PMID:38266156 SUPPORT DIRECT PRIMARY RESULT In Vitro

"reduce gene expression via impairing the translation process in a repeat-length-dependent manner"

Reporter assays support a translation effect in their specific construct context.

HEK repeat-associated poly-KGREG reporter CELL_LINE

Short AAGGG/CCCTT repeat reporters test peptide production in HEK cells.

Publication

PMID:39231235

Pathograph links

Repeat-Associated Poly-KGREG Production partially recapitulates fidelity: low observes: molecular AAGGG reporters produce poly-KGREG.

Limitations: Overexpressed short repeats and epitope-tagged constructs cannot establish endogenous peptide toxicity.

Show evidence (1 reference)

PMID:39231235 SUPPORT DIRECT PRIMARY RESULT In Vitro

"AAGGG repeats are translated into pentapeptide repeat proteins"

Reporter assays demonstrate translation.

HEK SV40-origin repeat replication assay CELL_LINE

SV40-origin replicating episomes test repeat-dependent fork stalling in human HEK cells.

Publication

PMID:38381906

Pathograph links

Repeat-Associated Replication Fork Stalling partially recapitulates fidelity: low observes: molecular AAGGG episomes impede fork progression.

Limitations: SV40 T-antigen replication differs from normal chromosomal replisomes, and postmitotic neuronal injury was not measured.

Show evidence (1 reference)

PMID:38381906 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Finally, the pathogenic, but not the nonpathogenic, repeat stalls replication fork progression in yeast and human cells."

Measures replication impediments in model systems.

Short-repeat expression in primary rat cortical neurons PRIMARY_CELL_CULTURE

Primary cortical neurons expressed 61-unit AAGGG or CCCTT constructs for ten days, with GFP and toxic CGG-repeat controls.

Publication

PMID:39231235

Pathograph links

Cerebellar Purkinje Cell Loss fails to recapitulate fidelity: low observes: cellular Short CANVAS-repeat constructs did not produce neuronal death.

Limitations: The cells are cortical rather than Purkinje neurons, repeats are shorter than clinical expansions, and expression occurs outside the endogenous locus; other contexts remain unresolved.

Show evidence (1 reference)

PMID:39231235 SUPPORT DIRECT PRIMARY RESULT In Vitro

"expression of 61 repeats is insufficient to elicit neurodegeneration in a rodent neuronal model system"

The negative survival assay limits a simple short-repeat toxicity model.

Isogenic sensory-neuron models in the 2025 preprint IPSC_DERIVED_MODEL

Unreviewed study using two CANVAS backgrounds and monoallelic or biallelic Alu-repeat deletions. NGN2/BRN3A-induced mechanoreceptor-like neurons showed about 15% lower RFC1 mRNA versus biallelic corrected cells, but similar unstressed survival.

Publication

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml

Pathograph links

Context-Dependent Reduction of RFC1 Transcript Abundance partially recapitulates fidelity: moderate observes: molecular RFC1 mRNA was modestly reduced; protein reduction was not demonstrated.

Limitations: The statistical difference was specific to the biallelic-corrected comparison; this preprint requires replication.

Show evidence (1 reference)

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml SUPPORT DIRECT PRIMARY RESULT In Vitro

"was 15% lower in CANVAS"

Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Sensory-neuron qPCR relative to isogenic biallelic corrections.

Delayed Repair of Platinum-Induced DNA Damage rescues fidelity: moderate observes: cellular Repeat-region deletion reduced cisplatin-induced apoptosis, reaching significance at 5 micromolar after 24 hours.

Limitations: Apoptosis is a downstream stress readout, not a direct repair-kinetics assay. Deletion does not identify the mediator of rescue.

Show evidence (1 reference)

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml SUPPORT DIRECT PRIMARY RESULT In Vitro

"reaching significance after 24 h of 5 µM cisplatin treatment"

Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Sensory-neuron stress response after repeat-region correction.

Dorsal Root Ganglion Sensory Neuronopathy fails to recapitulate fidelity: moderate observes: cellular Patient-repeat sensory neurons did not show reduced unstressed survival.

Limitations: One-month cultures cannot exclude slowly accumulating damage in adult sensory ganglia.

Show evidence (1 reference)

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml SUPPORT DIRECT PRIMARY RESULT In Vitro

"the survival of sensory neurons harbouring CANVAS-associated repeats was similar compared to isogenic control lines"

Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). The short-term cultures did not reproduce spontaneous sensory-neuron loss.

Isogenic lower-motor-neuron models in the 2025 preprint IPSC_DERIVED_MODEL

Unreviewed study of two CANVAS lines and isogenic corrections. RFC1 mRNA was about 23% lower versus isogenic controls but not significantly lower versus unrelated controls. Baseline morphology and neurite measures were similar.

Publication

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml

Pathograph links

Context-Dependent Reduction of RFC1 Transcript Abundance partially recapitulates fidelity: moderate observes: molecular The qPCR difference depends on isogenic comparison.

Limitations: No demonstrated protein reduction; distinct lineage and background control from the published cortical-neuron study.

Show evidence (1 reference)

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml SUPPORT DIRECT PRIMARY RESULT In Vitro

"expression could only be detected when comparing CANVAS lines with their isogenic corrected counterpart, but not when comparing CANVAS lines with non-isogenic controls"

Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Motor-neuron qPCR showed about 23% lower expression versus isogenic controls; sensory-neuron reduction was about 15%.

Delayed Repair of Platinum-Induced DNA Damage rescues fidelity: moderate observes: cellular Biallelic Alu-repeat deletion reduced cisplatin-induced apoptosis.

Limitations: Platinum challenge does not demonstrate spontaneous motor-neuron degeneration or universal DNA-repair deficiency.

Show evidence (1 reference)

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml SUPPORT DIRECT PRIMARY RESULT In Vitro

"leading to a marked reduction of the number of apoptotic cells in cisplatin-treated"

Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Isogenic correction rescues a platinum-stress phenotype.

Patient lymphoblastoid platinum-challenge models in the 2025 preprint CELL_LINE

Unreviewed comparison of five patient and five control lymphoblastoid lines, with continuous platinum exposure and pulse-chase platinum-DNA adduct measurements.

Publication

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml

Pathograph links

Delayed Repair of Platinum-Induced DNA Damage partially recapitulates fidelity: moderate observes: molecular Adduct removal was slower and apoptosis occurred earlier.

Limitations: Lymphoblasts are dividing peripheral cells. Recovery approached control levels by 72 hours, and other DNA-damage classes were not tested.

Show evidence (1 reference)

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml SUPPORT DIRECT PRIMARY RESULT In Vitro

"repair in CANVAS LCLs was significantly slower, reaching levels comparable to control cells only after 72 h"

Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Measures delayed repair after a cisplatin pulse.

Synthetic repeat nucleic-acid structural assays OTHER

Short DNA and RNA oligonucleotides were examined by NMR, circular dichroism, chemical probing and polymerase assays under controlled ionic conditions.

Publication

PMID:38266156

Pathograph links

Repeat DNA Secondary Structures partially recapitulates fidelity: low observes: molecular AAGGG DNA can form parallel G-quadruplexes or H-r triplexes.

Limitations: Short synthetic tracts and assay buffers do not establish the dominant structure of chromatinized patient repeats.

Show evidence (2 references)

PMID:38266156 SUPPORT DIRECT PRIMARY RESULT In Vitro

"we report that the pathogenic RFC1 AAGGG repeats form DNA and RNA parallel G-quadruplex (G4) structures that play a role in impairing biological processes"

Biophysical assays establish folding capacity of short repeats.

+ 1 more reference

Repeat RNA G-Quadruplex Formation partially recapitulates fidelity: low observes: molecular Short AAGGG RNA forms G-quadruplexes.

Limitations: The RNA strand and endogenous transcript context differ from RFC1 sense CCCTT RNA.

Show evidence (1 reference)

PMID:38266156 SUPPORT DIRECT PRIMARY RESULT In Vitro

"we report that the pathogenic RFC1 AAGGG repeats form DNA and RNA parallel G-quadruplex (G4) structures that play a role in impairing biological processes"

Biophysical assays establish folding capacity of short repeats.

🐁

Animal Models

Yeast plasmid AAGGG replication model

AAGGG tracts stall forks preferentially when the purine-rich strand is the lagging-strand template.

Species

Saccharomyces cerevisiae

Genotype

Plasmids containing orientation-controlled AAGGG repeats; comparison with AAAAG repeats and pif1 deletion

Publication

PMID:38381906

Pathograph links

Repeat-Associated Replication Fork Stalling partially recapitulates fidelity: low observes: molecular Pathogenic-repeat plasmids show fork stalling.

Limitations: Plasmid replication in dividing yeast does not reproduce the endogenous human intron or adult neuronal phenotype; PIF1 deletion did not enhance the stall.

Show evidence (1 reference)

PMID:38381906 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Analysis of yeast replication intermediates using two-dimensional gel electrophoresis demonstrates orientation-dependent stalling at (A2G3)60 repeats."

The yeast-specific replication-intermediate assay directly demonstrates the model phenotype.

Complete rfc1 knockout zebrafish

Complete loss causes early cerebellar progenitor DNA-damage accumulation, impaired proliferation, apoptosis and reduced granule/Purkinje-cell populations, followed by death by 10 days post fertilization. Heterozygotes survive normally.

Species

Danio rerio

Genotype

Homozygous 20-bp deletion in exon 5, predicted p.S182X

Publication

PMID:40595562

Pathograph links

Cerebellar Purkinje Cell Loss partially recapitulates fidelity: low observes: cellular Purkinje-cell numbers are reduced following early progenitor injury.

Limitations: This is a lethal developmental null model, not adult-onset degeneration caused by a patient repeat. Granule-cell depletion is also prominent, unlike relative granule-cell preservation in some human autopsies.

Show evidence (1 reference)

PMID:40595562 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the loss of RFC1 jeopardizes the genomic integrity of these progenitor cells"

Complete knockout disrupts developing progenitor populations.

Delayed Repair of Platinum-Induced DNA Damage perturbs fidelity: low observes: molecular DNA-damage markers accumulate in developing neural progenitors.

Limitations: Gamma-H2AX and apoptotic readouts do not specifically demonstrate the platinum-adduct repair defect proposed in human repeat-bearing cells.

Show evidence (1 reference)

PMID:40595562 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the loss of RFC1 jeopardizes the genomic integrity of these progenitor cells"

Complete knockout disrupts developing progenitor populations.

Neuronal Gnf1 knockdown flies in the 2025 preprint

Unreviewed neuronal knockdown model with late-life locomotor reduction, shortened survival and increased neuronal H2Av staining. Young flies initially retained normal activity; global knockdown was lethal. This is ortholog depletion, not a patient-repeat transgene.

Species

Drosophila melanogaster

Genotype

nsyb-Gal4-driven shRNA depletion of Gnf1, the RFC1 ortholog

Publication

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml

Pathograph links

Multisensory Balance Failure partially recapitulates fidelity: low observes: organism Older flies showed reduced locomotor activity.

Limitations: General fly activity does not resolve human cerebellar, sensory and vestibular components; the repeat allele is absent.

Show evidence (1 reference)

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml SUPPORT DIRECT PRIMARY RESULT Model Organism

"knockdown induced a significant reduction in total locomotor activity compared to driver- and transgene-alone controls"

Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Late-life behavioral effect after ortholog knockdown.

Delayed Repair of Platinum-Induced DNA Damage perturbs fidelity: low observes: molecular Neuronal H2Av staining increased before and during overt motor impairment.

Limitations: A damage marker after gene depletion does not establish a specific repair pathway or the molecular effect of the human repeat.

Show evidence (1 reference)

url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml SUPPORT DIRECT PRIMARY RESULT Model Organism

"a significant increase in neuronal H2Av staining ... knockdown flies compared to controls at both ages"

Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). DNA-damage-associated staining at 12 and 40–42 days.

{ }

Source YAML

click to show

name: CANVAS
category: Mendelian
creation_date: '2026-07-30T20:10:00Z'
synonyms:
- Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome
- RFC1 CANVAS spectrum disorder
- Cerebellar ataxia with bilateral vestibulopathy syndrome
- CABV syndrome
- RFC1-related disorders
description: 'CANVAS is an autosomal recessive RFC1-related neurodegenerative disorder characterized by sensory neuronopathy, cerebellar dysfunction and bilateral vestibular hypofunction. This entry includes the broader RFC1 spectrum, in which sensory neuropathy with or without cough may precede or remain unaccompanied by the complete triad. Neurological onset is usually in adulthood; a large cohort spanned ages 25–80 years. Chronic cough can precede imbalance by decades. Most affected individuals carry biallelic intronic repeat expansions, commonly AAGGG; rare individuals carry an expansion in trans with a truncating, splice or deletion allele. Sensory ganglion neuronal loss and Purkinje cell depletion are established pathological features. Clinical sensory loss may be length-dependent or non-length-dependent, and unrelated hearing loss can coexist. The molecular mechanism remains unresolved: structural-repeat effects, altered RNA processing, repeat-derived products, synaptic dysfunction and context-dependent RFC1 reduction have different levels of experimental support. Dedicated repeat testing is needed; coding sequencing can identify a second allele when only one expansion is found.'
disease_term:
  preferred_term: cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
  term:
    id: MONDO:0044720
    label: cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
parents:
- Hereditary Ataxia
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0044720
      label: cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
    mapping_justification: MONDO:0044720 is the exact disease concept — an autosomal recessive syndromic cerebellar ataxia caused by variation in RFC1, characterized by late-onset cerebellar dysfunction, bilateral vestibulopathy, and axonal sensory neuropathy.
references:
- reference: PMID:39230846
  title: Pseudodominance in RFC1-Spectrum Disorder.
- reference: PMID:36289003
  title: Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.
- reference: PMID:30926972
  title: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.
- reference: PMID:31230722
  title: 'Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS.'
- reference: PMID:32851396
  title: A Māori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele.
- reference: PMID:33103729
  title: A novel RFC1 repeat motif (ACAGG) in two Asia-Pacific CANVAS families.
- reference: PMID:37450567
  title: 'Normal and pathogenic variation of RFC1 repeat expansions: implications for clinical diagnosis.'
- reference: DOI:10.1101/2025.11.18.688292
  title: CANVAS causing AAGGG repeat expansions cause tissue-specific reduction in RFC1 expression and increase sensitivity to DNA damage
- reference: PMID:39231235
  title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
- reference: PMID:38266156
  title: Structural investigation of pathogenic RFC1 AAGGG pentanucleotide repeats reveals a role of G-quadruplex in dysregulated gene expression in CANVAS.
- reference: PMID:38381906
  title: Pathogenic CANVAS (AAGGG)n repeats stall DNA replication due to the formation of alternative DNA structures.
- reference: PMID:38062616
  title: RNA Foci in Two bi-Allelic RFC1 Expansion Carriers.
- reference: PMID:24682971
  title: Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS.
- reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
  title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
  tags:
  - GeneReviews
- reference: PMID:33492056
  title: The Pathology of the Vestibular System in CANVAS.
- reference: PMID:39811557
  title: Repeat expansions in RFC1 gene in refractory chronic cough.
- reference: PMID:34927205
  title: Motor neuron pathology in CANVAS due to RFC1 expansions.
- reference: PMID:38480525
  title: Cognitive Impairment Is Part of the Phenotype of Cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome (CANVAS).
- reference: PMID:38193360
  title: Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.
- reference: PMID:40908706
  title: Longitudinal Evaluation of Ataxia and Brain Structural Changes in RFC1-Related Disorder.
- reference: PMID:41964406
  title: Homozygous RFC1 AAGGG Repeat Expansions Are Common in Idiopathic Peripheral Neuropathy.
- reference: PMID:40481300
  title: Comprehensive Characterisation of the RFC1 Repeat in an Australian Cohort.
- reference: PMID:41532091
  title: Efficacy of morphine on cough in patients with repeat expansions of RFC1 and refractory chronic cough.
- reference: PMID:42473260
  title: DNA Repair Pathway Variants Are Enriched in Individuals with Biallelic AAGGG CANVAS and RFC1-Related Disease.
- reference: clinicaltrials:NCT05177809
  title: RFC1 Natural History Study
- reference: clinicaltrials:NCT07156214
  title: 'Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS: a Model to a Deeper Understanding of Molecular Mechanisms Underlying Late-onset Neurodegeneration'
- reference: clinicaltrials:NCT06817707
  title: Evaluation of Urinary Dysfunction in CANVAS Patients
- reference: PMID:40595562
  title: RFC1 regulates the expansion of neural progenitors in the developing zebrafish cerebellum.
inheritance:
- name: Autosomal recessive
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: Most cases carry two pathogenic repeat expansions; rare cases are compound heterozygous for an expansion and another pathogenic RFC1 allele. Pseudodominant pedigrees reflect frequent carrier alleles and do not establish dominant inheritance. Penetrance and presentation depend on age, repeat configuration and incompletely understood modifiers.
  evidence:
  - reference: PMID:39230846
    reference_title: Pseudodominance in RFC1-Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We describe pseudodominance in two families affected with RFC1 disorder (10 affected, 5 oligo/asymptomatic individuals).
    explanation: Documents actual multigenerational families, including oligo/asymptomatic biallelic relatives.
  - reference: PMID:36289003
    reference_title: Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We identified 7 patients from 5 unrelated families with clinically defined CANVAS carrying a heterozygous (AAGGG)n expansion together with a second truncating variant in trans in RFC1
    explanation: Establishes compound heterozygous expansion/truncating genotypes.
genetic:
- name: RFC1
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  gene_term:
    preferred_term: RFC1
    term:
      id: hgnc:9969
      label: RFC1
  notes: RFC1 encodes the large subunit of the canonical replication factor C complex that loads PCNA during DNA replication and repair. The usual disease allele is a nonreference intronic short tandem repeat expansion overlapping the AluSx3 poly(A) tail. AAGGG predominates; ACAGG, AGGGC and the Māori AAAGG-flanked AAGGG configuration also occur. Very large AAAGG alleles can be pathogenic, with uncertain penetrance; motif and size must be interpreted together. The September 2026 GeneReviews update still classifies AAGGC and AGAGG configurations as uncertain, despite the pathogenic interpretation proposed in a 2023 series. Rare expansion/truncating, splice or deletion genotypes broaden the allelic spectrum. Reduced expression is directly established for tested truncating alleles; the functional consequence of repeat-only genotypes is context-dependent and unresolved. Monoallelic enrichment in the 2026 neuropathy cohort was nonsignificant after adjustment; that study does not establish dominant RFC1 neuropathy.
  evidence:
  - reference: PMID:30926972
    reference_title: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: We used non-parametric linkage analysis and genome sequencing to identify a biallelic intronic AAGGG repeat expansion in the replication factor C subunit 1 (RFC1) gene as the cause of familial CANVAS and a frequent cause of late-onset ataxia, particularly if sensory neuronopathy and bilateral vestibular areflexia coexist.
    explanation: Identifies biallelic intronic RFC1 AAGGG expansion as the cause of CANVAS.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:31230722
    reference_title: 'Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: a recessively inherited, ancient RE located in intron 2 of RFC1 is the predominant cause of CANVAS
    explanation: Independent confirmation that the intron 2 repeat expansion is the predominant cause.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:32851396
    reference_title: A Māori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: We show a novel, possibly population-specific CANVAS configuration (AAAGG)10-25(AAGGG)exp, which was the cause of CANVAS in all patients.
    explanation: Documents a population-specific founder repeat configuration.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:33103729
    reference_title: A novel RFC1 repeat motif (ACAGG) in two Asia-Pacific CANVAS families.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: We screened an Asian-Pacific cohort for CANVAS and identified a novel RFC1 repeat expansion motif, (ACAGG)exp, in three affected individuals.
    explanation: Documents the ACAGG pathogenic motif in Asia-Pacific families.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:36289003
    reference_title: Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the finding of truncating variants associated with CANVAS indicate that full RFC1 sequencing is recommended in cases affected by typical CANVAS and carrying monoallelic (AAGGG)n expansions.
    explanation: Defines the rare second-allele diagnostic route.
  - reference: PMID:37450567
    reference_title: 'Normal and pathogenic variation of RFC1 repeat expansions: implications for clinical diagnosis.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We identified three novel repeat motifs, AGGGC (n = 6 from five families), AAGGC (n = 2 from one family) and AGAGG (n = 1), associated with CANVAS in the homozygous or compound heterozygous state with the common pathogenic AAGGG expansion.
    explanation: Reports alternative motifs; association in a few families does not settle pathogenicity for every configuration.
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Unknown significance, reported as part of complex repeats
    explanation: The September 2026 GeneReviews variant table classifies AAGGC as uncertain; its adjacent AGAGG row is also of unknown significance. These interpretations qualify the small 2023 association series.
  - reference: PMID:41964406
    reference_title: Homozygous RFC1 AAGGG Repeat Expansions Are Common in Idiopathic Peripheral Neuropathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: after controlling for potentially confounding covariates such as diabetes and B12 deficiency, this difference no longer reached statistical significance.
    explanation: The adjusted analysis supports the caution against inferring a dominant effect from monoallelic enrichment.
mechanistic_hypotheses:
- hypothesis_group_id: rfc1_loss_of_function
  hypothesis_label: Context-dependent RFC1 loss of function
  status: EMERGING
  description: Tested truncating alleles reduce RNA and protein. A 2025 preprint proposes smaller tissue-specific transcript reductions in repeat-only disease, whereas published cortical-like cell models and earlier tissue studies found preserved expression. A general protein-loss mechanism and the identity of vulnerable-cell intermediates remain unproven.
  evidence:
  - reference: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
    reference_title: ABSTRACT
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: expression could only be detected when comparing CANVAS lines with their isogenic corrected counterpart, but not when comparing CANVAS lines with non-isogenic controls
    explanation: Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Motor-neuron qPCR showed about 23% lower expression versus isogenic controls; sensory-neuron reduction was about 15%.
  - reference: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
    reference_title: ABSTRACT
    supports: REFUTE
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: we were unable to demonstrate a significant effect of the repeat expansion on RFC1 protein.
    explanation: Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). The preprint does not establish reduced protein abundance.
  - reference: PMID:30926972
    reference_title: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: does not affect RFC1 expression in patient peripheral and brain tissue, suggesting no overt loss of function
    explanation: Original bulk-tissue results argue against a universal expression-loss model.
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: REFUTE
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: we observed no changes in RFC1 mRNA or RFC1 protein levels between 6-week-old control (n = 3) and CANVAS (n = 3) patient iPSC–derived neurons
    explanation: Published patient-cell observations differ from the later preprint.
- hypothesis_group_id: repeat_structural_toxicity
  hypothesis_label: Repeat-intrinsic DNA and RNA structural effects
  status: EMERGING
  description: G-quadruplex and triplex formation, replication stalling and reporter translation effects are experimentally observed in defined systems. Their contribution at the endogenous locus in postmitotic vulnerable neurons remains hypothetical.
  evidence:
  - reference: PMID:38266156
    reference_title: Structural investigation of pathogenic RFC1 AAGGG pentanucleotide repeats reveals a role of G-quadruplex in dysregulated gene expression in CANVAS.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: we report that the pathogenic RFC1 AAGGG repeats form DNA and RNA parallel G-quadruplex (G4) structures that play a role in impairing biological processes
    explanation: Biophysical assays establish folding capacity of short repeats.
  - reference: PMID:38381906
    reference_title: Pathogenic CANVAS (AAGGG)n repeats stall DNA replication due to the formation of alternative DNA structures.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: The observed DNA polymerase stalling at the center of the (A2G3)10 strand strongly implicates H-r DNA triplex formation
    explanation: A competing structural explanation is supported under other assay conditions.
- hypothesis_group_id: intron2_retention_rna_processing
  hypothesis_label: Context-dependent intron retention
  status: ALTERNATIVE
  description: The original pre-mRNA retention finding has not been consistently reproduced. Altered RNA processing remains a candidate rather than an established obligatory mechanism.
  evidence:
  - reference: PMID:30926972
    reference_title: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: we detected a consistent increase across different tissues of the retention of intron 2 in RFC1 pre-mRNA
    explanation: Original observation in limited tissue samples.
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: REFUTE
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: no back-spliced reads were identified to map to RFC1 intron 2 or across the RFC1 transcript
    explanation: No detectable circular intronic RNA was found in this study.
- hypothesis_group_id: repeat_rna_peptide_effects
  hypothesis_label: Repeat RNA and pentapeptide effects
  status: EMERGING
  description: RNA foci and poly-KGREG signals occur in some tissues and reporters, but negative and incompletely specific findings constrain their interpretation. Production of a repeat-associated product does not demonstrate that it causes neuronal death.
  evidence:
  - reference: PMID:38062616
    reference_title: RNA Foci in Two bi-Allelic RFC1 Expansion Carriers.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: RNA fluorescence in situ hybridization of the 2 patients revealed CCTGT- and CCCTT-containing RNA foci, respectively, in neuronal nuclei of tissues with neuronal loss.
    explanation: Autopsy findings support foci formation in two cases; toxicity remains unproven.
  - reference: PMID:30926972
    reference_title: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We did not observe in patient brains the presence of RNA foci of either the sense or antisense repeated unit.
    explanation: Preserves the earlier negative finding.
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the overall abundance of foci was low, and the specificity was imperfect, with 8.94% of control neurons and 11.3% of CANVAS neurons showing antisense CCCTT RNA foci
    explanation: Patient-neuron signal was small and incompletely specific.
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: These data suggest that pentapeptide KGREG repeat proteins may be produced from AAGGG repeats in patients with CANVAS in a cell type–specific manner.
    explanation: Postmortem immunoreactivity is suggestive but not perfectly genotype-specific.
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: AAGGG repeats are translated into pentapeptide repeat proteins
    explanation: Reporter assays demonstrate translation.
pathophysiology:
- name: Biallelic RFC1 Intronic Repeat Expansion
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  description: The usual genotype contains two expanded nonreference pentanucleotide tracts within RFC1 intron 2, overlapping the poly(A) tail of AluSx3. AAGGG is written on the opposite strand to the RFC1 transcript (CCCTT). Motif, interruptions and length affect interpretation; neither intronic location nor repeat size alone proves regulatory loss of function.
  evidence:
  - reference: PMID:30926972
    reference_title: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: We used non-parametric linkage analysis and genome sequencing to identify a biallelic intronic AAGGG repeat expansion in the replication factor C subunit 1 (RFC1) gene as the cause of familial CANVAS and a frequent cause of late-onset ataxia, particularly if sensory neuronopathy and bilateral vestibular areflexia coexist.
    explanation: Identifies biallelic intronic RFC1 AAGGG expansion as the cause of CANVAS.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:31230722
    reference_title: 'Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: a recessively inherited, ancient RE located in intron 2 of RFC1 is the predominant cause of CANVAS
    explanation: Independent confirmation that the intron 2 repeat expansion is the predominant cause.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  role: trigger
  genes:
  - preferred_term: RFC1
    term:
      id: hgnc:9969
      label: RFC1
  genetic_context:
    gene:
      preferred_term: RFC1
      term:
        id: hgnc:9969
        label: RFC1
    variant_type: short tandem repeat expansion
    genomic_contexts:
    - intron
    variant_origin: GERMLINE
    functional_impact_category: UNKNOWN
    description: Biallelic pathogenic repeat expansions; their physical class and intronic Alu overlap are established, while the molecular effect remains disputed.
  downstream:
  - target: Repeat DNA Secondary Structures
    description: The AAGGG sequence forms noncanonical DNA structures in short-repeat biophysical assays; structure at the endogenous expanded locus has not been demonstrated.
    causal_link_type: UNKNOWN
    hypothesis_groups:
    - repeat_structural_toxicity
  - target: Repeat RNA G-Quadruplex Formation
    description: AAGGG RNA forms G-quadruplexes in defined short-repeat assays; their formation in vulnerable patient neurons is unresolved.
    causal_link_type: UNKNOWN
    hypothesis_groups:
    - repeat_structural_toxicity
  - target: RFC1 Intron 2 Retention
    description: The founding study detected increased intronic RNA, but later cell assays did not consistently reproduce retention.
    causal_link_type: UNKNOWN
    hypothesis_groups:
    - intron2_retention_rna_processing
  - target: Context-Dependent Reduction of RFC1 Transcript Abundance
    description: In the unreviewed 2025 preprint, isogenic deletion of the repeat-containing region increased transcript abundance in sensory and motor neurons; preserved-expression studies limit generalization.
    causal_link_type: UNKNOWN
    hypothesis_groups:
    - rfc1_loss_of_function
  - target: Repeat RNA Foci
    description: Two genetically confirmed autopsies contained repeat RNA foci, whereas earlier patient brains and later cell assays were negative.
    causal_link_type: UNKNOWN
    hypothesis_groups:
    - repeat_rna_peptide_effects
  - target: Repeat-Associated Poly-KGREG Production
    description: Short-repeat reporter constructs can produce poly-KGREG; this does not establish toxic peptide accumulation from the endogenous expanded alleles.
    causal_link_type: UNKNOWN
    hypothesis_groups:
    - repeat_rna_peptide_effects
  - target: Impaired Neuronal Synaptic Signaling
    description: Monoallelic deletion of the Alu-repeat region partially rescued synaptic readouts in one patient-derived neuronal line; the intervening molecular mechanism remains unresolved.
    causal_link_type: UNKNOWN
  - target: Dorsal Root Ganglion Sensory Neuronopathy
    description: Sensory neuronopathy is a defining manifestation of genetically confirmed RFC1 disease; the repeat-dependent route to ganglion injury remains unknown.
    causal_link_type: UNKNOWN
  - target: Cranial Sensory Ganglionopathy
    description: Vestibular failure in genetically confirmed disease is consistent with cranial ganglion pathology in historical clinical CANVAS, although those temporal-bone cases were not genotyped.
    causal_link_type: UNKNOWN
  - target: Cerebellar Purkinje Cell Loss
    description: A genetically confirmed CANVAS autopsy showed Purkinje depletion and Bergmann gliosis; the repeat-to-cell-death intermediates remain unresolved.
    causal_link_type: UNKNOWN
  - target: Autonomic Nervous System Dysfunction
    causal_link_type: UNKNOWN
    description: Autonomic testing documents sympathetic and parasympathetic dysfunction in RFC1 disease; the route from the repeat genotype to autonomic injury and its anatomical site remain unresolved.
  - target: Cough Reflex Hypersensitivity
    causal_link_type: UNKNOWN
    description: Heightened capsaicin sensitivity is documented in a small group of biallelic carriers with refractory cough; the repeat-dependent process causing reflex sensitization has not been demonstrated.
  - target: Motor Circuit Dysfunction
    causal_link_type: UNKNOWN
    description: Upper and lower motor signs in genetically confirmed cases suggest additional motor-circuit involvement, with axonal and glial abnormalities documented in one autopsy; the repeat-dependent mechanism remains unknown.
  - target: Cognitive Network Dysfunction
    causal_link_type: UNKNOWN
    description: Genetically confirmed CANVAS cohorts show cognitive deficits; the route from the repeat genotype to cerebellar or extra-cerebellar cognitive-network dysfunction remains unresolved.
- name: RFC1 Nonsense Allele in Trans with a Repeat Expansion
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  description: Rare patients carry a coding nonsense allele in trans with an expanded RFC1 repeat. Two siblings with c.1267C>T (p.Arg423Ter) showed mutant-transcript depletion and reduced full-length protein in fibroblasts. The coding single-nucleotide change and its measured consequences are distinct from the intronic repeat alteration.
  evidence:
  - reference: PMID:36289003
    reference_title: Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Together, the findings suggest that the transcript containing truncating variants in RFC1 undergo nonsense-mediated decay leading to RNA degradation.
    explanation: Patient fibroblast studies characterize the truncating allele in the compound genotype.
  role: trigger
  genes:
  - preferred_term: RFC1
    term:
      id: hgnc:9969
      label: RFC1
  genetic_context:
    gene:
      preferred_term: RFC1
      term:
        id: hgnc:9969
        label: RFC1
    genomic_contexts:
    - coding sequence
    variant_origin: GERMLINE
    zygosity: COMPOUND_HETEROZYGOUS
    functional_impact_category: LOSS_OF_FUNCTION
    description: A premature-termination single-nucleotide variant in RFC1 coding sequence, in trans with an intronic repeat expansion. The tested p.Arg423Ter allele undergoes preferential transcript depletion.
    variant_type: single nucleotide variant
  downstream:
  - target: Decay of Truncating RFC1 Transcripts
    description: Tested premature-termination alleles show preferential mutant-transcript depletion.
    causal_link_type: DIRECT
- name: RFC1 Frameshift Deletion in Trans with a Repeat Expansion
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  description: Rare patients carry a coding frameshift deletion in trans with an expanded RFC1 repeat. For c.2876del (p.Pro959GlnfsTer24), cDNA sequencing showed depletion of the deletion-bearing transcript and supported the trans configuration. Other reported deletions include c.1739_1740del and c.2191del; the RNA findings should not be assumed measured for every allele.
  evidence:
  - reference: PMID:36289003
    reference_title: Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Together, the findings suggest that the transcript containing truncating variants in RFC1 undergo nonsense-mediated decay leading to RNA degradation.
    explanation: Patient fibroblast studies characterize the truncating allele in the compound genotype.
  role: trigger
  genes:
  - preferred_term: RFC1
    term:
      id: hgnc:9969
      label: RFC1
  genetic_context:
    gene:
      preferred_term: RFC1
      term:
        id: hgnc:9969
        label: RFC1
    genomic_contexts:
    - coding sequence
    variant_origin: GERMLINE
    zygosity: COMPOUND_HETEROZYGOUS
    functional_impact_category: LOSS_OF_FUNCTION
    description: A coding deletion that shifts the reading frame and introduces premature termination, in trans with an intronic repeat expansion. Allele-specific RNA depletion was measured for c.2876del.
    variant_type: deletion
  downstream:
  - target: Decay of Truncating RFC1 Transcripts
    description: Tested premature-termination alleles show preferential mutant-transcript depletion.
    causal_link_type: DIRECT
- name: Decay of Truncating RFC1 Transcripts
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  description: Allele-specific RNA sequencing and cDNA analysis showed preferential depletion of transcripts carrying p.Arg423Ter or p.Pro959GlnfsTer24, supporting nonsense-mediated decay. This result applies to the coding truncating allele, not directly to the expanded-repeat allele.
  evidence:
  - reference: PMID:36289003
    reference_title: Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Together, the findings suggest that the transcript containing truncating variants in RFC1 undergo nonsense-mediated decay leading to RNA degradation.
    explanation: Patient fibroblast studies characterize the truncating allele in the compound genotype.
  biological_processes:
  - preferred_term: nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
    term:
      id: GO:0000184
      label: nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
    modifier: INCREASED
  downstream:
  - target: Reduced RFC1 Protein in Truncating-Allele Carriers
    description: Loss of mutant transcript reduces the contribution of the coding allele to full-length protein.
    causal_link_type: DIRECT
- name: Reduced RFC1 Protein in Truncating-Allele Carriers
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  description: Fibroblasts from two related expansion/p.Arg423Ter patients had approximately 50% lower full-length RFC1 protein. Truncated isoforms were not detected. Repeat-only fibroblasts did not show the same reduction. Unaffected relatives with a single truncating allele indicate that isolated haploinsufficiency is insufficient to explain CANVAS.
  evidence:
  - reference: PMID:36289003
    reference_title: Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: immunoblotting showed a concordant reduction of the 140 KD full-length RFC1 protein in fibroblasts from affected individuals
    explanation: Protein reduction accompanies allele-specific RNA decay.
  - reference: PMID:36289003
    reference_title: Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: parents of the affected patients in this study, carrying a truncating variant in RFC1 but no AAGGG expansion on the second allele, did not show a phenotype despite their old age
    explanation: Limits a simple dominant haploinsufficiency interpretation.
- name: Context-Dependent Reduction of RFC1 Transcript Abundance
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  description: An unreviewed November 2025 preprint reported modest RFC1 mRNA reduction in patient-derived sensory and motor neurons versus isogenic biallelic Alu-repeat deletions, and in targeted analysis of postmortem cerebellum. Protein reduction was not demonstrated. Earlier studies found preserved expression in peripheral cells, limited brain samples and mainly cortical-like neurons. Cell identity, genetic background, RNA quality and assay context may explain discrepancies. Repeat deletion removes more than an expression defect and does not identify the mediator of rescue.
  evidence:
  - reference: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
    reference_title: ABSTRACT
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: expression could only be detected when comparing CANVAS lines with their isogenic corrected counterpart, but not when comparing CANVAS lines with non-isogenic controls
    explanation: Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Motor-neuron qPCR showed about 23% lower expression versus isogenic controls; sensory-neuron reduction was about 15%.
  - reference: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
    reference_title: ABSTRACT
    supports: REFUTE
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: we were unable to demonstrate a significant effect of the repeat expansion on RFC1 protein.
    explanation: Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). The preprint does not establish reduced protein abundance.
  - reference: PMID:30926972
    reference_title: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: does not affect RFC1 expression in patient peripheral and brain tissue, suggesting no overt loss of function
    explanation: Original bulk-tissue results argue against a universal expression-loss model.
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: REFUTE
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: we observed no changes in RFC1 mRNA or RFC1 protein levels between 6-week-old control (n = 3) and CANVAS (n = 3) patient iPSC–derived neurons
    explanation: Published patient-cell observations differ from the later preprint.
  downstream:
  - target: Delayed Repair of Platinum-Induced DNA Damage
    description: Reduced expression and altered platinum response co-occur in the preprint, but expression-specific rescue was not performed.
    causal_link_type: UNKNOWN
    hypothesis_groups:
    - rfc1_loss_of_function
- name: Repeat DNA Secondary Structures
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  description: Short synthetic AAGGG DNA repeats adopt G-quadruplex or H-r triplex structures under different ionic and temperature conditions. Triplex-sensitive probing and cellular replication assays argue against assigning all stalling to G-quadruplexes. These structures have not been shown to mediate degeneration at the endogenous expanded locus in vulnerable human neurons.
  evidence:
  - reference: PMID:38266156
    reference_title: Structural investigation of pathogenic RFC1 AAGGG pentanucleotide repeats reveals a role of G-quadruplex in dysregulated gene expression in CANVAS.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: we report that the pathogenic RFC1 AAGGG repeats form DNA and RNA parallel G-quadruplex (G4) structures that play a role in impairing biological processes
    explanation: Biophysical assays establish folding capacity of short repeats.
  - reference: PMID:38381906
    reference_title: Pathogenic CANVAS (AAGGG)n repeats stall DNA replication due to the formation of alternative DNA structures.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: The observed DNA polymerase stalling at the center of the (A2G3)10 strand strongly implicates H-r DNA triplex formation
    explanation: A competing structural explanation is supported under other assay conditions.
  downstream:
  - target: Repeat-Associated Replication Fork Stalling
    description: Noncanonical DNA folding can impede polymerase progression in the tested biochemical and plasmid contexts.
    causal_link_type: DIRECT
    hypothesis_groups:
    - repeat_structural_toxicity
- name: Repeat-Associated Replication Fork Stalling
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  description: Pathogenic-repeat templates inhibit polymerase progression in vitro. AAGGG tracts also stall replication in yeast plasmids and SV40-origin episomes in human cells, with orientation dependence. Lack of enhancement after PIF1 deletion favors a triplex contribution in yeast. These assays use short repeats or non-native replication systems; they do not establish replication-fork injury in postmitotic CANVAS neurons.
  evidence:
  - reference: PMID:38381906
    reference_title: Pathogenic CANVAS (AAGGG)n repeats stall DNA replication due to the formation of alternative DNA structures.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Finally, the pathogenic, but not the nonpathogenic, repeat stalls replication fork progression in yeast and human cells.
    explanation: Measures replication impediments in model systems.
  biological_processes:
  - preferred_term: DNA replication
    term:
      id: GO:0006260
      label: DNA replication
    modifier: DECREASED
- name: Repeat RNA G-Quadruplex Formation
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  description: Synthetic AAGGG RNA forms parallel G-quadruplexes. The RFC1 sense transcript carries the complementary CCCTT sequence; strand and transcript context must be specified before extrapolating AAGGG reporter results to endogenous RFC1 RNA.
  evidence:
  - reference: PMID:38266156
    reference_title: Structural investigation of pathogenic RFC1 AAGGG pentanucleotide repeats reveals a role of G-quadruplex in dysregulated gene expression in CANVAS.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: we report that the pathogenic RFC1 AAGGG repeats form DNA and RNA parallel G-quadruplex (G4) structures that play a role in impairing biological processes
    explanation: Biophysical assays establish folding capacity of short repeats.
  downstream:
  - target: Reduced Translation in Repeat Reporter Assays
    description: Repeat folding is implicated in the reporter translation phenotype; relevance to endogenous RFC1 requires testing.
    causal_link_type: DIRECT
    hypothesis_groups:
    - repeat_structural_toxicity
- name: Reduced Translation in Repeat Reporter Assays
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  description: HEK293T reporters containing short upstream AAGGG repeats showed reduced EGFP protein with unchanged reporter mRNA. Stabilizing G-quadruplexes worsened this reporter effect. This measures translation of a construct, not reduced transcription of endogenous RFC1, and is not evidence for a therapeutic effect of G-quadruplex stabilizers.
  evidence:
  - reference: PMID:38266156
    reference_title: Structural investigation of pathogenic RFC1 AAGGG pentanucleotide repeats reveals a role of G-quadruplex in dysregulated gene expression in CANVAS.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: reduce gene expression via impairing the translation process in a repeat-length-dependent manner
    explanation: Reporter assays support a translation effect in their specific construct context.
  biological_processes:
  - preferred_term: translation
    term:
      id: GO:0006412
      label: translation
    modifier: DECREASED
- name: RFC1 Intron 2 Retention
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  description: The 2019 study found increased intron 2 retention in pre-mRNA in small lymphoblast, muscle and brain samples, without aberrantly spliced mature transcripts. The 2024 patient-cell study did not reproduce increased retention or circular RFC1 RNA; the 2025 preprint also found similar transcript processing. A uniform intron-retention mechanism is therefore unproven.
  evidence:
  - reference: PMID:30926972
    reference_title: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: we detected a consistent increase across different tissues of the retention of intron 2 in RFC1 pre-mRNA
    explanation: Original observation in limited tissue samples.
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: REFUTE
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: no back-spliced reads were identified to map to RFC1 intron 2 or across the RFC1 transcript
    explanation: No detectable circular intronic RNA was found in this study.
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: REFUTE
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: There were no differences between cases and controls in terms of intron retention or aberrant intron 2 splicing of RFC1 in patient fibroblasts, iPSC-derived neurons, or cortical and cerebellar regions of postmortem brain
    explanation: Direct negative RNA-processing result.
- name: Repeat RNA Foci
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  description: Repeat RNA foci were reported in two 2024 autopsies with ACAGG or AAGGG configurations. Earlier brain analysis was negative. Reporter foci are readily generated, but 2024 patient neurons showed only a small antisense signal difference with imperfect specificity (11.3% versus 8.94%) and no sense-repeat enrichment. Foci presence does not establish RNA-mediated toxicity.
  evidence:
  - reference: PMID:38062616
    reference_title: RNA Foci in Two bi-Allelic RFC1 Expansion Carriers.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: RNA fluorescence in situ hybridization of the 2 patients revealed CCTGT- and CCCTT-containing RNA foci, respectively, in neuronal nuclei of tissues with neuronal loss.
    explanation: Autopsy findings support foci formation in two cases; toxicity remains unproven.
  - reference: PMID:30926972
    reference_title: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We did not observe in patient brains the presence of RNA foci of either the sense or antisense repeated unit.
    explanation: Preserves the earlier negative finding.
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the overall abundance of foci was low, and the specificity was imperfect, with 8.94% of control neurons and 11.3% of CANVAS neurons showing antisense CCCTT RNA foci
    explanation: Patient-neuron signal was small and incompletely specific.
- name: Repeat-Associated Poly-KGREG Production
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  description: AAGGG reporter constructs produce poly-KGREG in HEK cells. Cerebellar granule-layer immunostaining was strong in three of four CANVAS brains, weak in one, and also present in one nonexpanded control; remaining Purkinje neurons lacked staining. Peptide production was not detected in eight-week patient neurons. Short-repeat expression did not reduce rat cortical-neuron survival over ten days, leaving length-, cell- and context-specific toxicity unresolved.
  evidence:
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: These data suggest that pentapeptide KGREG repeat proteins may be produced from AAGGG repeats in patients with CANVAS in a cell type–specific manner.
    explanation: Postmortem immunoreactivity is suggestive but not perfectly genotype-specific.
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: AAGGG repeats are translated into pentapeptide repeat proteins
    explanation: Reporter assays demonstrate translation.
- name: Impaired Neuronal Synaptic Signaling
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  description: Patient-derived predominantly glutamatergic forebrain neurons showed reduced synaptic transcripts and proteins and poorly synchronized network firing. Monoallelic deletion of the Alu-repeat region partially restored these readouts. RFC1 knockdown did not reproduce most abnormalities, and re-expression did not broadly rescue them, although some firing measures changed. These immature cortical-like cultures do not reproduce the selectively vulnerable sensory ganglion and Purkinje populations.
  evidence:
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Gene Ontology (GO) analysis indicated a significant overrepresentation of neuronal signaling processes including synaptic signaling and processes that regulate synaptic signaling
    explanation: Transcriptomic changes converge on neuronal signaling.
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: CANVAS patient iPSC–derived neurons remained devoid of detectable synchronous firing even between 7 and 11 weeks after differentiation
    explanation: Patient neurons had impaired network synchrony.
  biological_processes:
  - preferred_term: synaptic signaling
    term:
      id: GO:0099536
      label: synaptic signaling
    modifier: ABNORMAL
- name: Delayed Repair of Platinum-Induced DNA Damage
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  description: The unreviewed 2025 preprint found slower removal of platinum-DNA adducts in patient lymphoblastoid cells and greater cisplatin-induced apoptosis in sensory and motor neurons, improved by isogenic repeat-region deletion. Earlier cortical-like neurons had normal UV-induced DNA-damage recovery. The studies test different insults and cell types; neither universal repair failure nor RFC1 mRNA reduction as the causal mediator is established.
  evidence:
  - reference: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
    reference_title: ABSTRACT
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: repair in CANVAS LCLs was significantly slower, reaching levels comparable to control cells only after 72 h
    explanation: Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Measures delayed repair after a cisplatin pulse.
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: REFUTE
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: First-derivative analysis of normalized γ-H2AX indicated no differences in the rate of γ-H2AX recovery after UV induction between CANVAS and control neurons
    explanation: The published UV assay limits generalization across forms of DNA damage.
  biological_processes:
  - preferred_term: DNA repair
    term:
      id: GO:0006281
      label: DNA repair
    modifier: DECREASED
- name: Dorsal Root Ganglion Sensory Neuronopathy
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  description: Loss of dorsal root ganglion sensory neurons produces peripheral sensory deafferentation and secondary posterior-column degeneration. Historical autopsies predated RFC1 genotyping, while later genetically confirmed cases show concordant sensory and posterior-column pathology. The primary ganglion lesion does not require a uniformly non-length-dependent clinical distribution.
  evidence:
  - reference: PMID:24682971
    reference_title: Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Spinal cord pathology demonstrated a marked dorsal root ganglionopathy with secondary tract degeneration.
    explanation: Direct neuropathology in clinically defined CANVAS predating molecular diagnosis.
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Altered sensation in all limbs in either a length-dependent (distal extremities worse) or non-length-dependent pattern.
    explanation: Clinical distribution does not by itself determine the site of the primary lesion.
  cell_types:
  - preferred_term: sensory neuron of dorsal root ganglion
    term:
      id: CL:1001451
      label: sensory neuron of dorsal root ganglion
    modifier: DECREASED
  downstream:
  - target: Multisensory Balance Failure
    description: Loss of this sensory or cerebellar contribution impairs integrated balance control.
    causal_link_type: DIRECT
  - target: Sensory ataxia
    description: Loss of proprioceptive afferent input contributes to sensory incoordination.
    causal_link_type: UNKNOWN
  - target: Impaired proprioception
    description: Injury to sensory ganglion neurons impairs joint-position feedback.
    causal_link_type: UNKNOWN
  - target: Sensory neuropathy
    description: Sensory neuronopathy produces the clinical and electrophysiological sensory-neuropathy phenotype.
    causal_link_type: UNKNOWN
  - target: Areflexia
    description: Loss of sensory input can interrupt the afferent limb of tendon reflexes; reflexes may remain preserved or brisk in other cases.
    causal_link_type: UNKNOWN
  - target: Impaired lower-limb vibration sensation
    description: Large-fiber sensory dysfunction reduces distal vibration perception.
    causal_link_type: UNKNOWN
  - target: Paresthesia
    causal_link_type: UNKNOWN
    description: Dysfunction of sensory afferents can generate the pins-and-needles sensations described in the sensory-neuropathy spectrum.
  - target: Neuropathic pain
    causal_link_type: UNKNOWN
    description: Injury to sensory afferents provides a plausible substrate for neuropathic pain; the relative contributions of peripheral ectopic activity and central sensitization have not been established in RFC1 disease.
- name: Cranial Sensory Ganglionopathy
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  description: Five temporal bones from four clinically defined, ungenotyped CANVAS patients showed severe vestibular ganglion neuronal loss, with relative preservation of spiral ganglia, sensory hair cells and vestibular nuclei. Trigeminal and geniculate ganglia were also affected. Ganglionic Nageotte nodules reflect glial replacement of lost neurons; they are not psammoma bodies. Relative auditory sparing does not exclude coincident presbycusis or another cause of hearing loss.
  evidence:
  - reference: PMID:33492056
    reference_title: The Pathology of the Vestibular System in CANVAS.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: In CANVAS there is a severe cranial sensory ganglionopathy neuronopathy (ganglionopathy) involving the vestibular, facial, and trigeminal ganglia but sparing the auditory ganglia.
    explanation: Historical pathology localizes vestibular failure primarily to ganglion neurons; these donors were not RFC1-genotyped.
  cell_types:
  - preferred_term: vestibular ganglion sensory neuron
    term:
      id: CL:0000101
      label: sensory neuron
    modifier: DECREASED
  downstream:
  - target: Multisensory Balance Failure
    description: Loss of this sensory or cerebellar contribution impairs integrated balance control.
    causal_link_type: DIRECT
  - target: Vestibular areflexia
    description: Vestibular ganglion degeneration impairs the afferent limb of vestibular reflexes.
    causal_link_type: UNKNOWN
  - target: Oscillopsia
    description: Vestibular afferent failure impairs stabilization of gaze during head movement.
    causal_link_type: UNKNOWN
  notes: The CL vestibular ganglion SP-neuron term is restricted to substance-P-positive cells; marker-specific loss was not established, so the broader sensory-neuron binding is retained.
- name: Cerebellar Purkinje Cell Loss
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  description: Purkinje-cell depletion, often greatest in the vermis, and Bergmann gliosis are documented in clinical CANVAS autopsies and a genetically confirmed 2019 case. This lesion contributes to cerebellar gait, limb, speech and oculomotor dysfunction. Molecular intermediates connecting the repeat genotype to selective adult Purkinje degeneration remain unresolved.
  evidence:
  - reference: PMID:24682971
    reference_title: Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Cerebellar pathology showed loss of Purkinje cells, predominantly in the vermis.
    explanation: Documents selective cerebellar pathology in historical clinical CANVAS.
  - reference: PMID:30926972
    reference_title: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The patient with CANVAS showed severe, widespread depletion of Purkinje cells with associated prominent Bergmann gliosis, while cell density in the granule cell layer was well preserved.
    explanation: The 2019 study documents this pathology in a genetically confirmed CANVAS case.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  cell_types:
  - preferred_term: Purkinje cell
    term:
      id: CL:0000121
      label: Purkinje cell
    modifier: DECREASED
  conforms_to: cerebellar_purkinje_degeneration#Purkinje Neuron Degeneration
  downstream:
  - target: Multisensory Balance Failure
    description: Loss of this sensory or cerebellar contribution impairs integrated balance control.
    causal_link_type: DIRECT
  - target: Progressive cerebellar ataxia
    description: Purkinje-cell depletion impairs cerebellar coordination.
    causal_link_type: UNKNOWN
  - target: Dysarthria
    description: Cerebellar circuit injury can impair the timing and coordination of speech.
    causal_link_type: UNKNOWN
  - target: Cerebellar atrophy
    description: Loss of cerebellar neurons contributes to cerebellar volume loss.
    causal_link_type: UNKNOWN
  - target: Gaze-evoked nystagmus
    description: Cerebellar dysfunction can impair gaze-holding control.
    causal_link_type: UNKNOWN
  - target: Downbeat nystagmus
    description: Cerebellar ocular-motor dysfunction can produce vertical gaze instability.
    causal_link_type: UNKNOWN
  - target: Dysmetric saccades
    description: Cerebellar dysfunction impairs calibration of saccadic amplitude.
    causal_link_type: UNKNOWN
  - target: Saccadic pursuit
    description: Cerebellar dysfunction impairs smooth tracking and increases corrective saccades.
    causal_link_type: UNKNOWN
  - target: Dysphagia
    causal_link_type: UNKNOWN
    description: GeneReviews attributes later swallowing difficulty to cerebellar dysfunction; the precise swallowing circuits and any additional brainstem contributions are unresolved.
- name: Autonomic Nervous System Dysfunction
  biological_scale: ORGANISM
  mechanism_confidence: ESTABLISHED
  description: Sympathetic and parasympathetic dysfunction can affect blood pressure, bowel, bladder, sexual function and sweating. Severity is usually mild but can be substantial. A primary autonomic ganglion lesion has not been established across RFC1 disease; central and peripheral contributions remain possible.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Autonomic testing confirms the presence of a sympathetic and/or parasympathetic dysfunction in half of individuals undergoing specific investigations.
    explanation: Physiological dysfunction is established without assigning a specific ganglionic lesion.
  downstream:
  - target: Autonomic dysfunction
    description: Impaired autonomic control is expressed clinically across several organ systems.
    causal_link_type: UNKNOWN
  - target: Orthostatic hypotension
    description: Impaired autonomic cardiovascular control can reduce the blood-pressure response to standing.
    causal_link_type: UNKNOWN
  - target: Erectile dysfunction
    description: Autonomic genital control can be impaired in the reported dysautonomic spectrum.
    causal_link_type: UNKNOWN
  - target: Chronic constipation
    description: Autonomic gastrointestinal dysfunction can impair bowel motility.
    causal_link_type: UNKNOWN
  - target: Autonomic bladder dysfunction
    causal_link_type: UNKNOWN
    description: Autonomic lower urinary-tract control can be impaired.
  - target: Anhidrosis
    causal_link_type: UNKNOWN
    description: Impaired sudomotor control can reduce sweating.
  - target: Hyperhidrosis
    causal_link_type: UNKNOWN
    description: Abnormal sudomotor regulation can increase sweating in some patients.
- name: Cough Reflex Hypersensitivity
  biological_scale: ORGANISM
  mechanism_confidence: PROVISIONAL
  description: Biallelic RFC1 carriers with refractory cough show heightened capsaicin sensitivity relative to historical healthy controls, broadly comparable to other refractory-cough cohorts. The mechanism may involve peripheral or central sensitization or loss of inhibitory sensory inputs. Direct demonstration of a general vagal-afferent degenerative lesion causing the cough is lacking.
  evidence:
  - reference: PMID:39811557
    reference_title: Repeat expansions in RFC1 gene in refractory chronic cough.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: cough reflex sensitivity was heightened compared to historical healthy controls
    explanation: Four biallelic participants underwent cough-reflex testing; this is not a contemporaneous controlled comparison.
  downstream:
  - target: Chronic cough
    description: Heightened cough-reflex sensitivity accompanies refractory cough in studied carriers; the observational data do not identify its cause.
    causal_link_type: UNKNOWN
- name: Motor Circuit Dysfunction
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  description: Upper and lower motor signs suggest dysfunction of descending motor control and motor-unit circuits in a subset of RFC1 cases. Their lesion-level basis remains uncertain. One genetically confirmed autopsy showed anterior-horn astrocytic gliosis and axonal swelling around motor-neuron somata, with preserved anterior-horn neurons and corticospinal tracts. This supports a possible synaptic component but does not establish generalized motor-neuron death or identify the lesion responsible for upper motor signs.
  evidence:
  - reference: PMID:34927205
    reference_title: Motor neuron pathology in CANVAS due to RFC1 expansions.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We observed marked astrocytic gliosis and axonal swelling of the synapse between first and second motor neurons in the anterior horn at the lumbar level.
    explanation: The pathology supports circuit-level abnormality in one patient.
  - reference: url:https://discovery.ucl.ac.uk/id/eprint/10141005/1/awab449%20%281%29.pdf
    reference_title: https://discovery.ucl.ac.uk/id/eprint/10141005/1/awab449%20%281%29.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Although the second motor neurons in the anterior and lateral horns were preserved
    explanation: Preserved neuronal somata are part of the reported histological finding, not evidence against the described axonal and glial changes.
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Brisk reflexes, particularly in the upper limbs and at the knees, are commonly observed. Other signs of upper and lower motor neuron involvement, including spasticity and/or Babinski sign, muscle atrophy, fasciculations, and weakness, are uncommon.
    explanation: Current synthesis explicitly includes these features.
  downstream:
  - target: Hyperreflexia
    causal_link_type: UNKNOWN
    description: Altered descending control of spinal reflexes is a possible explanation for brisk reflexes; the single autopsy does not establish the responsible upper motor lesion.
  - target: Spasticity
    causal_link_type: UNKNOWN
    description: Impaired descending regulation of muscle tone is inferred from the reported upper motor signs; it has not been localized to the anterior-horn changes seen at autopsy.
  - target: Babinski sign
    causal_link_type: UNKNOWN
    description: An extensor plantar response indicates abnormal descending motor control, but a corresponding corticospinal lesion has not been demonstrated in the available autopsy.
  - target: Fasciculations
    causal_link_type: UNKNOWN
    description: Motor-unit dysfunction can produce fasciculations; the limited pathology permits a synaptic or axonal mechanism without requiring loss of motor-neuron somata.
  - target: Skeletal muscle atrophy
    causal_link_type: UNKNOWN
    description: Impaired motor-unit innervation can contribute to muscle wasting; this is a provisional explanation rather than evidence of generalized motor-neuron degeneration.
  - target: Muscle weakness
    causal_link_type: UNKNOWN
    description: Motor-circuit or motor-unit dysfunction can reduce force generation; sensory impairment and disuse may also contribute in individual patients.
- name: Cognitive Network Dysfunction
  biological_scale: ORGANISM
  mechanism_confidence: PROVISIONAL
  description: Executive, attention and working-memory abnormalities have been documented, sometimes meeting cerebellar cognitive affective syndrome criteria. Cerebellar and extra-cerebellar network contributions are plausible, but the responsible anatomical and molecular pathways are unresolved. Dementia is not a typical universal outcome.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Deficits most frequently involve executive functions and attention ... working memory.
    explanation: Current clinical synthesis identifies the affected domains.
  - reference: PMID:38480525
    reference_title: Cognitive Impairment Is Part of the Phenotype of Cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome (CANVAS).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Twenty-one patients underwent a complete assessment, including 71% scoring lower than the cutoff at the Montreal Cognitive assessment
    explanation: A small systematically tested cohort demonstrates impairment, not a population frequency.
  downstream:
  - target: Cognitive impairment
    causal_link_type: UNKNOWN
    description: The observed impairment of attention, working memory and executive performance is the clinical expression of the proposed cognitive-network dysfunction.
  - target: Impaired executive functioning
    causal_link_type: UNKNOWN
    description: Executive deficits are a specifically measured component of the cognitive phenotype; their cerebellar and extra-cerebellar substrates remain unresolved.
- name: Multisensory Balance Failure
  biological_scale: ORGANISM
  mechanism_confidence: ESTABLISHED
  description: Sensory, vestibular and cerebellar deficits contribute variably to progressive imbalance. Their convergence reduces compensation between balance systems, but the full triad is not required at every stage. In a 392-person cohort, only half were classified as complete CANVAS at last follow-up.
  evidence:
  - reference: PMID:38193360
    reference_title: Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Overall, 195 patients (50%) had complete CANVAS, 131 (33%) had a complex neuropathy, while 54 (14%) still showed an isolated sensory neuropathy.
    explanation: Defines the spectrum rather than universal progression to the triad.
  downstream:
  - target: Progressive gait imbalance and falls
    description: Combined sensory, vestibular and cerebellar deficits reduce postural stability.
    causal_link_type: UNKNOWN
phenotypes:
- name: Progressive cerebellar ataxia
  category: Neurological
  description: Cerebellar gait and limb incoordination develops variably during the disease course. The 84% rate of cerebellar signs at repeat examination in the 392-person cohort is a composite and is not assigned to this individual phenotype.
  phenotype_term:
    preferred_term: Progressive cerebellar ataxia
    term:
      id: HP:0002073
      label: Progressive cerebellar ataxia
    clinical_course: PROGRESSIVE
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Examination reveals oculomotor signs (including gaze-evoked nystagmus, downbeat nystagmus, saccadic pursuit, and dysmetric saccades) and gait and limb ataxia.
    explanation: Documents cerebellar manifestations.
- name: Vestibular areflexia
  category: Neurological
  description: Bilateral vestibular impairment can emerge after sensory symptoms. At repeat examination, 116/147 tested patients had areflexia; the denominator excludes people without a vestibular assessment.
  phenotype_term:
    preferred_term: Vestibular areflexia
    term:
      id: HP:0008568
      label: Vestibular areflexia
  evidence:
  - reference: PMID:38193360
    reference_title: Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Vestibular areflexia | 147/196 (75%) | 116/147 (79%)
    explanation: Table 1 gives assessed-patient frequencies at first and repeat examinations.
  frequency: FREQUENT
- name: Sensory ataxia
  category: Neurological
  description: Sensory deafferentation causes gait ataxia, positive Romberg testing and impaired coordination that worsens with eye closure.
  phenotype_term:
    preferred_term: Sensory ataxia
    term:
      id: HP:0010871
      label: Sensory ataxia
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Gait ataxia ... Positive Romberg and dysmetria worsened by eye closur
    explanation: The current GeneReviews examination summary describes sensory ataxia; the cached source truncates the final word.
- name: Impaired proprioception
  category: Neurological
  description: Position sense can be reduced distally; it is not uniformly absent.
  phenotype_term:
    preferred_term: Impaired proprioception
    term:
      id: HP:0010831
      label: Impaired proprioception
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: reduced vibration sensation in the lower limbs, and milder reduction of position sense distally
    explanation: Documents differential sensory modalities.
- name: Sensory neuropathy
  category: Neurological
  description: The characteristic clinical and electrophysiological sensory neuropathy reflects a predominant neuronopathy. Sensory action potentials are reduced or absent; clinical distribution may be length-dependent or non-length-dependent. All evaluated patients in the selected 392-person cohort had sensory impairment, but this is not a penetrance estimate.
  phenotype_term:
    preferred_term: Sensory neuropathy
    term:
      id: HP:0000763
      label: Sensory neuropathy
  evidence:
  - reference: PMID:38193360
    reference_title: Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: All cases had signs and/or symptoms of sensory neuropathy, when investigated.
    explanation: Sensory involvement was constant in this ascertained cohort.
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Altered sensation in all limbs in either a length-dependent (distal extremities worse) or non-length-dependent pattern.
    explanation: Avoids equating ganglion pathology with one mandatory clinical distribution.
- name: Areflexia
  category: Neurological
  description: Reflexes may be abolished, particularly at the ankles; preserved or brisk reflexes elsewhere do not exclude RFC1 disease.
  phenotype_term:
    preferred_term: Areflexia
    term:
      id: HP:0001284
      label: Areflexia
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Reflexes can be decreased/abolished, but retained and even brisk reflexes are possible.
    explanation: Documents variability rather than an obligatory examination sign.
- name: Autonomic dysfunction
  category: Neurological
  description: Blood-pressure, bladder, bowel, sexual and sudomotor symptoms vary widely across cohorts and are usually mild, with occasional severe dysautonomia.
  phenotype_term:
    preferred_term: Abnormal autonomic nervous system physiology
    term:
      id: HP:0012332
      label: Abnormal autonomic nervous system physiology
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Signs and symptoms including postural hypotension, erectile dysfunction, chronic constipation, urinary dysfunction, and altered sweating are relatively common but rarely disabling.
    explanation: Defines the autonomic spectrum without a single cross-cohort frequency.
- name: Dysphagia
  category: Gastrointestinal
  description: Swallowing difficulty can arise later, increasing aspiration and nutritional risk. A published 51% combined dysarthria/dysphagia endpoint is not a dysphagia-specific rate.
  phenotype_term:
    preferred_term: Dysphagia
    term:
      id: HP:0002015
      label: Dysphagia
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Dysarthria and dysphagia, attributed to cerebellar dysfunction, are possible complications later in the disease course.
    explanation: Separately records swallowing difficulty without misusing the composite rate.
- name: Chronic cough
  category: Respiratory
  description: Dry or minimally productive spasmodic cough can precede neurological manifestations by decades. It was present in 267/358 assessed patients at last follow-up in the large 2024 cohort; respiratory-clinic and highly selected neurological cohorts give different rates.
  phenotype_term:
    preferred_term: Chronic cough
    term:
      id: HP:0034315
      label: Chronic cough
  evidence:
  - reference: PMID:38193360
    reference_title: Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Chronic cough was investigated in 358 patients (91%) and reported by 267 of them (75%). Cough was the presenting symptom in half of the cases.
    explanation: Supports FREQUENT for this specified cohort.
  frequency: FREQUENT
- name: Oscillopsia
  category: Neurological
  description: Apparent movement of objects during head movement reflects an impaired vestibuloocular reflex. It was reported by 94/352 (27%) at last follow-up in the 2024 cohort.
  phenotype_term:
    preferred_term: Oscillopsia
    term:
      id: HP:0034773
      label: Oscillopsia
  evidence:
  - reference: PMID:38193360
    reference_title: Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Oscillopsia | 19/352 (6%) | 94/352 (27%)
    explanation: Table 1 provides symptom-specific counts.
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Oscillopsia, defined as a visual disturbance in which objects appear to oscillate during head movements
    explanation: Defines the symptom.
  frequency: OCCASIONAL
- name: Dysarthria
  category: Neurological
  description: Speech incoordination may develop later. The combined dysarthria/dysphagia rate is not assigned to dysarthria alone.
  phenotype_term:
    preferred_term: Dysarthria
    term:
      id: HP:0001260
      label: Dysarthria
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Dysarthria and dysphagia, attributed to cerebellar dysfunction, are possible complications later in the disease course.
    explanation: Documents the speech manifestation.
- name: Cerebellar atrophy
  category: Neurological
  description: MRI often shows vermian and variable hemispheric atrophy, but a normal early MRI does not exclude RFC1 disease. A small 2025 longitudinal cohort found progression in brainstem, thalamus, hippocampus and upper spinal cord without significant cerebellar or white-matter microstructural change over two years.
  phenotype_term:
    preferred_term: Cerebellar atrophy
    term:
      id: HP:0001272
      label: Cerebellar atrophy
  evidence:
  - reference: PMID:32851396
    reference_title: A Māori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Individual M2 III:4 had a normal brain MRI 3 years after symptom onset, but subsequent CT head scans showed cerebellar atrophy.
    explanation: Shows that imaging can lag clinical onset.
  - reference: PMID:40908706
    reference_title: Longitudinal Evaluation of Ataxia and Brain Structural Changes in RFC1-Related Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: No significant changes were observed in other regions of the cerebellum compared to the changes in the controls. Microstructural analysis of white matter integrity revealed no significant longitudinal changes between groups.
    explanation: Preserves the negative longitudinal imaging results alongside extra-cerebellar changes.
- name: Progressive gait imbalance and falls
  category: Neurological
  description: Imbalance often worsens in the dark. At last follow-up 366/388 (94%) reported unsteadiness in the large cohort; falls and walking-aid dependence increase with progression.
  phenotype_term:
    preferred_term: Unsteady gait
    term:
      id: HP:0002317
      label: Unsteady gait
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:38193360
    reference_title: Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Unsteadiness | 255/388 (66%) | 366/388 (94%)
    explanation: Frequency concerns unsteadiness, not the separate frequency of falls.
  frequency: VERY_FREQUENT
- name: Gaze-evoked nystagmus
  category: Neurological
  description: A cerebellar oculomotor manifestation; its presence and severity vary among affected individuals.
  phenotype_term:
    preferred_term: Gaze-evoked nystagmus
    term:
      id: HP:0000640
      label: Gaze-evoked nystagmus
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Examination reveals oculomotor signs (including gaze-evoked nystagmus, downbeat nystagmus, saccadic pursuit, and dysmetric saccades) and gait and limb ataxia.
    explanation: Documents cerebellar manifestations.
- name: Downbeat nystagmus
  category: Neurological
  description: A cerebellar oculomotor manifestation; its presence and severity vary among affected individuals.
  phenotype_term:
    preferred_term: Downbeat nystagmus
    term:
      id: HP:0010545
      label: Downbeat nystagmus
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Examination reveals oculomotor signs (including gaze-evoked nystagmus, downbeat nystagmus, saccadic pursuit, and dysmetric saccades) and gait and limb ataxia.
    explanation: Documents cerebellar manifestations.
- name: Dysmetric saccades
  category: Neurological
  description: A cerebellar oculomotor manifestation; its presence and severity vary among affected individuals.
  phenotype_term:
    preferred_term: Dysmetric saccades
    term:
      id: HP:0000641
      label: Dysmetric saccades
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Examination reveals oculomotor signs (including gaze-evoked nystagmus, downbeat nystagmus, saccadic pursuit, and dysmetric saccades) and gait and limb ataxia.
    explanation: Documents cerebellar manifestations.
- name: Saccadic pursuit
  category: Neurological
  description: A cerebellar oculomotor manifestation; its presence and severity vary among affected individuals.
  phenotype_term:
    preferred_term: Microsaccadic pursuit
    term:
      id: HP:0007792
      label: Microsaccadic pursuit
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Examination reveals oculomotor signs (including gaze-evoked nystagmus, downbeat nystagmus, saccadic pursuit, and dysmetric saccades) and gait and limb ataxia.
    explanation: Documents cerebellar manifestations.
- name: Hyperreflexia
  category: Neurological
  description: Reported within the expanded RFC1 phenotype. Brisk reflexes are relatively common, whereas overt pyramidal or lower-motor manifestations are less consistent; no single frequency is extrapolated across cohorts.
  phenotype_term:
    preferred_term: Hyperreflexia
    term:
      id: HP:0001347
      label: Hyperreflexia
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Brisk reflexes, particularly in the upper limbs and at the knees, are commonly observed. Other signs of upper and lower motor neuron involvement, including spasticity and/or Babinski sign, muscle atrophy, fasciculations, and weakness, are uncommon.
    explanation: Current synthesis explicitly includes these features.
- name: Spasticity
  category: Neurological
  description: Reported within the expanded RFC1 phenotype. Brisk reflexes are relatively common, whereas overt pyramidal or lower-motor manifestations are less consistent; no single frequency is extrapolated across cohorts.
  phenotype_term:
    preferred_term: Spasticity
    term:
      id: HP:0001257
      label: Spasticity
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Brisk reflexes, particularly in the upper limbs and at the knees, are commonly observed. Other signs of upper and lower motor neuron involvement, including spasticity and/or Babinski sign, muscle atrophy, fasciculations, and weakness, are uncommon.
    explanation: Current synthesis explicitly includes these features.
- name: Babinski sign
  category: Neurological
  description: Reported within the expanded RFC1 phenotype. Brisk reflexes are relatively common, whereas overt pyramidal or lower-motor manifestations are less consistent; no single frequency is extrapolated across cohorts.
  phenotype_term:
    preferred_term: Babinski sign
    term:
      id: HP:0003487
      label: Babinski sign
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Brisk reflexes, particularly in the upper limbs and at the knees, are commonly observed. Other signs of upper and lower motor neuron involvement, including spasticity and/or Babinski sign, muscle atrophy, fasciculations, and weakness, are uncommon.
    explanation: Current synthesis explicitly includes these features.
- name: Fasciculations
  category: Neurological
  description: Reported within the expanded RFC1 phenotype. Brisk reflexes are relatively common, whereas overt pyramidal or lower-motor manifestations are less consistent; no single frequency is extrapolated across cohorts.
  phenotype_term:
    preferred_term: Fasciculations
    term:
      id: HP:0002380
      label: Fasciculations
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Brisk reflexes, particularly in the upper limbs and at the knees, are commonly observed. Other signs of upper and lower motor neuron involvement, including spasticity and/or Babinski sign, muscle atrophy, fasciculations, and weakness, are uncommon.
    explanation: Current synthesis explicitly includes these features.
- name: Skeletal muscle atrophy
  category: Neurological
  description: Reported within the expanded RFC1 phenotype. Brisk reflexes are relatively common, whereas overt pyramidal or lower-motor manifestations are less consistent; no single frequency is extrapolated across cohorts.
  phenotype_term:
    preferred_term: Skeletal muscle atrophy
    term:
      id: HP:0003202
      label: Skeletal muscle atrophy
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Brisk reflexes, particularly in the upper limbs and at the knees, are commonly observed. Other signs of upper and lower motor neuron involvement, including spasticity and/or Babinski sign, muscle atrophy, fasciculations, and weakness, are uncommon.
    explanation: Current synthesis explicitly includes these features.
- name: Muscle weakness
  category: Neurological
  description: Reported within the expanded RFC1 phenotype. Brisk reflexes are relatively common, whereas overt pyramidal or lower-motor manifestations are less consistent; no single frequency is extrapolated across cohorts.
  phenotype_term:
    preferred_term: Muscle weakness
    term:
      id: HP:0001324
      label: Muscle weakness
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Brisk reflexes, particularly in the upper limbs and at the knees, are commonly observed. Other signs of upper and lower motor neuron involvement, including spasticity and/or Babinski sign, muscle atrophy, fasciculations, and weakness, are uncommon.
    explanation: Current synthesis explicitly includes these features.
- name: Paresthesia
  category: Neurological
  description: Pins and needles can accompany sensory neuronopathy and may precede overt ataxia.
  phenotype_term:
    preferred_term: Paresthesia
    term:
      id: HP:0003401
      label: Paresthesia
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: which include loss of feeling, pins and needles, pain, and cramps
    explanation: Documents positive sensory symptoms.
- name: Neuropathic pain
  category: Neurological
  description: Burning or other neuropathic pain occurs in a subset, including expansion/truncating-allele cases.
  phenotype_term:
    preferred_term: Neuropathic pain
    term:
      id: HP:0012531
      label: Pain
  evidence:
  - reference: PMID:36289003
    reference_title: Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: unsteadiness, worse in the dark, followed a few years later by neuropathic pain and oscillopsia related to head movements
    explanation: Clinical history directly documents neuropathic pain.
  notes: HP:6000040 Neuropathic pain is a pain-characteristic modifier rather than a descendant of Phenotypic abnormality, so the phenotype binds to Pain with its clinical specificity retained in preferred_term.
- name: Impaired lower-limb vibration sensation
  category: Neurological
  description: Vibration sensation is commonly reduced in the lower limbs, often more severely than distal joint position sense.
  phenotype_term:
    preferred_term: Impaired vibration sensation in the lower limbs
    term:
      id: HP:0002166
      label: Impaired vibration sensation in the lower limbs
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: reduced vibration sensation in the lower limbs, and milder reduction of position sense distally
    explanation: Documents differential sensory modalities.
- name: Cognitive impairment
  category: Neurological
  description: Systematic testing can reveal deficits despite mild complaints. Selected neuropsychological series are not representative prevalence samples; dementia is not common.
  phenotype_term:
    preferred_term: Cognitive impairment
    term:
      id: HP:0100543
      label: Cognitive impairment
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Deficits most frequently involve executive functions and attention ... working memory.
    explanation: Current clinical synthesis identifies the affected domains.
  - reference: PMID:38480525
    reference_title: Cognitive Impairment Is Part of the Phenotype of Cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome (CANVAS).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Twenty-one patients underwent a complete assessment, including 71% scoring lower than the cutoff at the Montreal Cognitive assessment
    explanation: A small systematically tested cohort demonstrates impairment, not a population frequency.
- name: Impaired executive functioning
  category: Neurological
  description: Executive deficits form part of the reported cognitive and cerebellar cognitive affective spectrum.
  phenotype_term:
    preferred_term: Impaired executive functioning
    term:
      id: HP:0033051
      label: Impaired executive functioning
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Deficits most frequently involve executive functions and attention ... working memory.
    explanation: Current clinical synthesis identifies the affected domains.
- name: Orthostatic hypotension
  category: Cardiovascular
  description: An individually reported autonomic manifestation; severity ranges from mild symptoms to substantial disability in selected cases.
  phenotype_term:
    preferred_term: Orthostatic hypotension
    term:
      id: HP:0001278
      label: Orthostatic hypotension
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Signs and symptoms including postural hypotension, erectile dysfunction, chronic constipation, urinary dysfunction, and altered sweating are relatively common but rarely disabling.
    explanation: Defines the autonomic spectrum without a single cross-cohort frequency.
- name: Erectile dysfunction
  category: Genitourinary
  description: An individually reported autonomic manifestation; severity ranges from mild symptoms to substantial disability in selected cases.
  phenotype_term:
    preferred_term: Erectile dysfunction
    term:
      id: HP:0100639
      label: Erectile dysfunction
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Signs and symptoms including postural hypotension, erectile dysfunction, chronic constipation, urinary dysfunction, and altered sweating are relatively common but rarely disabling.
    explanation: Defines the autonomic spectrum without a single cross-cohort frequency.
- name: Chronic constipation
  category: Gastrointestinal
  description: An individually reported autonomic manifestation; severity ranges from mild symptoms to substantial disability in selected cases.
  phenotype_term:
    preferred_term: Chronic constipation
    term:
      id: HP:0012450
      label: Chronic constipation
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Signs and symptoms including postural hypotension, erectile dysfunction, chronic constipation, urinary dysfunction, and altered sweating are relatively common but rarely disabling.
    explanation: Defines the autonomic spectrum without a single cross-cohort frequency.
- name: Parkinsonism
  category: Neurological
  description: Reported in selected cohorts, including 4/38 thoroughly characterized patients in the 2022 series. One autopsy had concomitant Lewy pathology, so the association does not establish that RFC1 expansions directly cause every parkinsonian presentation.
  phenotype_term:
    preferred_term: Parkinsonism
    term:
      id: HP:0001300
      label: Parkinsonism
  evidence:
  - reference: PMID:34927205
    reference_title: Motor neuron pathology in CANVAS due to RFC1 expansions.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Parkinsonism was more prevalent in this cohort than in the general population, 10% versus the expected 1%
    explanation: Reports an association in a selected series, not a general population estimate.
- name: REM sleep behavior disorder
  category: Neurological
  description: Reported in Māori and New Zealand European CANVAS cases; no general frequency estimate is available.
  phenotype_term:
    preferred_term: REM sleep behavior disorder
    term:
      id: HP:5200291
      label: REM sleep behavior disorder
  evidence:
  - reference: PMID:32851396
    reference_title: A Māori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We report rapid eye movement sleep behaviour disorder as a feature of CANVAS for the first time, occurring in both our New Zealand European and Māori patients
    explanation: Documents the feature without asserting a molecular mechanism.
- name: Autonomic bladder dysfunction
  category: Genitourinary
  description: Urinary dysfunction is part of the autonomic spectrum; symptom type and severity vary and merit urological assessment.
  phenotype_term:
    preferred_term: Autonomic bladder dysfunction
    term:
      id: HP:0005341
      label: Autonomic bladder dysfunction
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Signs and symptoms including postural hypotension, erectile dysfunction, chronic constipation, urinary dysfunction, and altered sweating are relatively common but rarely disabling.
    explanation: Defines the autonomic spectrum without a single cross-cohort frequency.
- name: Anhidrosis
  category: Neurological
  description: Reduced or absent sweating may occur as part of dysautonomia.
  phenotype_term:
    preferred_term: Anhidrosis
    term:
      id: HP:0000970
      label: Anhidrosis
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Chronic constipation and/or diarrhea ... Anhidrosis or increased sweating
    explanation: The clinical presentation list includes both reduced and increased sweating; no phenotype-specific frequency is assigned.
- name: Hyperhidrosis
  category: Neurological
  description: Increased sweating is an alternative sudomotor manifestation; it is not expected to coexist with anhidrosis in every patient.
  phenotype_term:
    preferred_term: Hyperhidrosis
    term:
      id: HP:0000975
      label: Hyperhidrosis
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Chronic constipation and/or diarrhea ... Anhidrosis or increased sweating
    explanation: The clinical presentation list includes both reduced and increased sweating; no phenotype-specific frequency is assigned.
histopathology:
- name: Sensory ganglion neuronal loss
  description: Loss of dorsal root ganglion sensory neurons produces peripheral sensory deafferentation and secondary posterior-column degeneration. Historical autopsies predated RFC1 genotyping, while later genetically confirmed cases show concordant sensory and posterior-column pathology. The primary ganglion lesion does not require a uniformly non-length-dependent clinical distribution. Five temporal bones from four clinically defined, ungenotyped CANVAS patients showed severe vestibular ganglion neuronal loss, with relative preservation of spiral ganglia, sensory hair cells and vestibular nuclei. Trigeminal and geniculate ganglia were also affected. Ganglionic Nageotte nodules reflect glial replacement of lost neurons; they are not psammoma bodies. Relative auditory sparing does not exclude coincident presbycusis or another cause of hearing loss.
  evidence:
  - reference: PMID:24682971
    reference_title: Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Spinal cord pathology demonstrated a marked dorsal root ganglionopathy with secondary tract degeneration.
    explanation: Direct neuropathology in clinically defined CANVAS predating molecular diagnosis.
  - reference: PMID:33492056
    reference_title: The Pathology of the Vestibular System in CANVAS.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: In CANVAS there is a severe cranial sensory ganglionopathy neuronopathy (ganglionopathy) involving the vestibular, facial, and trigeminal ganglia but sparing the auditory ganglia.
    explanation: Historical pathology localizes vestibular failure primarily to ganglion neurons; these donors were not RFC1-genotyped.
- name: Cerebellar Purkinje cell depletion
  description: Purkinje-cell depletion, often greatest in the vermis, and Bergmann gliosis are documented in clinical CANVAS autopsies and a genetically confirmed 2019 case. This lesion contributes to cerebellar gait, limb, speech and oculomotor dysfunction. Molecular intermediates connecting the repeat genotype to selective adult Purkinje degeneration remain unresolved.
  evidence:
  - reference: PMID:24682971
    reference_title: Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Cerebellar pathology showed loss of Purkinje cells, predominantly in the vermis.
    explanation: Documents selective cerebellar pathology in historical clinical CANVAS.
  - reference: PMID:30926972
    reference_title: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The patient with CANVAS showed severe, widespread depletion of Purkinje cells with associated prominent Bergmann gliosis, while cell density in the granule cell layer was well preserved.
    explanation: The 2019 study documents this pathology in a genetically confirmed CANVAS case.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- name: Spinal axonal swelling and astrocytic gliosis
  description: Upper and lower motor signs occur in a subset of RFC1 cases. One genetically confirmed autopsy showed anterior-horn astrocytic gliosis and axonal swelling around motor-neuron somata, with preserved anterior-horn neurons and corticospinal tracts. Synaptic dysfunction is proposed; generalized motor-neuron death is not established by this case. The same individual also had Lewy body pathology consistent with coexisting Parkinson disease.
  evidence:
  - reference: PMID:34927205
    reference_title: Motor neuron pathology in CANVAS due to RFC1 expansions.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We observed marked astrocytic gliosis and axonal swelling of the synapse between first and second motor neurons in the anterior horn at the lumbar level.
    explanation: The pathology supports circuit-level abnormality in one patient.
  - reference: url:https://discovery.ucl.ac.uk/id/eprint/10141005/1/awab449%20%281%29.pdf
    reference_title: https://discovery.ucl.ac.uk/id/eprint/10141005/1/awab449%20%281%29.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Although the second motor neurons in the anterior and lateral horns were preserved
    explanation: Preserved neuronal somata are part of the reported histological finding, not evidence against the described axonal and glial changes.
diagnosis:
- name: RFC1 repeat genotyping and second-allele sequencing
  description: Use motif-aware flanking and repeat-primed PCR, with Southern blotting, long-read sequencing or optical genome mapping when needed to resolve size and configuration. Specialized whole-genome pipelines can screen repeats; routine exome sequencing cannot reliably exclude them. If only one expansion is found in a typical phenotype, sequence RFC1 for a coding or splice second allele. Ambiguous motifs require cautious interpretation.
  evidence:
  - reference: PMID:36289003
    reference_title: Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: full RFC1 sequencing is recommended in cases affected by typical CANVAS and carrying monoallelic (AAGGG)n expansions.
    explanation: Supports the complementary role of coding sequencing.
  - reference: PMID:41964406
    reference_title: Homozygous RFC1 AAGGG Repeat Expansions Are Common in Idiopathic Peripheral Neuropathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Both WGS and PCR methods face challenges in precisely quantifying repeat number, particularly in the presence of multiple repeat motifs.
    explanation: Recognizes platform and motif limitations.
  - reference: PMID:40481300
    reference_title: Comprehensive Characterisation of the RFC1 Repeat in an Australian Cohort.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We also demonstrate the utility of targeted long-read sequencing in resolving complex alleles.
    explanation: Supports long-read resolution in an Australian clinical series.
  diagnosis_term:
    preferred_term: Genetic Testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
- name: Sensory nerve conduction studies
  description: Reduced or absent sensory action potentials support sensory neuronopathy. Motor conduction is often preserved, but motor abnormalities should not automatically exclude RFC1 testing. Needle EMG can assess additional motor involvement.
  evidence:
  - reference: PMID:36289003
    reference_title: Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Nerve conduction studies showed absent sensory action potentials in the upper and lower limbs but normal motor studies.
    explanation: Typical electrophysiology in an expansion/truncating case.
  - reference: PMID:41964406
    reference_title: Homozygous RFC1 AAGGG Repeat Expansions Are Common in Idiopathic Peripheral Neuropathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the presence of motor nerve involvement should not preclude patients from undergoing RFC1 repeat screening.
    explanation: The broader idiopathic-neuropathy cohort included sensorimotor cases.
  diagnosis_term:
    preferred_term: Nerve Conduction Velocity Test
    term:
      id: NCIT:C88502
      label: Nerve Conduction Velocity Test
- name: Vestibular and oculomotor examination
  description: Bedside and video head-impulse testing, caloric or rotational-chair testing assess bilateral vestibular loss. Impaired visually enhanced vestibuloocular reflex suggests combined vestibular and cerebellar involvement.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Examination reveals absent/reduced vestibuloocular reflex at bedside or video head impulse test. An impaired visually enhanced vestibuloocular reflex indicates the coexistence of vestibular and cerebellar pathology.
    explanation: Specifies the diagnostic physiological findings.
  diagnosis_term:
    preferred_term: Physical Examination
    term:
      id: NCIT:C20989
      label: Physical Examination
- name: Brain MRI
  description: Assess cerebellar vermian and hemispheric atrophy and alternative diagnoses. A normal early study does not exclude the disorder. Quantitative brainstem and other regional measures remain candidate progression biomarkers rather than validated diagnostic substitutes.
  evidence:
  - reference: PMID:32851396
    reference_title: A Māori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Individual M2 III:4 had a normal brain MRI 3 years after symptom onset, but subsequent CT head scans showed cerebellar atrophy.
    explanation: Shows that imaging can lag clinical onset.
  - reference: PMID:40908706
    reference_title: Longitudinal Evaluation of Ataxia and Brain Structural Changes in RFC1-Related Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: our small sample and late-stage cohort are limitations
    explanation: The ten-patient longitudinal biomarker study requires larger prospective validation.
  diagnosis_term:
    preferred_term: Magnetic Resonance Imaging
    term:
      id: NCIT:C16809
      label: Magnetic Resonance Imaging
- name: Autonomic assessment
  description: Evaluate postural blood pressure, bladder and bowel symptoms, sexual and sudomotor function; use targeted sympathetic and parasympathetic testing when clinically indicated.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Autonomic testing confirms the presence of a sympathetic and/or parasympathetic dysfunction in half of individuals undergoing specific investigations.
    explanation: Physiological dysfunction is established without assigning a specific ganglionic lesion.
  diagnosis_term:
    preferred_term: Physical Examination
    term:
      id: NCIT:C20989
      label: Physical Examination
prevalence:
- population: European-derived 2019 estimate of the recessive genotype at birth
  measure_type: BIRTH_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_per_100000: 5.0
  notes: >-
    Historical estimate of the biallelic genotype from the original expansion study, approximately 1 in 20,000. This is not measured clinical disease prevalence or a contemporary worldwide rate. Later population-sequencing studies report substantially higher genotype frequencies and reduced penetrance.
  evidence:
  - reference: PMID:30926972
    reference_title: "Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "with an estimated prevalence at birth of the recessive trait of approximately 1 in 20,000"
    explanation: Population birth prevalence of the recessive genotype, i.e. 5 per 100,000.
    quote_role: PRIMARY_RESULT
- population: European general population (carrier frequency)
  measure_type: CARRIER_FREQUENCY
  prevalence_class: ABOVE_1_IN_1000
  rate_per_100000: 700.0
  notes: >-
    The 2019 study estimated 0.7% heterozygous carriers in Europeans. This historical estimate should be distinguished from the higher frequencies in later population-sequencing studies summarized by GeneReviews in September 2026.
  evidence:
  - reference: PMID:30926972
    reference_title: "Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "an expansion carrier frequency of 0.7% in Europeans"
    explanation: Original carrier-frequency estimate in Europeans.
    quote_role: PRIMARY_RESULT
- population: Predominantly northern European populations, population sequencing summarized in September 2026 GeneReviews
  measure_type: CARRIER_FREQUENCY
  prevalence_class: ABOVE_1_IN_1000
  rate_per_100000: 8000.0
  notes: Heterozygote expansion-carrier estimate of 8%, not clinical disease prevalence. Short-read repeat calls and repeat-size-dependent penetrance affect interpretation.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: The heterozygote carrier frequency of ... AAGGG repeat expansions is 8% in populations of predominantly northern European origin
    explanation: The current chapter summarizes the population-sequencing estimate.
- population: Biallelic RFC1 AAGGG genotype in population-sequencing studies summarized in September 2026 GeneReviews
  measure_type: POINT_PREVALENCE
  prevalence_class: ABOVE_1_IN_1000
  notes: Biallelic AAGGG genotype frequency was estimated at 1:517 to 1:951. This is a genotype frequency, not the prevalence of symptomatic CANVAS; reduced penetrance, especially for shorter expansions, limits conversion to a clinical disease rate.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: The prevalence of individuals with biallelic AAGGG repeat expansions is 1:517 to 1:951
    explanation: A genotype-frequency range; clinical manifestations may be less frequent.
- population: Australian cohort referred with adult-onset ataxia
  notes: Diagnostic yield was 34.1% among 232 individuals referred with adult-onset ataxia, not population prevalence. The study also estimated approximately 1 in 16 heterozygous AAGGG carriers among 269 controls.
  evidence:
  - reference: PMID:40481300
    reference_title: Comprehensive Characterisation of the RFC1 Repeat in an Australian Cohort.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Biallelic pathogenic RFC1 variants were identified in 34.1% of affected individuals.
    explanation: Cohort-specific yield.
  measure_type: UNKNOWN
- population: US idiopathic peripheral neuropathy cohort
  notes: 18/788 patients carried biallelic AAGGG expansions versus 1/778 controls. Yield was 10/144 (6.9%) in pure sensory neuropathy. Monoallelic enrichment was not significant after appropriate control filtering (p=0.17); this study does not establish dominant RFC1 neuropathy.
  evidence:
  - reference: PMID:41964406
    reference_title: Homozygous RFC1 AAGGG Repeat Expansions Are Common in Idiopathic Peripheral Neuropathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: biallelic (AAGGG)exp in RFC1 accounted for 2.3% (18/788) of iPN cases
    explanation: Cohort-specific yield.
  measure_type: UNKNOWN
progression:
- phase: Adult neurological onset
  age_range: 25–80 years in the 392-person cohort
  notes: Median neurological onset was 54 years; cough was excluded from this definition and can begin decades earlier. An atypical Māori patient with childhood onset was reported, but the authors could not exclude a second condition.
  evidence:
  - reference: PMID:38193360
    reference_title: Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Median age at onset of neurological symptoms (cough excluded) was 54 years (IQR = 49–61), ranging from 25 to 80 years.
    explanation: Defines the cohort and onset endpoint.
  - reference: PMID:32851396
    reference_title: A Māori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the possibility of a second condition cannot be excluded.
    explanation: The unusual childhood presentation should not redefine the usual onset distribution.
- phase: Variable progression of multisystem involvement
  notes: At last follow-up, half of the 392-person cohort had complete CANVAS, one third complex neuropathy and 14% isolated sensory neuropathy. Walking aids were required by 54% after a median ten years and a wheelchair by 17% after fourteen years. These are retrospective cohort observations, not individual prognoses.
  evidence:
  - reference: PMID:38193360
    reference_title: Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Overall, 195 patients (50%) had complete CANVAS, 131 (33%) had a complex neuropathy, while 54 (14%) still showed an isolated sensory neuropathy.
    explanation: Defines the spectrum rather than universal progression to the triad.
  - reference: PMID:38193360
    reference_title: Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Fifty-four per cent of patients required walking aids after a median disease duration of 10 years (IQR = 5–16) and 17% needed a wheelchair after 14 years (IQR = 11–21).
    explanation: Quantifies disability milestones in a defined series.
- phase: Repeat size and modifying factors
  notes: Larger expansions, particularly the smaller allele, correlate with earlier onset and more complex or faster-progressing disease. Repeat size explained at most 6% of onset variation. Most measured transmissions changed by less than 10%; these results do not establish genetic anticipation.
  evidence:
  - reference: PMID:38193360
    reference_title: Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the repeat size explained only up to 6% of the variability in age of neurological disease onset
    explanation: Most onset variability remains unexplained.
  - reference: PMID:38193360
    reference_title: Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Expansion or contraction of the repeat across generations occurred with the same frequency.
    explanation: Limits anticipation claims.
treatments:
- name: Multidisciplinary supportive care
  description: Coordinate neurology, rehabilitation, ENT, respiratory, speech and swallowing care, with annual neurological and mobility review and more frequent assessment when symptoms change. Current care maximizes function and manages complications; no disease-modifying benefit has been established.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: The goals of treatment are to maximize function and reduce complications.
    explanation: Expert management synthesis; not a CANVAS-specific treatment trial.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
- name: Physical and vestibular rehabilitation
  description: Individualized balance, gait and strengthening work, occupational therapy, home adaptations and mobility aids address falls and daily function. Consider vestibular rehabilitation; these recommendations are largely extrapolated from rehabilitation practice.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: PT (balance exercises, gait training, muscle strengthening) to maintain mobility
    explanation: Current GeneReviews treatment table recommends rehabilitation.
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Consider vestibular rehab. ... Home adaptations to prevent falls
    explanation: Recommendations target balance and falls.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Physical Therapy
    term:
      id: NCIT:C15302
      label: Physical Therapy
  target_phenotypes:
  - preferred_term: Progressive gait imbalance and falls
    term:
      id: HP:0002317
      label: Unsteady gait
  - preferred_term: Vestibular areflexia
    term:
      id: HP:0008568
      label: Vestibular areflexia
- name: Speech and swallowing support
  description: Use speech-language therapy and communication aids as needed. Assess aspiration and nutrition; adjust food consistency for dysphagia based on swallowing assessment.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: speech-language therapy for dysarthria; modify food consistency to decrease aspiration risk in those with dysphagia
    explanation: Current expert guidance for bulbar manifestations.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_phenotypes:
  - preferred_term: Dysarthria
    term:
      id: HP:0001260
      label: Dysarthria
  - preferred_term: Dysphagia
    term:
      id: HP:0002015
      label: Dysphagia
- name: Specialist management of refractory cough
  description: Assess common treatable contributors. Cough-control speech or physical therapy and individualized neuromodulator trials may be considered; reflux treatment is appropriate when reflux is present. Benefits and tolerability vary.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Consider cough neuromodulator (e.g. gabapentin, amitriptyline, pregabalin). ... Consider speech therapy ... PT for cough control.
    explanation: Expert recommendations; comparative efficacy in RFC1 disease is uncertain.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_phenotypes:
  - preferred_term: Chronic cough
    term:
      id: HP:0034315
      label: Chronic cough
- name: Low-dose sustained-release morphine for refractory cough
  description: A prospective uncontrolled 2026 series offered sustained-release morphine sulfate 10 mg twice daily to 17 genetically confirmed patients for six months. Eleven reported residual nondebilitating cough, four cessation, one partial improvement and one withdrew because of nausea. Follow-up used unvalidated self-report, without placebo control or repeat baseline VAS/LCQ instruments. This is symptomatic evidence requiring individualized specialist assessment, not disease modification.
  evidence:
  - reference: PMID:41532091
    reference_title: Efficacy of morphine on cough in patients with repeat expansions of RFC1 and refractory chronic cough.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: 11 (64.7%) had good response with residual non-debilitating cough and four (23.5%) had cough cessation ... One (5.9%) patient had to discontinue morphine because of nausea.
    explanation: Small uncontrolled intervention series; outcomes require confirmation.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Sustained-release morphine sulfate treatment
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: Morphine Sulfate Sustained-Release Tablet
      term:
        id: NCIT:C84853
        label: Morphine Sulfate Sustained-Release Tablet
  target_phenotypes:
  - preferred_term: Chronic cough
    term:
      id: HP:0034315
      label: Chronic cough
- name: Autonomic symptom management
  description: Tailor care to orthostatic, urinary, bowel, sexual and sudomotor symptoms; severe manifestations warrant focused evaluation for competing or additional causes.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Consider treatment for erectile dysfunction, urinary incontinence/retention, constipation/diarrhea, dry eyes/mouth.
    explanation: Expert symptom-directed guidance.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_phenotypes:
  - preferred_term: Autonomic dysfunction
    term:
      id: HP:0012332
      label: Abnormal autonomic nervous system physiology
  - preferred_term: Orthostatic hypotension
    term:
      id: HP:0001278
      label: Orthostatic hypotension
  - preferred_term: Chronic constipation
    term:
      id: HP:0012450
      label: Chronic constipation
  - preferred_term: Erectile dysfunction
    term:
      id: HP:0100639
      label: Erectile dysfunction
- name: Individualized medication and alcohol review
  description: Assess medication necessity and potential peripheral, cerebellar or vestibular toxicity individually. The September 2026 GeneReviews update states that evidence does not support categorical avoidance of specific medications. Alcohol may worsen ataxia and should be consumed in moderation. A preprint association between heterozygous expansions and oxaliplatin neuropathy is not a validated prescribing rule.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: there is currently no evidence-based guidance recommending avoidance of specific medications, and treatment decisions should be based on clinical need.
    explanation: Replaces the older blanket medication-avoidance recommendation.
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Alcohol, which can exacerbate ataxia, should only be consumed in moderation.
    explanation: Current precautionary advice.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
- name: Genetic counseling
  description: Explain recessive inheritance, motif-dependent interpretation, possible pseudodominance and age-dependent or incomplete expression. Offer appropriate family testing and reproductive counseling after molecular clarification. If both parents are heterozygous carriers, each pregnancy has a 25% chance of a child with biallelic variants, a 50% chance of a heterozygous carrier, and a 25% chance of inheriting neither familial variant. Confirm parental genotypes because pseudodominance changes this calculation.
  evidence:
  - reference: PMID:39230846
    reference_title: Pseudodominance in RFC1-Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We describe pseudodominance in two families affected with RFC1 disorder (10 affected, 5 oligo/asymptomatic individuals).
    explanation: Documents actual multigenerational families, including oligo/asymptomatic biallelic relatives.
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Assuming that both parents are heterozygous for an ... pathogenic variant, each sib of an affected individual has at conception a 25% chance of inheriting biallelic ... pathogenic variants, a 50% chance of inheriting one pathogenic variant, and a 25% chance of inheriting neither of the familial pathogenic variants.
    explanation: Conditional recurrence risks for two heterozygous parents; not a universal risk for every RFC1 family.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
discussions:
- discussion_id: canvas_mechanism_unresolved
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: Which repeat-dependent processes mediate selective neuronal dysfunction, and how much depends on RFC1 expression in each vulnerable lineage?
  attaches_to:
  - pathophysiology#Context-Dependent Reduction of RFC1 Transcript Abundance
  - pathophysiology#Repeat DNA Secondary Structures
  - pathophysiology#RFC1 Intron 2 Retention
  - pathophysiology#Repeat RNA Foci
  - pathophysiology#Repeat-Associated Poly-KGREG Production
  - pathophysiology#Impaired Neuronal Synaptic Signaling
  - pathophysiology#Delayed Repair of Platinum-Induced DNA Damage
  rationale: Published 2024 cortical-like neurons show synaptic dysfunction and partial rescue after monoallelic Alu-repeat deletion, despite preserved RFC1 expression and normal UV-damage recovery. An unreviewed 2025 study of sensory/motor neurons reports modest isogenic-relative transcript reduction and rescue of platinum sensitivity by biallelic deletion. The same deletion can alter expression, repeat products and Alu regulatory functions, so neither result identifies a unique mediator. Foci findings conflict across tissue and assay contexts; positive autopsies keep RNA-mediated hypotheses open. Short-repeat negative toxicity assays cannot exclude longer or endogenous-context effects. Selective vulnerability and relative auditory preservation remain unexplained.
  proposed_experiments:
  - experiment_id: canvas_ganglion_resolved_rfc1_expression
    name: Ganglion-resolved RFC1 expression comparison
    description: Compare matched patient and corrected sensory, vestibular, auditory and Purkinje-lineage cultures using allele-resolved RNA, validated protein quantification and standardized maturation. Test RFC1 replacement independently of repeat deletion and quantify both synaptic and DNA-damage phenotypes.
    decision_criterion: Concordant lineage-specific protein reduction plus rescue by expression restoration would support an expression-mediated mechanism. Preserved protein or failure of adequately controlled replacement would constrain that model without excluding repeat-dependent processes.
  - experiment_id: canvas_g4_modulation_sensory_neurons
    name: G-quadruplex modulation in patient-derived sensory neurons
    description: Measure endogenous repeat DNA and RNA structures with orthogonal, strand-specific methods and perturb G-quadruplex versus triplex formation separately in isogenic neurons.
    decision_criterion: A structure-selective intervention must change the proposed structure and rescue a neuronal endpoint without merely changing RFC1 abundance or causing nonspecific toxicity.
  - experiment_id: canvas_replication_independent_toxicity
    name: Replication-independent repeat toxicity assay
    description: Reassess repeat RNA foci, R-loops and poly-KGREG with validated specificity controls across genotypes, repeat motifs, cell types and ages. Compare published negative short-repeat assays with native-locus and longer-repeat systems.
    decision_criterion: Reproducible genotype-associated products plus selective depletion and neuronal rescue would support toxicity. Product detection alone, or a negative result in one short-term model, would not settle the mechanism.
    evidence:
    - reference: PMID:38062616
      reference_title: RNA Foci in Two bi-Allelic RFC1 Expansion Carriers.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: RNA fluorescence in situ hybridization of the 2 patients revealed CCTGT- and CCCTT-containing RNA foci, respectively, in neuronal nuclei of tissues with neuronal loss.
      explanation: Autopsy findings support foci formation in two cases; toxicity remains unproven.
    - reference: PMID:30926972
      reference_title: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.
      supports: REFUTE
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: We did not observe in patient brains the presence of RNA foci of either the sense or antisense repeated unit.
      explanation: Preserves the earlier negative finding.
    - reference: PMID:39231235
      reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: the overall abundance of foci was low, and the specificity was imperfect, with 8.94% of control neurons and 11.3% of CANVAS neurons showing antisense CCCTT RNA foci
      explanation: Patient-neuron signal was small and incompletely specific.
  evidence:
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Gene Ontology (GO) analysis indicated a significant overrepresentation of neuronal signaling processes including synaptic signaling and processes that regulate synaptic signaling
    explanation: Transcriptomic changes converge on neuronal signaling.
  - reference: PMID:39231235
    reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: CANVAS patient iPSC–derived neurons remained devoid of detectable synchronous firing even between 7 and 11 weeks after differentiation
    explanation: Patient neurons had impaired network synchrony.
  - reference: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
    reference_title: ABSTRACT
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: expression could only be detected when comparing CANVAS lines with their isogenic corrected counterpart, but not when comparing CANVAS lines with non-isogenic controls
    explanation: Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Motor-neuron qPCR showed about 23% lower expression versus isogenic controls; sensory-neuron reduction was about 15%.
  - reference: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
    reference_title: ABSTRACT
    supports: REFUTE
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: we were unable to demonstrate a significant effect of the repeat expansion on RFC1 protein.
    explanation: Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). The preprint does not establish reduced protein abundance.
  - reference: PMID:38062616
    reference_title: RNA Foci in Two bi-Allelic RFC1 Expansion Carriers.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: RNA fluorescence in situ hybridization of the 2 patients revealed CCTGT- and CCCTT-containing RNA foci, respectively, in neuronal nuclei of tissues with neuronal loss.
    explanation: Autopsy findings support foci formation in two cases; toxicity remains unproven.
  - reference: PMID:30926972
    reference_title: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We did not observe in patient brains the presence of RNA foci of either the sense or antisense repeated unit.
    explanation: Preserves the earlier negative finding.
- discussion_id: canvas_ganglionopathy_not_axonopathy
  kind: INTERPRETATION
  status: OPEN
  prompt: Should the peripheral lesion of CANVAS be modeled as a ganglionopathy rather than conforming to the length-dependent peripheral axonal degeneration module?
  attaches_to:
  - pathophysiology#Dorsal Root Ganglion Sensory Neuronopathy
  rationale: Neuropathology localizes the predominant peripheral lesion to sensory ganglion neuronal bodies, with secondary tract degeneration. Clinical sensory loss can nevertheless show a distal-to-proximal gradient, so a length-dependent examination pattern does not refute the ganglion lesion. The existing peripheral_axonal_degeneration module specifies a primary dying-back process that is not established here. Purkinje-cell loss supports the existing cerebellar_purkinje_degeneration conformance. A future ganglionopathy module could capture the primary lesion without forcing every clinical case into one sensory distribution.
  notes: Retains the module-conformance question while removing the false claim that all CANVAS sensory loss is non-length-dependent.
  evidence:
  - reference: PMID:24682971
    reference_title: Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Spinal cord pathology demonstrated a marked dorsal root ganglionopathy with secondary tract degeneration.
    explanation: Direct neuropathology in clinically defined CANVAS predating molecular diagnosis.
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Altered sensation in all limbs in either a length-dependent (distal extremities worse) or non-length-dependent pattern.
    explanation: Clinical distribution does not by itself determine the site of the primary lesion.
- discussion_id: canvas_penetrance_modifiers
  kind: INTERPRETATION
  status: OPEN
  prompt: Do DNA-repair pathway variants modify penetrance of biallelic RFC1 expansions?
  attaches_to:
  - genetic#RFC1
  rationale: A 2026 study associated DNA mismatch-repair polygenic scores and rs245100 upstream of MSH3 with clinically affected biallelic carriers across discovery and replication cohorts. This is candidate modifier evidence, not proof that rs245100 regulates MSH3 or that altered somatic expansion mediates RFC1 disease. Clinical-record ascertainment, repeat configuration and age complicate classification of apparently unaffected carriers. A separate unreviewed platinum-neuropathy association in heterozygotes does not establish dominant CANVAS or a clinical pharmacogenetic recommendation.
  evidence:
  - reference: PMID:42473260
    reference_title: DNA Repair Pathway Variants Are Enriched in Individuals with Biallelic AAGGG CANVAS and RFC1-Related Disease.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: The variant rs245100, upstream MSH3, was the biggest contributor to this elevated risk
    explanation: Association nominates a locus; it does not establish a regulatory target or causal mechanism.
- discussion_id: canvas_ortholog_loss_model_mismatch
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  prompt: How closely do ortholog-depletion models represent the human intronic-repeat disorder?
  attaches_to:
  - pathophysiology#Context-Dependent Reduction of RFC1 Transcript Abundance
  - pathophysiology#Cerebellar Purkinje Cell Loss
  rationale: The zebrafish model is a complete rfc1 knockout with early cerebellar progenitor loss and death by 10 days; the fly preprint uses neuronal ortholog knockdown. Neither organism model carries the human intronic expansion. Human repeat-only neurons can preserve RFC1 protein, and clinical disease is usually late onset. The models support a requirement for RFC1 but cannot establish that expansion-mediated disease is equivalent to complete or partial gene depletion.
  evidence:
  - reference: PMID:40595562
    reference_title: RFC1 regulates the expansion of neural progenitors in the developing zebrafish cerebellum.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the loss of RFC1 jeopardizes the genomic integrity of these progenitor cells
    explanation: Complete knockout disrupts developing progenitor populations.
notes: 'RFC1-related disease includes both the complete CANVAS triad and less extensive sensory-predominant presentations. Historical ungenotyped neuropathology and genetically confirmed observations are distinguished because clinical CANVAS can have other genetic causes. The November 2025 Currò study (DOI:10.1101/2025.11.18.688292) remains a preprint; its sensory/motor-neuron and fly findings require independent confirmation. Experimental repeat-region deletion is a mechanistic intervention, not an established clinical therapy. The bioRxiv source XML is the full text of the Currò et al. preprint, CANVAS causing AAGGG repeat expansions cause tissue-specific reduction in RFC1 expression and increase sensitivity to DNA damage (DOI:10.1101/2025.11.18.688292). The UCL awab449 PDF is the accepted manuscript of PMID:34927205, Motor neuron pathology in CANVAS due to RFC1 expansions. Parkinsonism and REM sleep behavior disorder are recorded as observed associations without a causal graph connection: their basal-ganglia or brainstem substrates are not explained by the anterior-horn lesion, and coexisting Lewy pathology in one autopsy limits attribution to RFC1. Motor phenotype links represent
  provisional circuit-level explanations; preserved corticospinal tracts and motor-neuron somata in the available autopsy prevent localization of all motor signs to that lesion.'
clinical_trials:
- name: NCT05177809
  phase: NOT_APPLICABLE
  status: RECRUITING
  description: Prospective international observational natural-history and biomarker study, targeting 150 participants including RFC1 cases and controls over 24 months.
  notes: Registry status checked 2026-10-01. This is natural-history research, not a disease-modifying treatment study.
  evidence:
  - reference: clinicaltrials:NCT05177809
    reference_title: RFC1 Natural History Study
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: This international, multi-center, multi-modal and prospective observational study aims to determine the phenotypic spectrum and the natural progression of the RFC1 repeat expansion disease
    explanation: Registry summary defines the observational purpose.
- name: NCT07156214
  phase: NOT_APPLICABLE
  status: RECRUITING
  description: Basic-science biomarker study in CANVAS and controls, with serial blood sampling and research on available fibroblasts and induced pluripotent cells; planned enrollment 50.
  notes: Registry status checked 2026-10-01. Classified as interventional with BASIC_SCIENCE purpose; the intervention is sample-based assessment, not a tested therapy.
  evidence:
  - reference: clinicaltrials:NCT07156214
    reference_title: 'Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS: a Model to a Deeper Understanding of Molecular Mechanisms Underlying Late-onset Neurodegeneration'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: limited data are available regarding its natural history and the molecular mechanisms by which this dynamic mutation leads to neurodegeneration of selective neuronal populations.
    explanation: Registry rationale for mechanistic and biomarker research.
- name: NCT06817707
  phase: NOT_APPLICABLE
  status: RECRUITING
  description: Diagnostic study of urinary dysfunction, dysautonomia and urological complications in genetically confirmed CANVAS; planned enrollment 40.
  notes: Registry status checked 2026-10-01. The registered intervention is diagnostic evaluation, not a disease-modifying treatment.
  evidence:
  - reference: clinicaltrials:NCT06817707
    reference_title: Evaluation of Urinary Dysfunction in CANVAS Patients
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: The primary objective of this study is to evaluate the incidence of urinary symptoms in these patients, as well as the potential complications that might occur at the level of the upper and lower urinary system.
    explanation: Registry describes urinary assessment.
experimental_models:
- name: Expansion/truncating-allele patient fibroblasts
  experimental_model_type: PRIMARY_CELL_CULTURE
  description: Fibroblasts from two p.Arg423Ter siblings and one p.Pro959GlnfsTer24 carrier were compared with repeat-only cases, controls and an unaffected sibling. Protein data directly characterize the two p.Arg423Ter siblings.
  publication: PMID:36289003
  modeled_mechanisms:
  - target: Decay of Truncating RFC1 Transcripts
    description: Allele-specific RNA depletion supports nonsense-mediated decay.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: HIGH
    model_scale: MOLECULAR
    evidence:
    - reference: PMID:36289003
      reference_title: Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Together, the findings suggest that the transcript containing truncating variants in RFC1 undergo nonsense-mediated decay leading to RNA degradation.
      explanation: Patient fibroblast studies characterize the truncating allele in the compound genotype.
  - target: Reduced RFC1 Protein in Truncating-Allele Carriers
    description: Full-length RFC1 protein is reduced in tested compound heterozygotes.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: HIGH
    model_scale: MOLECULAR
    evidence:
    - reference: PMID:36289003
      reference_title: Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: immunoblotting showed a concordant reduction of the 140 KD full-length RFC1 protein in fibroblasts from affected individuals
      explanation: Protein reduction accompanies allele-specific RNA decay.
    limitations: Peripheral fibroblasts do not reproduce neuronal vulnerability, and protein reduction was not shown for every coding allele.
- name: Patient-derived glutamatergic forebrain neurons
  experimental_model_type: IPSC_DERIVED_MODEL
  description: Four patient and three control iPSC lines were generated; key functional comparisons used three per group. These predominantly cortical-like neurons are immature and do not directly represent sensory ganglia or Purkinje cells. One patient line supplied a monoallelic Alu-repeat deletion comparator.
  publication: PMID:39231235
  modeled_mechanisms:
  - target: Impaired Neuronal Synaptic Signaling
    description: Synaptic transcripts/proteins and network synchrony were abnormal.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    model_scale: CELLULAR
    evidence:
    - reference: PMID:39231235
      reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: CANVAS patient iPSC–derived neurons remained devoid of detectable synchronous firing even between 7 and 11 weeks after differentiation
      explanation: Patient neurons had impaired network synchrony.
    limitations: Short-term forebrain cultures do not establish the mechanism of adult sensory or cerebellar neuronal loss.
  - target: Impaired Neuronal Synaptic Signaling
    description: Monoallelic Alu-repeat deletion partially restored gene expression and synchrony (42% versus 70% control network correlation).
    relationship: RESCUES
    fidelity: MODERATE
    model_scale: CELLULAR
    evidence:
    - reference: PMID:39231235
      reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: with an average network correlation of 42% compared to 70% in controls
      explanation: Correction is partial and derives from one isogenic patient background.
    limitations: Deleting the Alu-repeat region can alter several functions; rescue does not isolate toxic RNA, peptide or expression mechanisms.
  - target: RFC1 Intron 2 Retention
    description: Intron retention and aberrant splicing were not increased.
    relationship: FAILS_TO_RECAPITULATE
    fidelity: MODERATE
    model_scale: MOLECULAR
    evidence:
    - reference: PMID:39231235
      reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: There were no differences between cases and controls in terms of intron retention or aberrant intron 2 splicing of RFC1 in patient fibroblasts, iPSC-derived neurons, or cortical and cerebellar regions of postmortem brain
      explanation: Direct negative RNA-processing result.
    limitations: This conflicts with earlier small-sample pre-mRNA results and does not exclude other tissues or RNA assays.
  - target: Delayed Repair of Platinum-Induced DNA Damage
    description: UV-induced gamma-H2AX recovery was normal.
    relationship: FAILS_TO_RECAPITULATE
    fidelity: MODERATE
    model_scale: MOLECULAR
    evidence:
    - reference: PMID:39231235
      reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: First-derivative analysis of normalized γ-H2AX indicated no differences in the rate of γ-H2AX recovery after UV induction between CANVAS and control neurons
      explanation: The published UV assay limits generalization across forms of DNA damage.
    limitations: UV recovery in cortical-like neurons differs from platinum-adduct repair in lymphoblasts and platinum sensitivity in sensory/motor neurons.
- name: RFC1 knockdown and re-expression in forebrain neurons
  experimental_model_type: IPSC_DERIVED_MODEL
  description: Sustained shRNA depletion in control neurons was compared with repeat-bearing patient neurons. Separate lentiviral RFC1 re-expression experiments tested patient-neuron rescue.
  publication: PMID:39231235
  modeled_mechanisms:
  - target: Impaired Neuronal Synaptic Signaling
    description: Knockdown failed to reproduce the CANVAS-like transcriptomic signature or most network deficits.
    relationship: FAILS_TO_RECAPITULATE
    fidelity: MODERATE
    model_scale: CELLULAR
    evidence:
    - reference: PMID:39231235
      reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: RFC1 knockdown in control neurons does not induce CANVAS-like transcriptomic alterations
      explanation: The negative transcriptomic comparison limits a simple depletion model.
    limitations: Knockdown did reduce burst strength; re-expression modestly changed firing correlation and burst rate but did not broadly restore the patient signature. This does not exclude effects in other neuronal lineages.
- name: HEK293T repeat-dependent translation reporter
  experimental_model_type: CELL_LINE
  publication: PMID:38266156
  description: Upstream AAGGG-repeat EGFP reporters test protein output in HEK293T cells.
  modeled_mechanisms:
  - target: Reduced Translation in Repeat Reporter Assays
    description: AAGGG reporter constructs reduce protein output without a corresponding reporter-mRNA reduction.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    model_scale: MOLECULAR
    evidence:
    - reference: PMID:38266156
      reference_title: Structural investigation of pathogenic RFC1 AAGGG pentanucleotide repeats reveals a role of G-quadruplex in dysregulated gene expression in CANVAS.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: reduce gene expression via impairing the translation process in a repeat-length-dependent manner
      explanation: Reporter assays support a translation effect in their specific construct context.
    limitations: This is a translation readout; it does not measure endogenous RFC1 transcription.
- name: HEK repeat-associated poly-KGREG reporter
  experimental_model_type: CELL_LINE
  publication: PMID:39231235
  description: Short AAGGG/CCCTT repeat reporters test peptide production in HEK cells.
  modeled_mechanisms:
  - target: Repeat-Associated Poly-KGREG Production
    description: AAGGG reporters produce poly-KGREG.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    model_scale: MOLECULAR
    evidence:
    - reference: PMID:39231235
      reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: AAGGG repeats are translated into pentapeptide repeat proteins
      explanation: Reporter assays demonstrate translation.
    limitations: Overexpressed short repeats and epitope-tagged constructs cannot establish endogenous peptide toxicity.
- name: HEK SV40-origin repeat replication assay
  experimental_model_type: CELL_LINE
  publication: PMID:38381906
  description: SV40-origin replicating episomes test repeat-dependent fork stalling in human HEK cells.
  modeled_mechanisms:
  - target: Repeat-Associated Replication Fork Stalling
    description: AAGGG episomes impede fork progression.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    model_scale: MOLECULAR
    evidence:
    - reference: PMID:38381906
      reference_title: Pathogenic CANVAS (AAGGG)n repeats stall DNA replication due to the formation of alternative DNA structures.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Finally, the pathogenic, but not the nonpathogenic, repeat stalls replication fork progression in yeast and human cells.
      explanation: Measures replication impediments in model systems.
    limitations: SV40 T-antigen replication differs from normal chromosomal replisomes, and postmitotic neuronal injury was not measured.
- name: Short-repeat expression in primary rat cortical neurons
  experimental_model_type: PRIMARY_CELL_CULTURE
  description: Primary cortical neurons expressed 61-unit AAGGG or CCCTT constructs for ten days, with GFP and toxic CGG-repeat controls.
  publication: PMID:39231235
  modeled_mechanisms:
  - target: Cerebellar Purkinje Cell Loss
    description: Short CANVAS-repeat constructs did not produce neuronal death.
    relationship: FAILS_TO_RECAPITULATE
    fidelity: LOW
    model_scale: CELLULAR
    evidence:
    - reference: PMID:39231235
      reference_title: AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: expression of 61 repeats is insufficient to elicit neurodegeneration in a rodent neuronal model system
      explanation: The negative survival assay limits a simple short-repeat toxicity model.
    limitations: The cells are cortical rather than Purkinje neurons, repeats are shorter than clinical expansions, and expression occurs outside the endogenous locus; other contexts remain unresolved.
- name: Isogenic sensory-neuron models in the 2025 preprint
  experimental_model_type: IPSC_DERIVED_MODEL
  description: Unreviewed study using two CANVAS backgrounds and monoallelic or biallelic Alu-repeat deletions. NGN2/BRN3A-induced mechanoreceptor-like neurons showed about 15% lower RFC1 mRNA versus biallelic corrected cells, but similar unstressed survival.
  publication: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
  modeled_mechanisms:
  - target: Context-Dependent Reduction of RFC1 Transcript Abundance
    description: RFC1 mRNA was modestly reduced; protein reduction was not demonstrated.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    model_scale: MOLECULAR
    evidence:
    - reference: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
      reference_title: ABSTRACT
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: was 15% lower in CANVAS
      explanation: Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Sensory-neuron qPCR relative to isogenic biallelic corrections.
    limitations: The statistical difference was specific to the biallelic-corrected comparison; this preprint requires replication.
  - target: Delayed Repair of Platinum-Induced DNA Damage
    description: Repeat-region deletion reduced cisplatin-induced apoptosis, reaching significance at 5 micromolar after 24 hours.
    relationship: RESCUES
    fidelity: MODERATE
    model_scale: CELLULAR
    evidence:
    - reference: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
      reference_title: ABSTRACT
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: reaching significance after 24 h of 5 µM cisplatin treatment
      explanation: Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Sensory-neuron stress response after repeat-region correction.
    limitations: Apoptosis is a downstream stress readout, not a direct repair-kinetics assay. Deletion does not identify the mediator of rescue.
  - target: Dorsal Root Ganglion Sensory Neuronopathy
    description: Patient-repeat sensory neurons did not show reduced unstressed survival.
    relationship: FAILS_TO_RECAPITULATE
    fidelity: MODERATE
    model_scale: CELLULAR
    evidence:
    - reference: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
      reference_title: ABSTRACT
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: the survival of sensory neurons harbouring CANVAS-associated repeats was similar compared to isogenic control lines
      explanation: Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). The short-term cultures did not reproduce spontaneous sensory-neuron loss.
    limitations: One-month cultures cannot exclude slowly accumulating damage in adult sensory ganglia.
- name: Isogenic lower-motor-neuron models in the 2025 preprint
  experimental_model_type: IPSC_DERIVED_MODEL
  description: Unreviewed study of two CANVAS lines and isogenic corrections. RFC1 mRNA was about 23% lower versus isogenic controls but not significantly lower versus unrelated controls. Baseline morphology and neurite measures were similar.
  publication: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
  modeled_mechanisms:
  - target: Context-Dependent Reduction of RFC1 Transcript Abundance
    description: The qPCR difference depends on isogenic comparison.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    model_scale: MOLECULAR
    evidence:
    - reference: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
      reference_title: ABSTRACT
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: expression could only be detected when comparing CANVAS lines with their isogenic corrected counterpart, but not when comparing CANVAS lines with non-isogenic controls
      explanation: Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Motor-neuron qPCR showed about 23% lower expression versus isogenic controls; sensory-neuron reduction was about 15%.
    limitations: No demonstrated protein reduction; distinct lineage and background control from the published cortical-neuron study.
  - target: Delayed Repair of Platinum-Induced DNA Damage
    description: Biallelic Alu-repeat deletion reduced cisplatin-induced apoptosis.
    relationship: RESCUES
    fidelity: MODERATE
    model_scale: CELLULAR
    evidence:
    - reference: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
      reference_title: ABSTRACT
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: leading to a marked reduction of the number of apoptotic cells in cisplatin-treated
      explanation: Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Isogenic correction rescues a platinum-stress phenotype.
    limitations: Platinum challenge does not demonstrate spontaneous motor-neuron degeneration or universal DNA-repair deficiency.
- name: Patient lymphoblastoid platinum-challenge models in the 2025 preprint
  experimental_model_type: CELL_LINE
  description: Unreviewed comparison of five patient and five control lymphoblastoid lines, with continuous platinum exposure and pulse-chase platinum-DNA adduct measurements.
  publication: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
  modeled_mechanisms:
  - target: Delayed Repair of Platinum-Induced DNA Damage
    description: Adduct removal was slower and apoptosis occurred earlier.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    model_scale: MOLECULAR
    evidence:
    - reference: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
      reference_title: ABSTRACT
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: repair in CANVAS LCLs was significantly slower, reaching levels comparable to control cells only after 72 h
      explanation: Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Measures delayed repair after a cisplatin pulse.
    limitations: Lymphoblasts are dividing peripheral cells. Recovery approached control levels by 72 hours, and other DNA-damage classes were not tested.
- name: Synthetic repeat nucleic-acid structural assays
  experimental_model_type: OTHER
  description: Short DNA and RNA oligonucleotides were examined by NMR, circular dichroism, chemical probing and polymerase assays under controlled ionic conditions.
  publication: PMID:38266156
  modeled_mechanisms:
  - target: Repeat DNA Secondary Structures
    description: AAGGG DNA can form parallel G-quadruplexes or H-r triplexes.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    model_scale: MOLECULAR
    evidence:
    - reference: PMID:38266156
      reference_title: Structural investigation of pathogenic RFC1 AAGGG pentanucleotide repeats reveals a role of G-quadruplex in dysregulated gene expression in CANVAS.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: we report that the pathogenic RFC1 AAGGG repeats form DNA and RNA parallel G-quadruplex (G4) structures that play a role in impairing biological processes
      explanation: Biophysical assays establish folding capacity of short repeats.
    - reference: PMID:38381906
      reference_title: Pathogenic CANVAS (AAGGG)n repeats stall DNA replication due to the formation of alternative DNA structures.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: The observed DNA polymerase stalling at the center of the (A2G3)10 strand strongly implicates H-r DNA triplex formation
      explanation: A competing structural explanation is supported under other assay conditions.
    limitations: Short synthetic tracts and assay buffers do not establish the dominant structure of chromatinized patient repeats.
  - target: Repeat RNA G-Quadruplex Formation
    description: Short AAGGG RNA forms G-quadruplexes.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    model_scale: MOLECULAR
    evidence:
    - reference: PMID:38266156
      reference_title: Structural investigation of pathogenic RFC1 AAGGG pentanucleotide repeats reveals a role of G-quadruplex in dysregulated gene expression in CANVAS.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: we report that the pathogenic RFC1 AAGGG repeats form DNA and RNA parallel G-quadruplex (G4) structures that play a role in impairing biological processes
      explanation: Biophysical assays establish folding capacity of short repeats.
    limitations: The RNA strand and endogenous transcript context differ from RFC1 sense CCCTT RNA.
animal_models:
- name: Yeast plasmid AAGGG replication model
  species: Saccharomyces cerevisiae
  genotype: Plasmids containing orientation-controlled AAGGG repeats; comparison with AAAAG repeats and pif1 deletion
  publication: PMID:38381906
  description: AAGGG tracts stall forks preferentially when the purine-rich strand is the lagging-strand template.
  modeled_mechanisms:
  - target: Repeat-Associated Replication Fork Stalling
    description: Pathogenic-repeat plasmids show fork stalling.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    model_scale: MOLECULAR
    evidence:
    - reference: PMID:38381906
      reference_title: Pathogenic CANVAS (AAGGG)n repeats stall DNA replication due to the formation of alternative DNA structures.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Analysis of yeast replication intermediates using two-dimensional gel electrophoresis demonstrates orientation-dependent stalling at (A2G3)60 repeats.
      explanation: The yeast-specific replication-intermediate assay directly demonstrates the model phenotype.
    limitations: Plasmid replication in dividing yeast does not reproduce the endogenous human intron or adult neuronal phenotype; PIF1 deletion did not enhance the stall.
- name: Complete rfc1 knockout zebrafish
  species: Danio rerio
  genotype: Homozygous 20-bp deletion in exon 5, predicted p.S182X
  publication: PMID:40595562
  description: Complete loss causes early cerebellar progenitor DNA-damage accumulation, impaired proliferation, apoptosis and reduced granule/Purkinje-cell populations, followed by death by 10 days post fertilization. Heterozygotes survive normally.
  modeled_mechanisms:
  - target: Cerebellar Purkinje Cell Loss
    description: Purkinje-cell numbers are reduced following early progenitor injury.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    model_scale: CELLULAR
    evidence:
    - reference: PMID:40595562
      reference_title: RFC1 regulates the expansion of neural progenitors in the developing zebrafish cerebellum.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: the loss of RFC1 jeopardizes the genomic integrity of these progenitor cells
      explanation: Complete knockout disrupts developing progenitor populations.
    limitations: This is a lethal developmental null model, not adult-onset degeneration caused by a patient repeat. Granule-cell depletion is also prominent, unlike relative granule-cell preservation in some human autopsies.
  - target: Delayed Repair of Platinum-Induced DNA Damage
    description: DNA-damage markers accumulate in developing neural progenitors.
    relationship: PERTURBS
    fidelity: LOW
    model_scale: MOLECULAR
    evidence:
    - reference: PMID:40595562
      reference_title: RFC1 regulates the expansion of neural progenitors in the developing zebrafish cerebellum.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: the loss of RFC1 jeopardizes the genomic integrity of these progenitor cells
      explanation: Complete knockout disrupts developing progenitor populations.
    limitations: Gamma-H2AX and apoptotic readouts do not specifically demonstrate the platinum-adduct repair defect proposed in human repeat-bearing cells.
- name: Neuronal Gnf1 knockdown flies in the 2025 preprint
  species: Drosophila melanogaster
  genotype: nsyb-Gal4-driven shRNA depletion of Gnf1, the RFC1 ortholog
  publication: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
  description: Unreviewed neuronal knockdown model with late-life locomotor reduction, shortened survival and increased neuronal H2Av staining. Young flies initially retained normal activity; global knockdown was lethal. This is ortholog depletion, not a patient-repeat transgene.
  modeled_mechanisms:
  - target: Multisensory Balance Failure
    description: Older flies showed reduced locomotor activity.
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    model_scale: ORGANISM
    evidence:
    - reference: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
      reference_title: ABSTRACT
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: knockdown induced a significant reduction in total locomotor activity compared to driver- and transgene-alone controls
      explanation: Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). Late-life behavioral effect after ortholog knockdown.
    limitations: General fly activity does not resolve human cerebellar, sensory and vestibular components; the repeat allele is absent.
  - target: Delayed Repair of Platinum-Induced DNA Damage
    description: Neuronal H2Av staining increased before and during overt motor impairment.
    relationship: PERTURBS
    fidelity: LOW
    model_scale: MOLECULAR
    evidence:
    - reference: url:https://www.biorxiv.org/content/early/2025/11/18/2025.11.18.688292.source.xml
      reference_title: ABSTRACT
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: a significant increase in neuronal H2Av staining ... knockdown flies compared to controls at both ages
      explanation: Unreviewed November 2025 preprint (Currò et al.; DOI:10.1101/2025.11.18.688292). DNA-damage-associated staining at 12 and 40–42 days.
    limitations: A damage marker after gene depletion does not establish a specific repair pathway or the molecular effect of the human repeat.
differential_diagnoses:
- name: GAA-FGF14-related ataxia
  disease_term:
    preferred_term: spinocerebellar ataxia 27B, late-onset
    term:
      id: MONDO:0859340
      label: spinocerebellar ataxia 27B, late-onset
  description: Late-onset cerebellar ataxia with oscillopsia and sometimes abnormal vestibular testing.
  distinguishing_features:
  - Episodic onset or exercise/alcohol-triggered symptoms favor SCA27B.
  - Neuropathy is usually absent or mild sensorimotor; prominent sensory neuronopathy and chronic cough favor RFC1 disease.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Episodic ataxic features (may be triggered by exercise, alcohol intake, or caffeine) are common at disease onset.
    explanation: The differential table distinguishes GAA-FGF14 ataxia.
- name: Friedreich ataxia
  disease_term:
    preferred_term: Friedreich ataxia
    term:
      id: MONDO:0100339
      label: Friedreich ataxia
  description: Sensory ataxia and possible vestibular impairment overlap with CANVAS.
  distinguishing_features:
  - Usually earlier onset, although late-onset cases exist.
  - Cardiomyopathy, diabetes, pyramidal signs and skeletal deformities may help distinguish the phenotype.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Muscle weakness, pyramidal involvement (Babinski signs), ... skeletal deformities (pes cavus, scoliosis) are frequent features.
    explanation: Current differential table identifies useful clinical contrasts.
- name: Multiple system atrophy
  disease_term:
    preferred_term: multiple system atrophy
    term:
      id: MONDO:0007803
      label: multiple system atrophy
  description: Cerebellar ataxia and autonomic failure can resemble CANVAS.
  distinguishing_features:
  - More rapid progression and severe early autonomic failure favor MSA.
  - Prominent sensory neuronopathy and bilateral vestibular failure favor RFC1 disease; MRI pattern can help.
  - REM sleep behavior disorder and parkinsonism can occur in RFC1 disease and are not absolute exclusions.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable
    reference_title: RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Multisystem atrophy (MSA) is a rapidly progressive neurodegenerative disease that can present with a wide range of clinical manifestations, including cerebellar ataxia and autonomic failure
    explanation: Highlights tempo and autonomic overlap.

📚

References & Deep Research

References

PMID:39230846

Pseudodominance in RFC1-Spectrum Disorder.

No top-level findings curated for this source.

PMID:36289003

Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome.

No top-level findings curated for this source.

PMID:30926972

Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.

No top-level findings curated for this source.

PMID:31230722

Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS.

No top-level findings curated for this source.

PMID:32851396

A Māori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele.

No top-level findings curated for this source.

PMID:33103729

A novel RFC1 repeat motif (ACAGG) in two Asia-Pacific CANVAS families.

No top-level findings curated for this source.

PMID:37450567

Normal and pathogenic variation of RFC1 repeat expansions: implications for clinical diagnosis.

No top-level findings curated for this source.

DOI:10.1101/2025.11.18.688292

CANVAS causing AAGGG repeat expansions cause tissue-specific reduction in RFC1 expression and increase sensitivity to DNA damage

No top-level findings curated for this source.

PMID:39231235

AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons.

No top-level findings curated for this source.

PMID:38266156

Structural investigation of pathogenic RFC1 AAGGG pentanucleotide repeats reveals a role of G-quadruplex in dysregulated gene expression in CANVAS.

No top-level findings curated for this source.

PMID:38381906

Pathogenic CANVAS (AAGGG)n repeats stall DNA replication due to the formation of alternative DNA structures.

No top-level findings curated for this source.

PMID:38062616

RNA Foci in Two bi-Allelic RFC1 Expansion Carriers.

No top-level findings curated for this source.

PMID:24682971

Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS.

No top-level findings curated for this source.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK564656/?report=printable

RFC1-Related Disorders - GeneReviews® - NCBI Bookshelf

No top-level findings curated for this source.

PMID:33492056

The Pathology of the Vestibular System in CANVAS.

No top-level findings curated for this source.

PMID:39811557

Repeat expansions in RFC1 gene in refractory chronic cough.

No top-level findings curated for this source.

PMID:34927205

Motor neuron pathology in CANVAS due to RFC1 expansions.

No top-level findings curated for this source.

PMID:38480525

Cognitive Impairment Is Part of the Phenotype of Cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome (CANVAS).

No top-level findings curated for this source.

PMID:38193360

Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease.

No top-level findings curated for this source.

PMID:40908706

Longitudinal Evaluation of Ataxia and Brain Structural Changes in RFC1-Related Disorder.

No top-level findings curated for this source.

PMID:41964406

Homozygous RFC1 AAGGG Repeat Expansions Are Common in Idiopathic Peripheral Neuropathy.

No top-level findings curated for this source.

PMID:40481300

Comprehensive Characterisation of the RFC1 Repeat in an Australian Cohort.

No top-level findings curated for this source.

PMID:41532091

Efficacy of morphine on cough in patients with repeat expansions of RFC1 and refractory chronic cough.

No top-level findings curated for this source.

PMID:42473260

DNA Repair Pathway Variants Are Enriched in Individuals with Biallelic AAGGG CANVAS and RFC1-Related Disease.

No top-level findings curated for this source.

clinicaltrials:NCT05177809

RFC1 Natural History Study

No top-level findings curated for this source.

clinicaltrials:NCT07156214

Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS: a Model to a Deeper Understanding of Molecular Mechanisms Underlying Late-onset Neurodegeneration

No top-level findings curated for this source.

clinicaltrials:NCT06817707

Evaluation of Urinary Dysfunction in CANVAS Patients

No top-level findings curated for this source.

PMID:40595562

RFC1 regulates the expansion of neural progenitors in the developing zebrafish cerebellum.

No top-level findings curated for this source.

Deep Research

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (1)

Create: CANVAS (RFC1 repeat expansion) · 2026-07-30T20:39:28Z · View source

De novo curation of CANVAS (MONDO:0044720), an uncurated late-onset ataxia from the priority-disease EPIC (#1079). Deep research run with the claude_code provider (research/CANVAS-deep-research-claude_code.md); NEC preflight passed (RFC1 dominant at 98 mentions, matching the MONDO causal gene, no competing gene). GeneReviews baseline (PMID:33237689, RFC1 CANVAS / Spectrum Disorder) cross-referenced and tagged, including its Agents/Circumstances to Avoid section. Modeled 8 atomic pathophysiology nodes: the biallelic intronic RFC1 repeat, repeat-intrinsic G-quadruplex structural toxicity, and the three selectively vulnerable neuronal populations (dorsal root ganglion, cranial sensory ganglia, cerebellar Purkinje cells) converging on multisensory balance failure, plus the vagal-afferent cough arm and the autonomic ganglion arm. Declared conformance to cerebellar_purkinje_degeneration#Purkinje Neuron Degeneration; deliberately did NOT conform to peripheral_axonal_degeneration because CANVAS is a non-length-dependent ganglionopathy rather than a length-dependent dying-back axonopathy, and recorded that decision as an INTERPRETATION discussion proposing a future ganglionopathy module. Captured the unresolved pathogenic mechanism as competing mechanistic_hypotheses (loss-of-function ALTERNATIVE, refuted by unchanged RFC1 expression; repeat structural toxicity EMERGING) plus a KNOWLEDGE_GAP discussion with three proposed experiments. Validated: linkml schema, term validation with --labels, reference validator, folded-hyphen check, 77/77 snippets exact, pathograph connected (8 nodes, 13 phenotypes, 22 edges, no dangling/duplicate/unevidenced edges, no orphan phenotypes), compliance 96.0%.

Claude Code ▸

CANVAS (Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome) / RFC1-Related Disease: Comprehensive Research Report

claude-haiku-4-5-20251001, claude-sonnet-5 33 citations 2026-07-30T20:29:22.540660

CANVAS (Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome) / RFC1-Related Disease: Comprehensive Research Report

1. Disease Information

Overview: CANVAS is a late-onset (typically 6th decade), recessively inherited neurodegenerative disorder caused by biallelic intronic pentanucleotide repeat expansions in RFC1 (Replication Factor C subunit 1). The eponymous acronym reflects its three cardinal domains: Cerebellar Ataxia, Neuropathy (sensory neuronopathy), and Vestibular Areflexia Syndrome. Since the genetic discovery in 2019, the disease is now understood to represent one pole of a much broader phenotypic continuum, and many authors now prefer the umbrella term "RFC1 CANVAS/spectrum disorder" or simply "RFC1 disease" (NCBI Bookshelf, GeneReviews, https://www.ncbi.nlm.nih.gov/books/NBK564656/).

Key identifiers: - OMIM (phenotype): #614575 — Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome; CANVAS - OMIM (gene): 102579 — Replication Factor C, Subunit 1; RFC1 - MONDO: MONDO:0044720 - Orphanet: ORPHA:504476 - SNOMED CT:* 1236804009 - (GARD/NIH also lists it as "Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome," https://rarediseases.info.nih.gov/diseases/17937/)

Synonyms/alternative names: CANVAS syndrome; RFC1-related ataxia; RFC1 CANVAS/spectrum disorder; RFC1 disease; sensory ataxia with bilateral vestibulopathy and cough. Some limited-phenotype presentations are described in the literature as "CANVAS-minus" (isolated sensory neuronopathy, isolated bilateral vestibulopathy, ataxia with chronic cough, ataxia-neuropathy without vestibular loss).

Evidence base: Information is derived predominantly from aggregated disease-level clinical cohorts (retrospective and prospective multicenter case series, e.g., the 100-patient GeneReviews-cited cohort, the ARCA registry natural history study), rather than single-patient case reports, supplemented by molecular/genetic population-frequency data (gnomAD-style control cohorts) and increasingly by iPSC-neuron and animal-model mechanistic studies.

2. Etiology

Primary cause: Biallelic (homozygous or compound heterozygous), non-reference intronic pentanucleotide repeat expansions in intron 2 of RFC1, most commonly the motif (AAGGG)n replacing the reference (AAAAG)11 allele. This was independently discovered by two groups in 2019: - Cortese A, et al. "Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia." Nat Genet. 2019;51(4):649-658. - Rafehi H, et al. "Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentanucleotide Repeat in RFC1 Causes CANVAS." Am J Hum Genet. 2019;105(1):151-165. PMID: 31178126.

Genetic risk factors: - Biallelic pathogenic repeat configurations at the RFC1 intron 2 locus (see Section 4 for full motif table). - High population carrier frequency of the pathogenic (AAGGG)exp allele creates risk of pseudodominance — apparent vertical transmission across generations in the absence of consanguinity, due to a carrier partner marrying into the family (Cerebellum, 2024, "Pseudodominance in RFC1-Spectrum Disorder," https://link.springer.com/article/10.1007/s12311-024-01735-5). - Population/ethnicity-specific founder configurations (see Section 9).

Environmental risk factors: No environmental/infectious/toxic causal factor is established. However, several agents are reported to exacerbate or unmask the underlying vulnerability rather than cause it: - Neurotoxic chemotherapy agents and pyridoxine (peripheral nerve toxicity) - Phenytoin (cerebellar toxicity) - Aminoglycosides (vestibulotoxicity) - Chronic alcohol use (GeneReviews management section explicitly lists these as agents/circumstances to avoid because they may worsen the phenotype.)

Age/sex: Onset is typically in mid-to-late adulthood (mean ~52 years, range 19–76); no strong sex skew has been consistently reported across cohorts.

Protective factors: None established. Heterozygous carriers of a single pathogenic expansion are, to date, uniformly reported as asymptomatic — i.e., monoallelic carriage itself functions as implicitly "protective" relative to the biallelic state, but no specific protective allele or modifier variant has been validated.

Gene-environment interaction: Not established as a primary disease mechanism; the described environmental "risk factors" act at the level of symptomatic exacerbation of an already-genetically-determined neurodegenerative process (multi-hit model: genetically vulnerable dorsal root ganglion/vestibular ganglion/Purkinje neurons made symptomatic sooner by additional neurotoxic insults).

3. Phenotypes

The clinical picture is a multisystem, spatiotemporally evolving ganglionopathy/cerebellopathy. Using GeneReviews-cited retrospective cohort data (n=100) and additional cohort studies:

Phenotype	Frequency	Onset/Course	Suggested HPO term
Sensory neuropathy/neuronopathy (non-length-dependent, DRG)	100%	Often earliest manifestation; progressive	HP:0003474 (Peripheral axonal neuropathy) / HP:0007141 (Axonal loss); consider HP:0012394 (sensory neuronopathy context)
Bilateral vestibular areflexia/hypofunction	69% overall (93% of those formally tested)	Mid-course; produces oscillopsia	HP:0007751 (Bilateral sensorineural hearing impairment - N/A) → better: HP:0025406 (Vestibular dysfunction)
Chronic dry/spasmodic cough	64–97% (higher in some cohorts)	Can precede neurologic onset by years-to-decades, sometimes starting in the 2nd–3rd decade	HP:0031246 (Chronic cough)
Full CANVAS triad (cerebellar + sensory + vestibular)	~63% (up to two-thirds); full triad may take >10 yrs to manifest	Progressive, sequential	—
Cerebellar syndrome (gait/limb ataxia, dysarthria, oculomotor signs)	63%	Progressive, later-appearing element	HP:0001251 (Ataxia); HP:0001260 (Dysarthria); HP:0000639 (Nystagmus); HP:0000751 (Gaze-evoked nystagmus); HP:0007766 (Downbeat nystagmus)
Oscillopsia	~33%	Related to bilateral VOR failure	HP:0025430-type visual disturbance (no exact dedicated HPO term; often coded under nystagmus/vestibular categories)
Dysautonomia (orthostatic hypotension, erectile dysfunction, constipation, urinary dysfunction, sweating changes)	32–50%	Usually mild, rarely disabling (contrasts with MSA)	HP:0001278 (Orthostatic hypotension); HP:0000021 (Erectile dysfunction); HP:0002019 (Constipation)
Dysphagia	Later-stage	Progressive	HP:0002015 (Dysphagia)
Motor neuron involvement (fasciculations, mild weakness/wasting)	~55% in some cohorts (motor-neuron-focused study)	Can mimic ALS/MND presentations	HP:0002380 (Fasciculations); HP:0007083 (motor neuron degeneration context)
Parkinsonism	~10%	Overlaps with/mimics atypical parkinsonism, MSA-C	HP:0001300 (Parkinsonism)
Truncal/appendicular ataxia, saccadic dysmetria	Core cerebellar sign	Progressive	HP:0002078 (Truncal ataxia); HP:0001305 (Dysmetria)

Quality of life impact: Progressive gait imbalance (worse in darkness, due to combined sensory + vestibular + cerebellar deafferentation) is typically the presenting and most disabling complaint. Natural history data (GeneReviews) indicate: ~50% require an assistive mobility device (cane) by 10 years from onset, and ~25% become wheelchair-dependent by ~15 years; life expectancy is not reduced. Chronic cough itself can be socially disabling and diagnostically misleading (frequently treated for years as idiopathic/refractory chronic cough before neurologic diagnosis) (European Respiratory Society, "CANVAS: a neurogenic cough prototype," https://publications.ersnet.org/content/erjor/10/4/00024-2024).

Diagnostic yield caveat: Even in cohorts selected for the "full" CANVAS phenotype, biallelic RFC1 expansions are found in 82–97% (i.e., some phenocopies without RFC1 expansion exist); in broader "late-onset ataxia" cohorts unselected for the full triad, the yield drops to 14–22% (GeneReviews, https://www.ncbi.nlm.nih.gov/books/NBK564656/).

4. Genetic/Molecular Information

Causal gene: RFC1 (chromosome 4p14; encodes the large subunit of Replication Factor C, the clamp-loader complex for PCNA). OMIM gene: *102579.

Locus/repeat details — normal vs. pathogenic motifs (per GeneReviews and Currie et al., Brain 2023, "Normal and pathogenic variation of RFC1 repeat expansions: implications for clinical diagnosis," https://academic.oup.com/brain/article/146/12/5060/7224416):

Allele class	Motif / structure	Repeat size	Population frequency	Pathogenicity
Reference/common normal	(AAAAG)11	11	~0.75	Benign
Normal, expanded but non-pathogenic	(AAAAG)12–200	12–200	~0.13	Benign
Normal, expanded but non-pathogenic	(AAAGG)40–1000	40–1000	~0.08	Benign
Non-pathogenic (heterozygous, found in patients and controls)	AAGAG, AGAGG, interrupted AAAAG	variable	—	Benign
Pathogenic (most common)	(AAGGG)exp	~400 to >2000 (max reported 2750)	allele frequency 0.01–0.04	Fully penetrant when biallelic
Pathogenic (Asia-Pacific/Japanese)	(ACAGG)exp	~1000	rare; carrier freq ~0.26% South Asia, ~0% Europe	Pathogenic, common in East Asians
Pathogenic (Māori/Cook Islands founder)	(AAAGG)10–25(AAGGG)exp(AAAGG)4–6	990–1940	Founder population-specific	Pathogenic (Beecroft et al., Brain 2020;143(9):2673-2680)
Other reported pathogenic motifs	AGGGC, AAGGC (South Asian family)	variable	rare	Pathogenic in trans with AAGGG or homozygous

The repeat sits within an AluSx3 transposable-element-derived poly(A) tract in intron 2 — i.e., the expansion co-opts a retrotransposon-derived sequence, and the pathogenic (AAGGG)n motif is on the antisense strand relative to the reference (AAAAG)n.

Variant classification/type: Non-coding (intronic) short tandem repeat/microsatellite expansion — a repeat-expansion disorder mechanistically analogous to other STR diseases (e.g., Friedreich ataxia GAA, myotonic dystrophy CTG), but recessive rather than the more typical dominant repeat-expansion pattern. Rare truncating point variants/small indels in RFC1 have also been reported in trans with an expanded allele or, less commonly, biallelically, broadening the allelic spectrum (Neurology, "Truncating Variants in RFC1 in CANVAS," PMC9931080, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931080/).

Allele frequency in population databases: Carrier (heterozygous) frequency of pathogenic AAGGG expansion estimated at 0.7–6.8% depending on population/method, with more conservative recent estimates around 0.2% (2/1000) in Caucasian cohorts once biallelic segregation was more strictly required; ~2.24% in a Chinese Han population. Predicted homozygous/biallelic population frequency ranges from ~1/625 to ~1/712 in earlier estimates (making RFC1 disease one of the most common causes of inherited ataxia), though the more conservative later estimate implies a substantially lower biallelic frequency (GeneReviews; ResearchGate Māori founder study; Neurology Genetics prevalence study, https://www.neurology.org/doi/10.1212/NXG.0000000000000440).

Somatic vs. germline: Germline only; no somatic mosaicism or cancer association reported.

Functional consequence / mechanism (loss-of-function debate): Counter-intuitively for a recessive disease, "preliminary studies have not shown reduced expression or overt loss of function of RFC1 protein" in early work (GeneReviews). More recent mechanistic studies refine this: - The pathogenic (AAGGG)n repeat (DNA and transcribed RNA) forms stable parallel G-quadruplex (G4) structures (and can also form triplex structures), which stall DNA replication forks, reduce RFC1 transcript/gene expression in a tissue-specific manner, and increase cellular sensitivity to DNA damage (PMC10563062; PMC10954463; 2025 bioRxiv "CANVAS causing AAGGG repeat expansions cause tissue-specific reduction in RFC1 expression and increase sensitivity to DNA damage," https://www.biorxiv.org/content/10.1101/2025.11.18.688292). - A 2024 human iPSC-neuron (iNeuron) study (Science Advances, https://www.science.org/doi/10.1126/sciadv.adn2321; PMC11373605) found that CRISPR deletion of a single expanded (AAGGG) allele rescues synaptic/developmental deficits in patient neurons, but simple restoration of RFC1 protein does NOT rescue the phenotype — arguing for a repeat-dependent but RFC1-protein-independent ("RFC1-independent") toxic mechanism, i.e., a repeat-RNA or R-loop/G4-mediated gain-of-toxic-function superimposed on a partial expression loss, rather than a pure loss-of-function model. - Structural work on RFC1 as part of the CTF18-RFC alternative clamp loader (cryo-EM, 2024–2025, eLife/PNAS) clarifies normal RFC1 biology (PCNA loading, replication/repair fidelity) but is not itself CANVAS-specific.

Modifier genes: No clinically validated modifier genes; "no clinically relevant genotype-phenotype correlations have been identified" per GeneReviews, though larger repeat size has been loosely associated with earlier age of onset in some series.

Epigenetics: Not a major established mechanism for CANVAS specifically (contrast with e.g. Fragile X, where CGG expansion drives promoter methylation/silencing); the dominant proposed nucleic-acid mechanism is G-quadruplex/secondary-structure formation rather than DNA methylation-mediated silencing, though tissue-specific transcript reduction is documented.

Chromosomal abnormalities: None; this is a single-locus repeat expansion, not a copy-number/structural chromosomal disorder.

Suggested ontology terms: Gene: HGNC RFC1 (hgnc:9969 approx. — verify via HGNC before use); process: GO:0006281 (DNA repair), GO:0006260 (DNA replication), GO:0032201 (telomere maintenance — related clamp-loader biology), GO:0051973 (positive regulation of telomerase activity — tangential).

5. Environmental Information

Environmental factors: None established as causal. As above, certain iatrogenic exposures (neurotoxic chemotherapeutics, pyridoxine excess, phenytoin, aminoglycosides) and chronic alcohol use are documented as aggravating/unmasking factors rather than causal ones.
Lifestyle factors: No specific dietary, occupational, or lifestyle causal association reported in the literature reviewed.
Infectious agents: None implicated.

6. Mechanism / Pathophysiology

Causal chain (proposed, still partially unresolved):

Trigger: Biallelic intronic (AAGGG)n (or other pathogenic-motif) expansion in RFC1 intron 2, embedded in an AluSx3-derived poly(A) tract.
Molecular consequence: Repeat DNA/RNA folds into G-quadruplex (and triplex) secondary structures → replication fork stalling, tissue-specific reduction of RFC1 transcript, and (per newer iNeuron data) additional RFC1-protein-independent toxic mechanisms affecting neuronal development and synaptic connectivity. Increased sensitivity to DNA damage has also been demonstrated in cellular/Drosophila models.
Cellular process: Selective, non-length-dependent degeneration of specific neuronal populations with high metabolic/genomic-integrity demands: dorsal root ganglion (DRG) sensory neurons, vestibular ganglion neurons, and cranial nerve ganglia V (trigeminal) and VII (facial), plus cerebellar Purkinje cells and (in a subset) motor neurons.
Tissue-level pathology: Post-mortem/pathology studies show ganglionic and nerve-root atrophy with neuronal cell loss replaced by psammoma bodies and satellite (glial) cell proliferation in the DRG/cranial ganglia (a "ganglionopathy"/sensory neuronopathy pattern rather than a classic dying-back axonopathy), plus cerebellar and basal ganglia atrophy with diffuse Purkinje cell loss.
Systemic/clinical output: Progressive sensory ataxia (proprioceptive loss) + bilateral vestibular failure (loss of VOR, oscillopsia) + cerebellar dysfunction (gait/limb ataxia, dysarthria, oculomotor abnormalities) — a triple-deafferentation syndrome that compounds imbalance beyond any single system's contribution. Chronic cough is hypothesized to reflect a similar sensory neuronopathy affecting vagal/laryngeal afferents (a "neurogenic cough" mechanism), often the earliest and longest-preceding symptom.

Molecular pathways: DNA replication/repair pathway (RFC1 as the large subunit of the RFC clamp-loader complex, loading PCNA onto DNA to enable processive DNA polymerase activity — canonical role, GO:0006260, GO:0006281); no classical signaling cascade (Wnt/MAPK/mTOR/PI3K-AKT) has been specifically implicated as primary driver — the mechanism is nucleic-acid structural/genome-integrity based rather than a signal-transduction defect.

Cellular processes: Impaired DNA damage response/replication stress in affected neurons; selective neuronal vulnerability of post-mitotic ganglionic neurons (an interesting paradox for a "replication" gene, suggesting a replication-independent, transcription-coupled or R-loop-related toxicity in non-dividing cells); neurodevelopmental impact demonstrated in zebrafish (impaired granule and Purkinje cell progenitor expansion/differentiation) suggesting RFC1 also has a role in normal neurodevelopmental proliferation, distinct from its adult neurodegenerative role.

Protein dysfunction: Not a classical misfolding/aggregation disease (unlike polyQ repeat disorders) — mechanism centers on the repeat DNA/RNA nucleic acid structure itself (G-quadruplex, R-loop potential) rather than an aberrant RFC1 protein conformer; early studies found preserved RFC1 protein levels overall, though newer tissue-specific transcript-reduction data complicates this.

Immune system involvement: Not a primary autoimmune mechanism; however, satellite glial cell proliferation in ganglia may represent a secondary neuroinflammatory/reactive response to neuronal loss. Note also (separately) that RFC1 expansions have been found at increased frequency in some cohorts of "immune-mediated neuropathy" patients (Scientific Reports 2023, https://www.nature.com/articles/s41598-023-45011-8), raising the possibility of diagnostic overlap/mimicry rather than a shared immune mechanism.

Tissue damage mechanisms: Selective ganglionic/Purkinje neuronal loss (a form of programmed neurodegeneration linked to genomic instability/replication stress) rather than classical oxidative-stress/ischemia/fibrosis mechanisms.

Advanced/omics findings: - Single-cell/model organism: Zebrafish rfc1 loss-of-function model (CRISPR/Cas9) shows a developmental role for rfc1 in expansion/differentiation of cerebellar granule and Purkinje neuronal progenitor pools (Nat Commun 2025, https://www.nature.com/articles/s41467-025-60775-5; PMC12217872). - iPSC-neuron transcriptomic/functional profiling: CANVAS patient-derived iNeurons show synaptic connectivity and neurodevelopmental gene-expression deficits rescued by CRISPR correction of the repeat but not by RFC1 re-expression (Science Advances 2024). - Structural biology: Cryo-EM structures of RFC1-containing clamp loader complexes (2024–2025) clarify normal PCNA-loading biology, providing a structural backdrop, though not disease-specific. - G-quadruplex structural studies: NMR/biophysical work (PMC10563062, PMC10954463) directly demonstrates that pathogenic AAGGG (but not benign AAAAG) repeats form G4/triplex structures that stall replication and dysregulate gene expression — proposed as a druggable structural target (small-molecule G4 ligands, helicases).

Suggested GO terms: GO:0006260 (DNA replication), GO:0006281 (DNA repair), GO:0000731 (DNA synthesis involved in DNA repair), GO:0051983 (regulation of chromosome segregation - tangential), GO:0002087 (regulation of respiratory gaseous exchange by nervous system control of breathing — for cough mechanism, speculative). Suggested CL terms: CL:0000540 (neuron), CL:0000617 (GABAergic neuron - Purkinje cell subtype context), CL:1001580 (Purkinje cell, if available in CL) — verify via OAK; CL:0000561 (amacrine cell — N/A); sensory ganglion neuron terms should be verified (dorsal root ganglion sensory neuron). Suggested UBERON terms: UBERON:0002037 (cerebellum), UBERON:0000044 (dorsal root ganglion), UBERON:0001846 (vestibular ganglion — verify exact ID), UBERON:0001651 (trigeminal ganglion), UBERON:0001654 (facial nerve/geniculate ganglion — verify).

7. Anatomical Structures Affected

Organ level: - Primary: Cerebellum (vermis, crus I especially), peripheral sensory nervous system (dorsal root ganglia), vestibular end-organs/vestibular ganglion (bilateral), cranial nerve ganglia V and VII. - Secondary: Spinal cord (posterior column degeneration visible on MRI as T2 hyperintensity, with cord atrophy), basal ganglia (atrophy reported at autopsy, correlating with parkinsonism in a subset), lower motor neurons (subset with motor neuron involvement/fasciculations), autonomic nervous system (mild). - Body systems: Nervous system (central + peripheral + autonomic); secondarily respiratory system (chronic cough — likely neurogenic/vagal afferent rather than primary pulmonary pathology); gastrointestinal system (dysphagia, constipation); genitourinary system (erectile dysfunction, bladder dysfunction).

Tissue/cell level: Neuronal loss in dorsal root ganglia and cranial sensory ganglia with replacement by psammoma bodies and satellite glial cell proliferation; diffuse cerebellar Purkinje cell loss; cerebellar granule cell layer involvement (per zebrafish developmental model).

Subcellular level: Nuclear/genomic — the core molecular lesion is an intronic DNA repeat forming G-quadruplex secondary structure, implicating nuclear DNA replication/repair machinery (GO Cellular Component: nucleus, replication fork) rather than a specific organelle like mitochondria or lysosome.

Localization: Bilateral and symmetric in essentially all core features (bilateral vestibular areflexia by definition, bilateral/symmetric sensory neuropathy, cerebellar vermian atrophy) — no lateralization reported, consistent with a systemic/genetic rather than focal-structural mechanism.

8. Temporal Development

Onset: Adult/late-onset disease. Mean age of neurological symptom onset ~52 years (range 19–76). Chronic cough, when present, frequently precedes neurological onset by years to decades (onset sometimes in the 2nd–3rd decade of life). Onset pattern is insidious/chronic, not acute or subacute.

Progression: Slowly progressive, with a well-documented spatiotemporal pattern: early involvement of sensory (DRG) neurons, followed years later by vestibular dysfunction, followed by cerebellar dysfunction — full triad may take over a decade to manifest, and only ~two-thirds of patients ever develop all three domains. Disease course is chronic and lifelong (non-remitting), without a defined staging system (unlike cancer staging); natural history/longitudinal imaging studies are ongoing (PubMed 40908706, "Longitudinal Evaluation of Ataxia and Brain Structural Changes in RFC1-Related Disorder").

Progression rate: Notably slower than its key mimic, multiple system atrophy (MSA) — mean survival from onset to death in MSA is ~9.3 years, whereas RFC1 CANVAS/spectrum disorder progresses very slowly and does not appear to shorten life expectancy.

Patterns: No spontaneous remission described. No clearly defined "critical period" for intervention, given the current absence of disease-modifying therapy; the main "window" emphasized in the literature is for early diagnostic recognition (e.g., of isolated chronic cough or bilateral vestibulopathy) to shorten the diagnostic odyssey.

9. Inheritance and Population

Epidemiology: - RFC1-associated repeat expansions are one of the most common identified genetic causes of adult-onset/late-onset ataxia, found in 14–22% of unselected late-onset ataxia cohorts and up to 82–97% of cohorts selected for the full CANVAS phenotype. - Predicted biallelic (disease) population frequency estimates range widely: ~1/625–1/712 (early estimates) down to more conservative later estimates (~2/1000 carrier frequency implying a lower biallelic frequency) in Caucasian populations — reflecting evolving methodology (Southern blot/long-read vs. PCR-only screening) (Neurology Genetics, https://www.neurology.org/doi/10.1212/NXG.0000000000000440). - More than 200 individuals (simplex or familial autosomal recessive pattern) had been reported with biallelic AAGGG expansions as of the GeneReviews review.

Inheritance pattern: Autosomal recessive. Because carrier frequency of the pathogenic allele is unusually high for a recessive disease, pseudodominance (apparent multi-generational transmission mimicking autosomal dominant inheritance) is well documented and should not be mistaken for AD inheritance.

Penetrance: Full penetrance reported for biallelic (AAGGG)exp/(AAGGG)exp and compound heterozygous pathogenic genotypes (age-dependent — the disease is late-onset, so "full penetrance" is realized only with sufficient lifespan/observation).

Expressivity: Variable — phenotypic spectrum ranges from full CANVAS triad to isolated/limited system involvement (pure sensory neuronopathy, isolated bilateral vestibulopathy, isolated cough), with no established genotype-phenotype correlation to explain this variability (repeat size shows only a loose association with age of onset).

Genetic anticipation: Not a feature of this disorder (in contrast to unstable dominant repeat-expansion diseases like Huntington disease or myotonic dystrophy) — consistent with a recessive, non-anticipating repeat disorder.

Germline mosaicism: Not specifically reported/characterized in the literature reviewed.

Founder effects: Multiple population-specific founder configurations documented: - A distinct (AAAGG)10–25(AAGGG)exp(AAAGG)4–6 configuration is a founder allele in New Zealand Māori and Cook Island populations (Beecroft et al., Brain 2020;143(9):2673-2680, ResearchGate summary: "A Maori-Specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele"). - The (ACAGG)exp motif is common in East Asian populations (identified in Asia-Pacific and Japanese CANVAS families), essentially absent in European cohorts (carrier frequency 0% Europe, 0.03% Africa, 0.26% South Asia). - The common (AAGGG)exp allele is the predominant pathogenic configuration in European/Caucasian populations.

Consanguinity: Not a major driver given the relatively high population carrier frequency of pathogenic alleles (unlike most rare AR diseases where consanguinity is the dominant risk factor); however, consanguinity would still increase biallelic risk in any given family.

Carrier frequency: Heterozygous carrier frequency 0.7–4% in populations of Northern European origin; ~2.24% in Chinese Han; ranges up to 6.5–6.8% reported in some individual control cohorts, with more conservative pooled estimates around 0.2–2/1000 for confirmed biallelic-pathogenic carriers in later, more rigorously validated cohorts.

Population demographics: No strong sex-ratio skew reported in the literature surveyed. Geographic/ethnic variation is substantial and motif-specific (see founder effects above) — curators should note that a given population's dominant pathogenic motif differs (AAGGG in Europeans, ACAGG in East Asians, the compound AAAGG/AAGGG/AAAGG configuration in Māori/Cook Islanders), which has direct implications for assay design (repeat-primed PCR designed only for AAGGG will miss ACAGG or Māori-configuration alleles).

10. Diagnostics

Clinical suspicion: Onset after age 35 (though can be younger) with one or more of: sensory neuropathy/neuronopathy, bilateral vestibular dysfunction, cerebellar dysfunction, chronic cough, or dysautonomia. No formal consensus diagnostic criteria have been established (per GeneReviews).

Electrophysiology: - Nerve conduction studies: reduced/absent sensory nerve action potentials (SNAPs) with normal motor conduction studies — the electrophysiological signature of a sensory neuronopathy/ganglionopathy (non-length-dependent). - Abnormal blink reflex; H-reflex often preserved. - Nerve ultrasound: reduced nerve cross-sectional area (a discriminating feature vs. inflammatory neuropathies), now formally studied as a predictive tool alongside cough and neuronopathy pattern (Brain Communications 2025, "Nerve ultrasound, neuronopathy and cough predict sensory neuropathy patients with RFC1 expansions," PMC12662233).

Vestibular testing: Bilaterally abnormal video head impulse test (vHIT); reduced/absent caloric responses; abnormal VOR gain — confirms bilateral vestibular areflexia/hypofunction.

Imaging: - Brain MRI: cerebellar atrophy, particularly vermian and crus I atrophy (can be subtle early in disease). - Spine MRI: spinal cord atrophy and T2-weighted posterior-column hyperintensity (dorsal column degeneration signature). - Comprehensive multimodal deep-phenotyping studies integrating electrophysiology + imaging + otoneurological data are an active area of research (PMC12558705).

Pathology/biopsy: Not typically required for diagnosis; when performed (autopsy/rare biopsy series), shows ganglionic/nerve-root atrophy, neuronal loss, psammoma bodies, satellite glial cell proliferation, and diffuse Purkinje cell loss with cerebellar/basal ganglia atrophy.

Genetic testing (central to diagnosis): - Cannot be detected by standard sequence-based multigene panels or exome sequencing — this is a critical practical point, since the pathogenic repeat is intronic and expanded, invisible to short-read exome capture. - Repeat-primed PCR (RP-PCR) and conventional PCR are first-line targeted assays (must specifically target the pathogenic motif(s) — AAGGG, and regionally ACAGG or the Māori configuration as appropriate). - Southern blotting is used for definitive sizing and confirmation of biallelic status. - Long-read sequencing (e.g., Oxford Nanopore, PacBio) is an emerging/gold-standard technology that can resolve repeat motif, size, and complex/compound configurations in one assay, and is increasingly used to reanalyze existing genome sequencing data to improve diagnostic yield (medRxiv 2024, "RFC1 repeat expansion analysis from whole genome sequencing data simplifies screening and increases diagnostic rates"). - Standard short-read genome sequencing can raise suspicion of an expansion (via specialized repeat-expansion-calling algorithms, e.g., ExpansionHunter) but generally requires orthogonal confirmation (RP-PCR/Southern/long-read).

Differential diagnosis (detailed in GeneReviews): - Multiple system atrophy (MSA) — the single most important mimic/misdiagnosis risk, especially the MSA-cerebellar (MSA-C) and parkinsonian subtypes; distinguished by RFC1 disease's slower progression, normal life expectancy, milder dysautonomia, presence of sensory neuronopathy and bilateral vestibular failure, and absence of the "hot cross bun" pontine sign or severe putaminal atrophy on MRI. - Spinocerebellar ataxia type 3 (SCA3/Machado-Joseph disease) — dystonic-rigid extrapyramidal signs, sensorimotor (not pure sensory) neuropathy, ophthalmoplegia. - Friedreich ataxia (late-onset presentations) — typical onset <25 years, cardiomyopathy, diabetes, skeletal deformity, pyramidal signs. - Mitochondrial disorders (NARP, MIDD, Kearns-Sayre, POLG-related) — earlier onset, multisystem involvement, ophthalmoplegia, hearing/vision loss. - RNF170-related disease — sensory ataxia + vestibular areflexia but normal cerebellar function/SNAPs. - Usher syndrome types I/II — vestibular hypofunction plus hearing and visual loss. - Other causes of bilateral vestibular areflexia (aminoglycoside ototoxicity, Ménière disease, bilateral vestibular neuritis, NF2, infectious/inflammatory vestibulopathy). - Idiopathic/immune-mediated peripheral neuropathy and idiopathic bilateral vestibulopathy cohorts, in which RFC1 screening is increasingly recommended given non-trivial diagnostic yield (Neurology 2023, "Frequency and Phenotype of RFC1 Repeat Expansions in Bilateral Vestibulopathy," https://www.neurology.org/doi/10.1212/WNL.0000000000207553). - Motor neuron disease/ALS phenocopies — a German cohort study specifically screened MND-phenotype patients for biallelic RFC1 expansions (PMC11377604). - Parkinson's disease/atypical parkinsonism — recent 2025 work frames "Parkinson's disease and MSA [as] gateways to RFC1-related disorders," i.e., RFC1 expansion screening is now advocated within apparent idiopathic PD/MSA cohorts.

Screening: No population/newborn screening program (adult-onset, no early intervention available); carrier screening and cascade testing in relatives of an affected proband is appropriate once a family's specific pathogenic motif is known; prenatal and preimplantation genetic testing are technically available once the familial genotype is defined.

11. Outcome/Prognosis

Survival/mortality: Life expectancy does not appear to be reduced by RFC1 CANVAS/spectrum disorder — a key prognostic and counseling point, and a major discriminator from MSA (median survival ~9.3 years from onset in MSA vs. a much longer, non-life-limiting course in RFC1 disease).
Morbidity/function: Progressive disability trajectory — approximately 50% of patients require an assistive ambulatory device (e.g., cane) roughly 10 years after symptom onset; approximately 25% become wheelchair-dependent by ~15 years after onset. Falls risk is significant given combined sensory + vestibular + cerebellar deafferentation.
Quality of life: Substantially affected by chronic imbalance/fall risk, oscillopsia (which impairs reading/visual tasks during head movement), dysarthria/dysphagia in later stages, and the often years-long unexplained chronic cough that precedes diagnosis (with associated diagnostic-odyssey burden).
Complications: Falls and fall-related injury; aspiration risk from dysphagia; social/occupational impact of dysarthria and chronic cough.
Prognostic factors: No validated formal prognostic biomarker; loosely, larger repeat expansion size has been associated with earlier age of onset in some series, but no validated predictor of overall disease trajectory/severity exists. Ongoing natural-history/biomarker studies (e.g., the ARCA-registry-based global multicenter RFC1 natural history study) aim to establish quantitative outcome measures (SARA — Scale for Assessment and Rating of Ataxia; INAS — Inventory of Non-Ataxia Signs; CMTNS — Charcot-Marie-Tooth Neuropathy Score) for future trial readiness.

12. Treatment

No disease-modifying or curative treatment currently exists. Management is entirely multidisciplinary and symptomatic/supportive (per GeneReviews):

Ataxia: Physical and occupational therapy (balance/gait training, strengthening); adaptive mobility devices (canes, walkers, motorized wheelchairs); inpatient rehabilitation; home fall-prevention modification; weight management. (MAXO:0000011 physical therapy)
Vestibular dysfunction: Vestibular rehabilitation therapy — the standard of care for bilateral vestibular hypofunction generally; a CANVAS-specific case report on vestibular rehabilitation exists (ScienceDirect 2023, https://www.sciencedirect.com/science/article/pii/S167229302300048X). (MAXO term for vestibular/physical rehabilitation — verify exact MAXO ID)
Sensory neuropathy: Counseling on injury avoidance (given impaired proprioception/pain sensation); pain management rarely required.
Autonomic dysfunction: Symptomatic treatment of erectile dysfunction, urinary incontinence/retention, constipation/diarrhea, dry eyes/mouth. (MAXO:0000950 supportive care; NCIT:C15986 Pharmacotherapy as generic action term with appropriate therapeutic_agent)
Dysarthria: Speech-language therapy; augmentative/alternative communication as needed. (MAXO term for speech therapy — MAXO:0000930)
Dysphagia: Modified food consistency, videofluoroscopic/esophagographic evaluation, aspiration-risk assessment. (MAXO:0001351 occupational therapy / relevant swallowing-therapy term — verify)
Chronic cough: Proton pump inhibitors if reflux contributes; pulmonology/ENT referral for refractory neurogenic cough. (NCIT:C15986 Pharmacotherapy + appropriate therapeutic_agent for PPI, e.g., omeprazole)
Agents to avoid (iatrogenic worsening): Neurotoxic chemotherapy agents, high-dose pyridoxine, phenytoin, aminoglycosides, chronic alcohol use.

Investigational/experimental therapeutics: - Noisy galvanic vestibular stimulation and prosthetic vestibular implants are cited as promising investigational approaches for the bilateral vestibular hypofunction component (general bilateral vestibular weakness literature, Curr Treat Options Neurol 2026, https://link.springer.com/article/10.1007/s11940-026-00866-w), not yet CANVAS-specific approved therapies. - Mechanism-targeted small-molecule/G-quadruplex-ligand strategies: Structural biology work explicitly proposes that resolved G4 structures formed by pathogenic AAGGG repeats could guide rational design of small-molecule ligands or helicases to resolve the toxic secondary structure — a preclinical concept, not yet in trials (PMC10954463, PMC10563062). - No published antisense oligonucleotide (ASO), gene-replacement, or gene-editing clinical program was identified in this search for RFC1/CANVAS specifically (searches for ASO/gene therapy approaches returned no CANVAS-specific hits) — this remains an unmet therapeutic gap, consistent with the disease being explicitly described in the primary literature as "currently untreatable" (Science Advances 2024). - Natural history/biomarker study: A prospective global 2-year multicenter natural history study (ARCA registry, 31 centers) is underway to define clinical outcome measures and biomarkers in preparation for future interventional trials (Ataxia Global Initiative, https://ataxia-global-initiative.net/projects/rfc1-a-global-multicenter-multimodal-natural-history-clinical-outcome-and-biomarker-study-based-on-the-arca-registry/). The National Ataxia Foundation's CRC-SCA observational study also now includes RFC1 Ataxia/CANVAS as an eligible cohort.

Treatment strategy/algorithm: Sequential, symptom-triggered multidisciplinary referral (neurology, PT/OT, physiatry, speech-language pathology, respiratory/ENT, gastroenterology) with annual neurologic surveillance (or more frequently during acute change) using SARA and CMTNS as standardized outcome measures, per GeneReviews management/surveillance recommendations.

13. Prevention

Primary prevention: None available — this is a genetic, adult-onset disorder with no known modifiable environmental cause to intervene upon prior to disease onset.
Secondary prevention/early detection: Increasing clinical index of suspicion (screening idiopathic bilateral vestibulopathy, idiopathic chronic cough, and idiopathic late-onset ataxia/peripheral neuropathy cohorts for RFC1 expansions) shortens diagnostic delay and enables earlier supportive intervention/fall-prevention counseling, though it does not alter the underlying disease course given the absence of disease-modifying therapy.
Genetic/reproductive prevention: Genetic counseling for affected individuals, carriers, and at-risk relatives regarding autosomal recessive inheritance and pseudodominance; carrier testing of at-risk relatives once the familial pathogenic motif is known; prenatal testing and preimplantation genetic testing are technically available options for reproductive planning; DNA banking is recommended given the rapidly evolving assay landscape (RP-PCR → Southern blot → long-read sequencing).
Tertiary prevention: Avoidance of neurotoxic exposures (aminoglycosides, phenytoin, neurotoxic chemotherapy, high-dose pyridoxine, chronic alcohol) to prevent iatrogenic acceleration of neuropathy/cerebellar/vestibular injury in known or at-risk individuals; fall-prevention home modification; aspiration-risk mitigation for dysphagia.
Screening programs: No population-level or newborn screening program exists (late-onset disease); targeted cascade genetic screening within affected families is the practical current approach.

14. Other Species / Natural Disease

Naturally occurring disease in other species: No naturally occurring veterinary/wildlife CANVAS-like disease attributable to RFC1 was identified in the literature reviewed (no OMIA entry surfaced in this search). This appears to be a human-specific clinical entity as currently documented, likely reflecting both the specific human AluSx3-derived repeat locus (Alu elements are primate-specific transposons) and the recency of genetic characterization.
Orthologous gene: RFC1 is a broadly conserved gene across vertebrates (mouse Rfc1, zebrafish rfc1, and more distant orthologs in Drosophila and yeast, given its fundamental role in DNA replication/PCNA loading) — see NCBI Gene for ortholog records. No repeat-expansion equivalent is expected in these species since the pathogenic locus is a human/primate-specific Alu-derived repeat.
Comparative pathology/evolutionary conservation: The core RFC1 clamp-loader function is deeply conserved (yeast to human), underscoring why complete loss of function is developmentally lethal across species (see Section 15), while the CANVAS-causing repeat-expansion mechanism itself is a human-specific genomic event superimposed on this conserved gene.
Transmission/zoonotic potential: Not applicable — this is a genetic (non-infectious) human disease.

15. Model Organisms

Mouse: A conventional Rfc1 knockout allele (Jackson Laboratory Phenotyping Center / IMPC-type resource) is embryonic and/or pre-weaning lethal in the homozygous state, precluding straightforward modeling of the human disease (which is caused by a hypomorphic repeat-expansion allele, not complete null) via simple knockout. This lethality itself is informative: it underscores that the human CANVAS-causing repeat allele must be substantially hypomorphic/partial-function (or repeat-toxic-gain-of-function) rather than a complete null, since affected humans are viable into adulthood.
Zebrafish: To circumvent mouse embryonic lethality, a CRISPR/Cas9-generated zebrafish rfc1 loss-of-function model was developed. rfc1⁻/⁻ larvae are viable long enough (dying prematurely after ~10 days) to permit functional neurodevelopmental analysis. This model revealed a key developmental role for rfc1 in the expansion and differentiation of cerebellar granule and Purkinje cell neuronal progenitor pools (Nat Commun 2025, https://www.nature.com/articles/s41467-025-60775-5; PMC12217872) — informative for understanding baseline RFC1 neurodevelopmental biology, though it models complete loss-of-function rather than the repeat-expansion-specific toxic mechanism per se.
Drosophila: A neuronal RFC1 Drosophila model expressing the pathogenic AAGGG repeat demonstrated tissue-specific reduction in RFC1 transcript expression, impaired RFC1 function, and increased sensitivity to DNA damage — directly modeling the repeat-toxicity mechanism rather than simple gene knockout (per 2025 bioRxiv preprint, https://www.researchgate.net/publication/397733610).
Human iPSC-derived neurons (iNeurons): The most disease-relevant model to date. CANVAS patient fibroblast-derived iPSCs differentiated into neurons recapitulate defects in neuronal development and diminished synaptic connectivity; critically, CRISPR-mediated deletion of a single expanded (AAGGG) allele rescues these phenotypes, while simple re-expression of RFC1 protein does not rescue them — the key evidence for an RFC1-protein-independent, repeat-dependent toxic mechanism (Science Advances 2024, https://www.science.org/doi/10.1126/sciadv.adn2321; PMC11373605).
Model limitations: No current animal model fully recapitulates the adult-onset, multisystem (cerebellar + sensory ganglionopathy + vestibular + cough) human phenotype with the biallelic repeat expansion genotype in vivo; existing models variably capture (a) complete RFC1 loss-of-function developmental biology (mouse/zebrafish knockouts) or (b) repeat-specific molecular toxicity in a heterologous/reduced system (Drosophila, human iNeurons) — a genuine human-model-mismatch gap exists between repeat-toxicity cellular models and an in vivo repeat-expansion "knock-in" animal model reproducing the full adult neurodegenerative phenotype, which had not yet been reported as of the sources reviewed here.
Research applications: These models collectively support study of (1) normal RFC1 developmental neurobiology (granule/Purkinje progenitor expansion), (2) repeat-driven G-quadruplex/replication-stress toxicity, and (3) candidate therapeutic screening (e.g., G4-resolving small molecules, ASO/CRISPR repeat-targeting strategies) in a currently treatment-free disease.
Resources: MGI (mouse Rfc1 knockout phenotype data, IMPC), ZFIN (zebrafish rfc1 model), standard Drosophila stock/CRISPR resources, and patient-derived iPSC lines (institution-specific biobanks, not yet indexed in a large public repository per this search).

Summary Ontology Term Suggestions for KB Curation

Disease: MONDO:0044720; Orphanet ORPHA:504476; OMIM #614575
Gene: RFC1 (hgnc: — verify exact HGNC numeric ID before use, e.g. via uv run runoak -i sqlite:obo:hgnc info RFC1)
Key HP terms: HP:0001251 (Ataxia), HP:0007141/HP:0003474 (axonal sensory neuropathy features — verify most specific term for "sensory neuronopathy"), HP:0025406/vestibular dysfunction term (verify exact HPO ID), HP:0031246 (Chronic cough), HP:0001278 (Orthostatic hypotension), HP:0000639 (Nystagmus), HP:0007766 (Downbeat nystagmus), HP:0001260 (Dysarthria), HP:0002015 (Dysphagia), HP:0002380 (Fasciculations), HP:0001300 (Parkinsonism)
GO terms: GO:0006260 (DNA replication), GO:0006281 (DNA repair)
CL terms: dorsal root ganglion sensory neuron, Purkinje cell, vestibular ganglion neuron (verify exact CL IDs via OAK before curation)
UBERON terms: UBERON:0002037 (cerebellum), UBERON:0000044 (dorsal root ganglion), plus vestibular/trigeminal/facial ganglion terms (verify exact IDs)
MAXO terms: MAXO:0000011 (physical therapy), MAXO:0000950 (supportive care), MAXO:0000930 (speech therapy), NCIT:C15986 (Pharmacotherapy, for PPI/symptomatic drugs)

Important curatorial note (NEC risk): Given that "CANVAS" and "RFC1 disease" nomenclature has evolved rapidly (2019–2025) and overlaps phenotypically with MSA, SCA3, Friedreich ataxia, and idiopathic bilateral vestibulopathy, curators should verify the MONDO:0044720 gene/OMIM anchors (RFC1, OMIM #614575/*102579) against any deep-research output before use, per the project's Named Entity Confusion preflight protocol.

Ask OpenScientist

OpenScientist Report

Mappings

Inheritance

Mechanistic Hypotheses

Discussions and Knowledge Gaps

Pathophysiology

Histopathology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Progression

Prevalence

Differential Diagnoses

Clinical Trials

Experimental Models

Animal Models

Source YAML

References & Deep Research

References

Deep Research

CANVAS (Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome) / RFC1-Related Disease: Comprehensive Research Report

1. Disease Information

2. Etiology

3. Phenotypes

4. Genetic/Molecular Information

5. Environmental Information

6. Mechanism / Pathophysiology

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome/Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Summary Ontology Term Suggestions for KB Curation

Sources